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Summary 
 
The present work is focused on the development of nanocomposite systems for biomedical applications 
and has been carried out in the framework of the European Project called “Newbone” (EU-FP6); in 
particular, the main goal of the thesis was to realize biocompatible coatings for orthopedic prosthesis 
endowed with antimicrobial properties. Nanocomposite systems based on a chitosan-derived 
polysaccharide (Chitlac) that stabilizes metal nanoparticles (silver and gold) have been prepared in 
colloidal solutions which possess broad spectrum antibacterial properties. As a complementary work, it 
was studied and defined a particular chemical mechanism of silver ions reduction carried out by the 
lactose moieties of Chitlac; the optical properties of the metallic nanoparticles obtained through this 
mechanism were tested by means of Raman spectroscopy, thus detecting considerable enhancements of 
the signal due to the SERS effect (Surface Enhanced Raman Scattering). Given the better biological 
properties of silver-based systems (Chitlac-nAg) with respect to gold in terms of antimicrobial efficacy 
and biocompatibility, only the former metal was chosen in the following steps towards the preparation of 
the nanocomposite coating for the prosthesis. Studies on the biocidal mechanism of the Chitlac-nAg 
solution ascribed the activity to the interaction metal-bacteria membrane. On the other hand, since the 
lack of physical barriers to nanoparticle diffusion into eukaryotic cells determines the risk of a massive 
uptake with cytotoxic outcomes, we focused our attention toward the preparation of Chitlac-based three-
dimensional structures entrapping silver nanoparticles. To this end, the gel forming properties of the 
polysaccharide alginate were exploited allowing the production of a semi-solid system in a mixture with 
Chitlac-nAg: this material displays potent antibacterial properties without showing cytotoxic effects 
towards eukaryotic cells, as verified by in vitro and in vivo tests.  Such result was particularly important 
in relation to the state of the art in this research field. Since the core material of the prosthesis is made of 
methacrylic thermosets, in order to coat this substrate material we have devised a technique based on 
surface activation followed by deposition of the Chitlac-based layer. Such technique allows obtaining a 
nanocomposite coating where silver nanoparticles are entrapped within the Chitlac matrix. This bioactive 
layer endows the thermoset surface with considerable antimicrobial properties, as bacteria are rapidly 
killed upon direct contact with the material. At the same time, in vitro tests proved that eukaryotic cells 
adhere and proliferate on the nanocomposite coating, which indicates the possibility to have good 
integration of the material in the tissues surrounding the implant. The combination of these properties 
determined the choice of our coating for the final in vivo test in a minipig model as a conclusion of the 
European project; this test is in progress at the moment and it will hopefully confirm the encouraging 
studies in vitro. 
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Sommario 
 
Questo lavoro riguarda lo sviluppo di materiali nanocompositi per applicazioni biomediche e si configura 
all’ interno del progetto europeo “Newbone” (EU-FP6); in particolare, lo scopo principale della tesi era 
realizzare un rivestimento biocompatibile e dotato di proprietà antibatteriche per protesi ortopediche. 
Sono stati preparati sistemi nanocompositi basati su un polisaccaride derivato dal chitosano (Chitlac) che 
permette di ottenere soluzioni colloidali di nanoparticelle (argento e oro) con proprietà antibatteriche. 
Parallelamente, è stato studiato un particolare meccanismo chimico di riduzione degli ioni argento ad 
opera dei residui di lattitolo del Chitlac; le proprietà ottiche delle nanoparticelle ottenute attraverso questo 
meccanismo sono state valutate attraverso spettroscopia Raman, evidenziando la possibilità di avere un 
incremento del segnale grazie al verificarsi dell’ effetto SERS. Essendo state riscontrate migliori proprietà 
biologiche del sistema a base di argento (Chitlac-nAg) rispetto a quello a base di oro in termini di 
efficacia antimicrobica e biocompatibilità, Chitlac-nAg è stato scelto per i successivi studi di 
realizzazione del rivestimento per la protesi. Test sul meccanismo antimicrobico della soluzione Chitlac-
nAg hanno dimostrato l’interazione tra le nanoparticelle e la membrana batterica. Allo stesso tempo, 
poiché la mancanza di barriere fisiche può favorire la diffusione delle nanoparticelle all’ interno delle 
cellule eucariote con rischio di effetti citotossici causati dalla loro internalizzazione, si è voluto realizzare 
delle strutture tridimensionali a base di Chitlac in grado di intrappolare le nanoparticelle. A questo scopo, 
sono state sfruttate le proprietà di gelificazione del polisaccaride alginato in modo da ottenere un sistema 
semi-solido in miscela con Chitlac-nAg; il materiale ottenuto possiede marcate proprietà antibatteriche 
senza però risultare tossico per le cellule eucariote, come dimostrato da test in vitro e in vivo. Questo 
risultato è particolarmente importante in relazione allo stato dell’ arte sull’ argomento. Poiché la parte 
portante della protesi è costituita da un polimero metacrilico, al fine di rivestire questo materiale di 
substrato è stata messa a punto una tecnica basata sull’ attivazione della superficie e successiva 
deposizione del rivestimento a base di Chitlac. Questa tecnica permette di ottenere un rivestimento 
nanocomposito costituito da nanoparticelle di argento incorporate nella matrice di Chitlac. Grazie a 
questo strato bioattivo la superficie della protesi acquisisce un’ efficace attività antibatterica che si 
manifesta quando i batteri entrano in diretto contatto con il materiale. Inoltre, test in vitro hanno 
dimostrato che le cellule eucariote aderiscono e proliferano sul rivestimento nanocomposito, suggerendo 
quindi una buona integrazione del materiale nei tessuti attorno all’ impianto. La combinazione di tali 
proprietà ha determinato la scelta di questo rivestimento per il test in vivo su “minipig” a conclusione del 
progetto europeo: questo test è al momento in via di svolgimento e da esso ci si può attendere una 
conferma degli incoraggianti risultati ottenuti dagli studi in vitro. 
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ARTICLE PUBLISHED ON THE NANOTECHNOLOGY PORTAL 
 “NANOWERK” 
 
 
  
NANOWERK SPOTLIGHT 
(http://www.nanowerk.com/spotlight/spotid=11406.php)   
Posted: June 29, 2009  
 
“How to make nanosilver non-cytotoxic with sugar “ 
(Michael Berger) 
 
This on-line article posted on the website www.nanowerk.com was based on the scientific results 
discussed by the author in Paper 2 (Travan et al., “Non-cytotoxic Silver Nanoparticle-
Polysaccharide Nanocomposites with Antimicrobial Activity”.  Biomacromolecules 2009, 10, 
1429–1435). 
. 
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1. INTRODUCTION 
 
1.1 SILVER NANOCOMPOSITES 
 
By definition, nanocomposites are materials containing domains or inclusions that are of 
nanometer size scale[1]. Nanocomposite materials that exploit the properties of silver at the 
nanoscale for biomedical applications are of increasing interest in the scientific literature (Figure 
1)  and today they can be found in many commercial products, like wound dressings and creams. 
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Figure 1. Publication counts derived from the Thompson ISI Web of Science database on October 2009, using the 
key    word “silver nanocomposites”.  
 
 
The idea behind these novel materials is that silver at the nanometer scale displays unique 
properties that can be used for different purposes, ranging from antimicrobial to optical and 
catalytic applications[2;3]. 
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1.2 PREPARATION AND CHARACTERIZATION OF SILVER 
NANOCOMPOSITES 
 
1.2.1 Preparation Techniques 
Since silver nanocomposite constructs are meant to exploit the properties of silver at the nano-
scale,  many efforts are aimed at finding efficient and reproducible routes to produce silver 
nanoparticles (hereafter AgNPs). Many potential uses for these novel materials are being 
explored, ranging from antimicrobial purposes to molecular imaging.  
When preparing homogeneous nanocomposite materials containing AgNPs, a crucial issue is the 
tendency of nanoparticles to aggregate, which leads to the loss of the peculiar properties 
associated with the nano-scale. For instance, in the antimicrobial field, studies by Lok et al.[4] 
revealed that non-stabilized AgNPs prepared by standard chemical methods (reduction of silver 
salt solutions) tend to aggregate in culture media and biological buffers which have high salt 
contents (chloride and phosphate being considered the most problematic anions): the aggregation 
leads to a decrease in the effective surface of the nanoparticles or the degree to which they can 
associate to bacteria.  
The so called “ex situ” preparation methods consist in the synthesis of nanoparticles as a first 
step, and then in mixing the pre-formed nanoparticles with a matrix (typically a polymer); 
however with this conventional technique it is difficult to disperse homogeneously the 
nanoparticles[5]. At variance, an “in situ” approach aims at synthesizing the nanoparticles within 
a suitable matrix in order to achieve a homogeneous dispersion in the composite materials. 
To date, the preparation and stabilization of metal nanoparticles represent an open challenge. The 
methods for preparing non-aggregated AgNPs for biomedical applications can be divided into 
two groups[6]: 
 
• wet chemical synthesis in the presence of a reducing agent and a stabilizing agent; 
• synthesis through physical processes  
 
The chemical approach is based on the use of a silver salt in an aqueous environment; silver ions 
are then reduced to zeroth-valent silver in the presence of a stabilizing agent in order to limit 
aggregation of the so-formed nanoparticles. The stabilizing agent is meant to cap the particles 
and prevent further growth. The most accepted mechanism for the synthesis of a particle 
suggests a two-step process, i.e., nucleation followed by successive growth. In the first step, part 
of the metal ions in solution is reduced by a suitable reducing agent. The atoms thus produced 
 15 
act as nucleation centres and catalyze the reduction of the remaining metal ions present in the 
bulk solution. The atomic coalescence leads to the formation of metal clusters whose dimensions 
can be controlled by ligands, surfactants or polymers; in the absence of a stabilizer, clusters in 
aqueous solution undergo further growth leading ultimately to precipitation of the metal[7]. 
Polymers and more generally many organic molecules can bind to the particle surface and thus 
serve the role of stabilizer. In general, the stabilization of metal nanoparticles is explained by the 
electronic interaction of the polymer functional groups with the metal particles. In fact,  
nucleophilic groups can bind the metal particles by donating electrons[8]. A common approach 
to prepare stable AgNPs involves the use of polymer solutions: to this end, a variety of polymers 
can be used, ranging from synthetic to natural ones. Nitrogen-containing stabilizing polymers, 
such as poly-(ethyleneimine) and poly(vinylpyrrolidone), act via lone electron pairs. Protective 
polymers can coordinate metal ions before reduction, forming a polymer-ion complex; such a 
complex can then be reduced under mild conditions, resulting in metal particles of smaller 
dimensions and a narrower size distribution than those obtained without protective polymers[9]. 
Once the reduction occurred, the stabilizing effect of these macromolecules is attributable to the 
fact that either the particles are attached to the much larger protecting polymers or the protecting 
molecules cover or encapsulate the metal particles[10]. This chemical approach can be 
generalized in Figure 2. 
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Figure 2. Preparation of AgNPs in the presence of a stabilizing polymer (wet synthesis) 
 
In particular, owing to the presence of many different functional groups, polyelectrolytes are 
successfully used in the preparation of stable AgNPs. Polyelectrolytes at low concentrations 
(such as polyphosphate, polyacrylate, poly-(vinyl-sulfate), poly-(ethylene-imine)[2;11;12], poly-
(allyl-amine)[10], and chitosan[13-15]) have been used with different outcomes to stabilize 
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nanoparticles preventing the growth of aggregates. As already mentioned, poly-(vinyl-
pyrrolidone)[5;16], a neutral polymer, has been widely used for the stabilization of silver 
nanoparticles. It must be noticed that in order to find applications in the field of biomaterials, 
both the stabilizing and the reducing agents must not represent a biological hazard[17]. 
Considering the reduction step, various exogenous agents can be used, such as ascorbic 
acid[18;19], sodium borohydride[20], sodium citrate[21;22], alcohols[23], hydrogen[24], 
polyols, hydroxyalkyl radicals, and aldehyde groups of reducing sugars[25-27]. For a “green 
synthesis” of nanoparticles[28], reducing saccharides can be used as non-toxic and 
environmental-friendly reducing agents. In this case the synthesis is based on a Tollens reaction 
that involves the reduction of a silver ammoniacal solution with a reducing sugar (e.g., glucose, 
maltose, xylose…)[29].  
By the choice of the stabilizer and the reducing agent, one can control the growth process and 
manipulate shape and size of the metal nanoparticles in the nanocomposites. For instance, a 
lactose-substituted chitosan (1-deoxylactit-1-yl chitosan, shortly named “Chitlac”) was 
successfully used to prepare stable silver nanoparticles using this particular polymer either as 
stabilizing agent only, or as both reducing and stabilizing agent at the same time[30;31]. In the 
first case, the nanoparticles are obtained in a polysaccharide solution with silver ions reduced by 
ascorbic acid (C6H8O6) according to the following stoichiometry[32;33]: 
 
2Ag+ + C6H8O6                                    2Ag0     +     C6H6O6     +     2H+ 
 
The nanoparticles thus obtained were mostly round-shaped and well dispersed with an average 
diameter of 30 nm as revealed by image analysis based on transmission electron micrographs. 
This polysaccharide acts as an efficient stabilizing ligand for silver ions and AgNPs thanks to the 
presence of amino groups. Esumi et al.[34] demonstrated that metal nanoparticles can be 
protected by the exterior amino groups of dendrimers which act as stabilizers. 
Huang et al.[35]discussed the preparation of silver-chitosan nanocomposites obtained by 
chemical synthesis from a chitosan solution in the presence of AgNO3 reduced by NaBH4; the 
evaporation of the solvent in this colloidal solution brings to the formation of a nanocomposite 
film. The morphology of the film shows a rod-like structure, whose formation is attributed to the 
presence of the silver clusters that act as an accelerant to the precipitation of polymer crystallites.  
Silver nanocomposites can be prepared in the form of nanofibres by means of the electrospinning 
technique, a process by which a suspended droplet of polymer solution is charged to high voltage 
to produce fibres with a diameter typically smaller than 500 nm. If the solution contains AgNPs 
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stabilized by the polymer, it is possible to obtain nanocomposite fibres. Wang et al.[5] 
successfully prepared AgNPs through reduction of AgNO3 by ethanol in PVP/ethanol solution 
and managed to obtain nanocomposite fibres with AgNPs smaller than 10 nm. 
The need to obtain antimicrobial coatings and films can be fulfilled by incorporating AgNPs into 
polymeric matrixes by means of the so-called “layer-by-layer” technique. This is a simple and 
straightforward approach based on the alternate deposition on a substrate of layers of 
polyelectrolytes with opposite charges through a dipping process (Figure 3, left).  
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Figure 3. Left) Schematics of the layer-by-layer self-assembly procedure for creating polymeric thin films, adapted 
from Grunlan et al. (2005). Right) TEM image of a silver-PEI-PAA film that shows the dispersion of  spherical 
AgNPs with a mean diameter of 4 nm. From Dai et al. (2002), reproduced with permission. 
 
The dipping process is repeated until a desired number of layers is obtained, each layer having a 
thickness in the range of a few nanometers. With this method it is possible to incorporate in one 
or more layers bioactive agents like silver. According to this approach, Grunlan et al.[36] 
prepared polyelectrolyte multilayers using silver nitrate and/or cetrimide (antiseptic agent) as 
antimicrobial agents. The films were prepared by alternately dipping poly(ethylene terephtalate) 
(PET) substrate into solutions of poly(acrylic acid) (PAA) and poly(ethylene imine) in mixture 
with the bioactive agents. Dai et al.[2] followed the layer-by-layer approach to obtain 
multilayered polyelectrolyte films that incorporate homogeneously dispersed AgNPs; in this 
work a polyethyleneimmine (PEI) solution was used to prepare stabilized silver ions from 
AgNO3. Then, the alternated deposition on a substrate of the PEI-silver layer and of a 
poly(acrylic acid) (PAA) solution followed by reduction with NaBH4 led to the formation of a 
multilayered film based on the two oppositely charged polysaccharides containing finely 
dispersed AgNPs (Figure 3, right). 
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Multilayers can be fabricated by means of the layer-by-layer technique not only on planar 
substrates, but also on three-dimensional templates. In the case of a spherical template, its 
eventual dissolution after the film formation allows obtaining multlayered capsules that can 
embed bioactive agents like AgNPs; Choi et al.[37]synthesised polyelectrolyte capsules with two 
types of nanoparticles embedded: AgNPs for the antimicrobial activity and goethite 
nanoparticles to endow the capsules with the possibility to be moved by external magnetic fields. 
The capsules were prepared by means of copolymerized polyelectrolytes composed of 
poly(styrene sulfonate) (PSS) and poly(acrylic acid) (PAA) in addition to poly(allylamine 
hydrochloride) (PAH). Then, metal ions were loaded from aqueous solution into the capsules and 
were finally let react to create the two different types of nanoparticles. Ho et al.[38]developed a 
nanocomposite film where a polymer network based on poly(ethylene imine) derivatized with 
double bonds was copolymerized with 2-hydroxyethyl acrylate; after a UV-initiated 
polymerization the film was loaded with silver ions that were subsequently reduced to form 
AgNPs. After immersing the film in AgNO3 solution, the chemical reduction of Ag+ complexed 
within the polymer network occurred by treating the film in ascorbic acid solution until the film 
turned to yellowish-brown, which suggests the formation of well dispersed nanoparticles. 
Polyols can be used as reducing agents for silver ions: in this case, the silver-reduction 
mechanism typically involves a heat treatment. Wiley et al.[39;40] prepared AgNPs with 
different shapes (quasi-spherical particles, single-crystal cubes, tetrahedrons, rods, triangular 
nanoplates, nanowires with pentagonal cross sections, twinned structures…) by reducing AgNO3 
with ethylene glycol at high temperature in the presence of PVP.  
 
 
Figure 4. Schematic showing the reduction of silver ions by ethylene glycol (I); the formation of silver clusters (II); 
the nucleation of seeds (III); and the growth of seeds into nanocubes, nanorods or nanowires, and nanospheres (IV). 
From Wiley et al. (2005), reproduced with permission. 
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These studies showed how the crystallinity of seeds was determined by the molar ratio between  
the capping agent (PVP) and AgNO3 as well as by the strength of the chemical interaction 
between the polymer and various crystallographic planes of silver (Figure 4). 
Silver nanocomposites can be prepared using polymeric dendrimers as stabilizing agents. In fact 
dendrimers are branched macromolecules that possess architecture and ligand sites that allow the 
pre-organization of metal ions and an effective stabilization of silver owing to the formation of 
stable complexes at atomic/molecular level dispersion. Balogh et al.[41] discussed the 
preparation of silver complexes within poly(amidoamine) dendrimers for antimicrobial 
applications. Kuo et al.[10] reported the formation of AgNPs stabilized in pseudo-dendritic 
poly(allylamine) derivates. 
Following the same strategy, other organic macromolecules can be used to stabilize AgNPs: for 
instance Lok et al.[42] reported the preparation of antimicrobial AgNPs stabilized by bovine 
serum albumin (BSA). 
Inorganic stabilizers are also being explored for the preparation of silver nanocomposites. Su et 
al.[43] prepared AgNPs immobilized within inorganic phyllosilicate clays in order to obtain 
nanohybrids exploiting an ion exchange between Ag+ (provided by AgNO3) and  Na+ from the 
clay, followed by in situ reduction of silver ions by methanol at 80°C. In this case the 
nanoparticles thus formed are free of polymeric surfactants and have a narrow size distribution 
with an average diameter around 30 nm (Figure 5).  
 
 
Figure 5. Silver nanoparticles dispersed on silicate clay. (A) The surface structure of the AgNP/Clay is characterized 
by Field-Emission SEM. (B) Representations of the nanocomposite structure. From Su et al. (2009), reproduced 
with permission. 
 
Silver nanocomposites can be obtained in the form of bioceramics in order to endow 
osteoconductive materials with antimicrobial properties. Rameshbabu et al.[44] prepared silver-
substituted hydroxyapatite nanocrystals by microwave processing. 
Although the conventional chemical synthesis represents to date the most popular approach for 
the preparation of silver nanocomposites, other techniques are being explored which are based 
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on physical processes. A promising technique is the radiolytic method  used for the generation of 
AgNPs in solution; with this technique, radiolytically generated species, solvated electrons and 
secondary radicals, exhibit strong reducing potentials towards metal ions. Krkljes et al.[45] 
reported the preparation of Ag-PVA nanocomposites by radiolytic procedure using steady state 
gamma irradiation. 
Alternatively, ablation of a metal surface immersed in a liquid can produce nanoparticles of the 
metal in the liquid. In the laser ablation technique metal atoms and small metal clusters are 
ablated from a metal rod by laser irradiation; self-aggregation of the nanoparticles suspended in 
the liquid can be prevented by hindering direct contact of the nanoparticles by means of a 
surfactant. Mafunè et al.[46] performed the preparation of AgNPs by laser ablation against a 
silver plate in an aqueous solution of sodium dodecyl sulphate. 
Photochemical methods can be used to prepare polymer-stabilized AgNPs[47]. Mallick et al.[48] 
prepared colloidal silver under UV photo irradiation of silver nitrate solution in the presence of 
methoxy poly(ethylene glycol) which acts as a reducing and stabilizing agent. 
Further interesting routes to prepare silver nanocomposites are sonochemical treatments[49], 
potentiostatic and galvanostatic methods[50], vapour deposition[51], microwave irradiation[52], 
electron beam irradiation[53], synthesis templated by DNA[54], Langmuir-Blodgett-based 
techniques [55], ion implantation, sputtering, vapor-phase co-deposition, and vacuum co-
condensation[56]. 
 
1.2.2 Characterization Techniques 
The characterization of silver nanocomposites can be performed by means of different 
techniques; the most important ones are spectroscopic techniques (UV-Vis, infrared and X-ray 
photoelectron spectroscopy), X-ray diffraction and microscopic techniques (TEM, SEM, Dark-
Field, AFM, NSOM). 
In the chemical synthesis, colloidal solutions of AgNPs are obtained upon reduction of Ag+ to 
the metal atom and consecutive coalescence of atoms yelding larger particles. The transition 
from atom to metal nanoparticle can be studied by pulse radiolysis techniques[57;58]. When a 
sufficient number of atoms coalesce, the particles start to display a typical property called 
“Surface Plasmon Resonance”, which is produced by a collective excitation of all the free 
electrons in the particles[59]. Under the influence of the electric field due to the incoming light, 
the movement of electrons leads to a dipole excitation across the particle sphere that makes the 
electrons oscillate (Figure 6, left).  
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Figure 6. Left) Polarization of a spherical metal particle by the electrical field vector of the incoming light. Adapted 
from Henglein (1993). Right) A plasmon resonance band in the UV-Vis spectrum accounts for the presence of 
metallic nanoparticles. 
 
The electron density within a surface layer (a few angstroms thick) oscillates, while the density 
in the interior of the particle remains constant. When the condition of resonance is reached, the 
UV-Vis spectrum displays an intense absorption band called “Surface Plasmon Resonance 
Band” (Figure 6, right). A symmetrical shape of the plasmon band suggests that the 
nanoparticles are well dispersed and spherical[10]. At variance, the aggregation of nanoparticles 
leads to a broader plasmon band, with a red-shifted maximum[60]. A systematic study on the 
formation of silver nanoparticles by absorption spectroscopy was tackled by Henglein[61] who 
reported the preparation of AgNPs from AgClO4 solutions at a fixed concentration and studied 
the variations of the UV-Vis spectra as a function of the concentration of sodium citrate used as 
both reducing and capping agent. The UV-Vis spectra suggested that sodium citrate plays a 
drastic effect on the formation of AgNPs with different size; in fact according to its 
concentration it can determine the formation of well stabilized AgNPs or the coalescence of 
poorly stabilized polycrystallites. 
Excess charge carriers influence the wavelength of the plasmon resonance band; a blue shift of 
the plasmon peak occurs upon electron donation to the particles, while a red shift occurs upon 
injection of positive holes into the particles. Furthermore, chemical modification on the surface 
of the particles, like interaction with organic molecules, strongly affects the plasmon absorption 
band.  
Anions able to form complexes or insoluble salts with silver ions are strongly adsorbed on silver 
particles. Also the Fermi level floats upon chemisorption, depending whether the adsorbed 
molecule is nucleophilic or electrophilic. A surface atom carrying an adsorbed nucleophile 
molecule acquires a slightly positive charge (“preoxidation state”); the excess electron density is 
simultaneously transferred into the metal particle. Thus, the chemisorption of a nucleophile is 
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accompanied by a shift of the Fermi potential to a more negative value. AgNPs are highly 
sensitive to oxygen, resulting in the formation of partially oxidized AgNPs with chemisorbed 
Ag+ on the surface. In the absorption spectra this partial oxidation leads to a red-shift of the 
surface plasmon resonance band, according to the following equation[62]: 
 
λ = λ 0(1 + [Ag+]/[Ag])1/2 
 
where λ0 is the wavelength of the plasmon peak before oxidation, and λ after oxidation. 
 
Lok et al.[63] reported that borohydride reduced (zeroth-valent) AgNPs in the presence of citrate 
exhibit a surface plasmon resonance peak at 375 nm, while subsequent exposure to oxygen led to 
a rapid shift of the absorption peak to 398 nm, with broadening of the band width and lowering 
of the maximum absorption. These changes in the absorption spectrum can be attributed to the 
partial oxidation of the nanoparticles with the formation of chemisorbed Ag+ on their surface, 
indicating the sensitivity of AgNPs to oxygen. Further addition of borohydride induced a shift in 
the plasmon resonance band to the intensity and shape of non-oxidized zeroth-valent 
nanoparticles. It is important to notice that the presence of oxidized (or partially oxidized) atoms 
on the surface of the nanoparticle affects its biological properties, as discussed in chapter 3.4. 
Infrared spectroscopy (IR) can provide information about the interaction (chemical bonding) 
between the nanoparticles and the matrix in a silver nanocomposite structure. Krkljes et al.[64] 
carried out IR analysis to point out the interaction between AgNPs and PVA chains via its OH 
groups. By means of Fourier Transform IR Dai et al.[2] characterized poly(acrylic 
acid)/polyethyleneimine-silver nanocomposites in order to evaluate the influence of silver 
reduction on the polymer matrix and Zhang et al.[65] verified the formation of coordination 
bonds between the amino/amide groups of a poly(amidoamine) derivative and AgNPs.  
Transmission Electron Microscopy (TEM) is commonly used to investigate size, structure 
(crystallography, existence of twin planes, stacking faults…) and dimensional distribution of 
AgNPs. Wiley et al.[40;66] carried out TEM investigations to study a polymer-mediated polyol 
process that allows for the preparation of silver nanostructures with a number of different 
morphologies (e.g., cubes, rods, wires, and spheres) as reported in Figure 7.  
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Figure 7. TEM characterization of AgNPs with different morphologies obtained  by polyol synthesis. From Wiley et 
al. (2005), reproduced with permission. 
 
Wang et al.[67] prepared polyelectrolyte multilayer films containing AgNPs and evaluated the 
distribution of the particles in the polymer matrix by means of cross-sectional TEM imaging. 
The pictures show spherical particles uniformly and randomly distributed throughout the film 
(Figure 8, left). 
 
 
Figure 8. Left)  Cross-sectional TEM image of a polyelectrolyte multilayer containing AgNPs. From Wang et al. 
(2002), reproduced with permission. Right) FE-SEM image of AgNPs obtained by polyol synthesis. The main 
image shows truncated cubes (indicated by an octagon) and truncated tetrahedrons (indicated by a hexagon), while 
the insets show the convergent beam electron diffraction patterns showing that these particles are single crystals. 
From Wiley et al. (2004), reproduced with permission. 
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Metal nanocomposites have been studied by means of Scanning Electron Microscopy (SEM), 
especially equipped with field-emission guns (FE-SEM) that allow avoiding the sputtering step 
of conventional SEM which could cover or affect the nanoparticles on the surface of the 
nanocomposite material[68;69]. Wiley et al.[70] carried out a polyol synthesis of AgNPs whose 
structure was analysed by FE-SEM: the images proved the formation of single-crystal, truncated 
cubes and tetrahedrons (Figure 8, right). 
Among other techniques, Atomic Force Microscopy (AFM) is a useful means to characterize the 
morphology of nanocomposites materials containing a dispersion of nanoparticles[71;72]. 
Deshmukh et al.[73] explored by AFM the surface and bulk morphology of poly(methyl 
methacrylate) (PMMA) nanocomposite films containing AgNPs. Figure 9 (left) shows AFM 
image of the nanoparticles on the surface of the polymer film. 
 
             
Figure 9. Left) AFM image and size distribution of silver nanoparticles dispersed in a PMMA film. The x-axis 
corresponds to the size of the protruding nanoparticles covered by the PMMA layer. From Deshmukh et al. (2007), 
reproduced with permission. Centre and Right) TEM image of a cross section and AFM (phase mode) image of the 
surface of poly(ethylene imine)-based films containing silver nanoparticles. From Ho et al. (2004), reproduced with 
permission. 
 
Ho et al.[38]compared AFM and TEM techniques to characterize nanocomposite films based on 
poly(ethylene imine) and AgNPs. AFM images in the phase-contrast mode show the dispersion 
of nanoparticles that appear as bright spots on the surface of the film, while the corresponding 
TEM image of a cross-section of the film indicates the presence of non-aggregated nanoparticles 
with a size that ranges from 4 to 50 nm (Figure 9, centre and right). 
The crystallographic structure of AgNPs formed within a matrix can be studied by means of 
XRD. Wang et al.[5] used such technique to carachterize Ag/PVP nanocomposite films: the 
XRD pattern revealed the presence of face-centred cubic (fcc) nanocrystals formed within the 
polymer matrix.  
X-ray photoelectron spectroscopy (XPS) is a surface chemical analysis technique that can be 
used to analyze silver-nanocomposite materials. XPS was used by Zeng et al.[74] to characterize 
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polymer films (poly(styrene) and acrylonitrile–styrene copolymer) filled with silver 
nanoparticles: this technique pointed to the existence of charge transfer interaction between 
AgNPs and acrylonitrile segments, while no obvious interaction between silver and styrene 
segments was found. Stofik et al.[75]prepared silver-dendrimer nanocomposites for 
immunosensors application and confirmed with XPS the synthesis of AgNP. XPS studies on 
PVP-silver nanocomposite fibres showed the interaction between silver and the carbonyl oxygen; 
this strong Ag:O coordination can prevent AgNPs from aggregation within the polymer 
matrix[5]. 
Silver nanoparticles are extremely bright and can be directly observed using dark-field single 
nanoparticle optical microscopy and spectroscopy; with this technique Lee et al.[76] 
characterized AgNPs embedded in zebrafish embryos for studying their transport, 
biocompatibility, and toxicity in real time. Lu et al.[77] reported dark-field images of a high-
density nanocomposite film obtained from poly (N-isopropylacrylamide) and AgNP.  
Silver nanocomposites have also been characterized by means of Near-Field Scanning Optical 
Microscopy (NSOM), a microscopic technique that allows a surface inspection with high spatial, 
spectral and temporal resolution overcoming the far-field resolution limit by exploiting the 
properties of evanescent waves. Zhou et al.[78] studied the dispersion of AgNPs in polymer 
films containing azo groups by NSOM. 
All the above mentioned techniques are the most widely used means of characterization for 
biomedical silver nanocomposites. Nevertheless, other techniques can provide valuable 
information regarding this new class of materials; to name a few, DSC[79], TGA[80], Dynamic 
Light Scattering[81;82] and Zeta Potential measurements[83] can also provide a deeper insight 
into some specific properties of the constructs, like thermodynamic properties and thermal 
stability, size, surface charge and diffusion. 
 
 
1.3 BIOMEDICAL APPLICATIONS 
 
1.3.1 General considerations 
Nanoscale materials have emerged as novel bioactive agents thanks to their unique physical-
chemical properties and their high surface area-to-volume ratio. A large interest in silver-based 
nanocomposites is due to silver biocidal properties[84;85]. In fact, silver has been extensively 
used to control infections since ancient times. For centauries it has been in use for the treatment 
of burns and chronic wounds. In the 1940s penicillin was introduced and the use of silver for the 
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treatment of bacterial infections diminished. In 1968 silver nitrate was combined with 
sulphonamide to obtain silver sulfadizine cream to treat burns[86]. Nowadays antibiotic-resistant 
bacterial strains have become a major issue in public health care and this is why silver-based 
nanocomposites in a variety of forms (i.e. wound dressings, coated medical devices, hydrogels) 
have made a tremendous comeback for anti-infective applications[87]. Silver-based medical 
products, ranging from topical ointments and bandages for wound healing to coated stents, have 
been proven to be effective in retarding and preventing bacterial infections[88].  
Improvements in the development of novel silver nanoparticles-containing products are 
continuously sought. In particular, there is an increasing interest towards the exploitation of 
silver nanoparticles technology in the development of new bioactive biomaterials, aiming at 
combining the unique antibacterial properties of the metal at the nano-scale with the performance 
of the biomaterial[10;89-92]. Silver containing nanomaterials represent a promising strategy to 
combat infections related to indwelling medical devices like catheters, stents and bone 
prosthesis. These infections are the fifth leading-cause of hospital patients’ death it the US[93].  
Although silver is known and used primarily for its antibacterial properties, silver nanoparticles 
have been shown to exhibit also promising antiviral and antifungal properties. AgNPs exert 
cytoprotective activities towards HIV-infected T-cells by inhibiting the in vitro production of 
extracellular virions. It is hypothesized that the direct interaction between these nanoparticles 
and double-stranded DNA of HBV viral particles is responsible for their antiviral 
mechanism[94]; however, the effects of silver nanoparticles towards other kinds of viruses 
remain largely unexplored.  
Although antifungal drug resistance does not seem to be as much of a problem as resistance to 
antibacterial agents in bacteria, one long-term concern is that the number of fundamentally 
different types of antifungal agents that are available for treatment remains extremely limited. 
There is an inevitable and urgent medical need for drugs with novel antifungal mechanisms. In 
the last years attention has been focused on the potential use of silver as an antifungal agent. 
Experimental results evidence that AgNPs exhibit potent antifungal effects on tested fungi, 
probably through destruction of membrane integrity[95-97].  
 
1.3.2 Overview of in vitro results 
This section overviews the most promising applications of silver nanocomposites as biocidal 
systems developed during the last few years. Silver-based materials are generally considered as 
good candidate for coating medical devices and many recent literature data deal with the 
preparation of nanocomposite-coatings based on polymers and silver nanoparticles. As it will be 
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discussed in chapter 3.4, the mechanism by which silver-based materials exert biocidal activity is 
only partially understood; this fact often leads to different interpretations of experimental results. 
For this reason, the results and discussions summarized in this paragraph in some cases may 
appear conflicting. For central venous catheter (CVCs) applications, Stevens et al.[98] reported 
the use of various hydrophilic polymer coatings loaded with silver nanoparticles in order to 
assess both the antimicrobial efficacy and the impact of silver on the coagulation of contacting 
blood. The roll-plate assay[99] showed that bacteria inhibition begins when silver ions released 
from the nanoparticles into the suspension exceeds 100 nM and no bacteria are found for Ag+ 
concentrations higher than 10 µM. On the other hand, thrombin generation and platelet 
activation starts at Ag+ concentrations higher than 100 µM. Interestingly, thrombin generation 
can occur also upon activation of blood platelets through collision (direct contact) with silver 
particles exposed on the surface, so it was suggested that the use of silver nanocomposite 
coatings for CVCs may enhance thrombus formation. Su et al.[100] successfully prepared 
AgNPs/Clay nanocomposites and by inductively coupled plasma mass spectrometry (ICP-MS) 
analysis showed that the immersion of the nanocomposite in water at 0.1 wt% after 
centrifugation causes a release of silver ions of only 139 ppb. A nanocomposite concentration of 
0.05 wt% was enough for a complete inhibition of S. aureus, S. pyogenes, P. aeruginosa and E. 
coli. It must be noticed that the solution obtained from 0.5 wt% dispersion after centrifugation of 
the slurry was not effective for the inihition of S. aureus. This fact means that in this case 
AgNPs, and not the released Ag+, appear to be involved in the antibacterial mechanism. In the 
case of multilayered nanocomposites, Dai et al.[2]demonstrated that their film based on the 
alternated deposition of poly(ethylene imine) and poly(acrylic acid) including AgNPs was 
effective in inhibiting E. coli growth. Remarkably, the effect was the same when the film 
contained silver ions or when it contained AgNPs; the latter case may be more desirable because 
it should minimize the amount of Ag+ absorbed in the body. Grunlan et al.[101]prepared a 
multilayered film based on poly(acrylic acid) and poly(ethylene imine) containing silver ions and 
cetrimide (an organic quaternary ammonium molecule) as antimicrobial agents. The biocidal 
activity was studied by means of the Zone Of Inhibition (ZOI) test with E. coli and S. aureus. It 
was shown that such materials were effective in preventing bacteria growth and the antimicrobial 
efficacy of the silver containing films was further enhanced by the use of cetrimide. Choi et 
al.[102] tested nanocomposite capsules based on polyelectrolytes with AgNPs with a suspension 
of E. coli; optical density measurements at 260 nm, which are proportional to the number of 
bacteria, showed that the amount of bacteria decreased after only 1 min exposure to silver-
embedded capsules. As a control, in the absence of silver the optical density of the E. coli 
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suspension remained almost unchanged. Ho et al.[38] reported the preparation of antimicrobial 
nanocomposite films based on poly(ethylene imine) and AgNPs which exploit both the release of 
silver ions and the direct contact between bacteria and nanoparticles (Figure 10). 
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Fig 10. Representation of an antimicrobial nanocomposite coating that exploits both the release of silver ions and the 
direct contact of silver nanoparticles within a polymer matrix (adapted from Ho et al. 2004) 
 
S. aureus was allowed to adhere to the film surface and then cultivated in agar to evaluate the 
viable cells. Results show that the film inhibits bacteria growth for 12 hours. When the amount 
of silver in the film reached the value of 10 µg/cm2 no bacteria could grow even after two weeks, 
indicating a bactericidal effect of the nanocomposite material. 
 
1.3.3 Effects of nanoparticles properties and role of the matrix 
Many factors influence the biocidal activity associated with AgNPs-based constructs, which may 
complicate the understanding of the antibacterial mechanism, as discussed in chapter 3.4; for this 
reason it is not easy to evaluate one property at a time, which can lead to conflicting results in 
the literature. Moreover the biological effects of AgNPs are affected by the dispersing agent or 
matrix of each particular nanocomposite system.  
In general, it can be stated that nanoparticles size, shape, surface properties, dispersion and 
stability are important issues for tailoring their biological performances. In particular, the effect 
of the particles dimensions has often been taken into account while characterizing the 
antibacterial activity: various researchers have documented that the size of AgNPs affects the 
biocidal effectiveness[103;104]. The antibacterial activity of AgNPs can be related to their size 
since the activity of smaller particles is higher due to the increase in surface area when compared 
on the basis of equivalent silver mass content. For such speculations it can be useful to evaluate 
the number of silver atoms in a nanoparticle (n) from the following relation[105]: 
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where dm is the particle diameter in nanometres, Na is Avogadro’s number and Vm is the molar 
volume of silver (mL/mol). Considering the effect of AgNPs dimensions against E. coli, Lok et 
al.[106] showed that AgNPs with an average diameter of 9.2 nm were 9 times more active than 
particles with an average diameter of 62 nm. Morones et al.[107] reported that the bactericidal 
properties of the carbon-stabilized AgNPs are size dependent in four types of Gram-negative 
bacteria, since the only nanoparticles that displayed a direct interaction with bacteria 
preferentially had a diameter of 1–10 nm. At variance, Su et al.[108] prepared silver 
nanocomposites of different sizes (45.7 nm and 25.9 nm) within a silicate clay and found that the 
bacterial growth inhibition was not significantly dependent on the particle size but only on the 
silver amount (Figure 11). 
 
                
Figure 11. Antimicrobial study on AgNP/Clay nanocomposites: in this system the biocidal effect depends on the 
silver content and not on particles size (redrawn from Su et al. 2009) 
 
The crystallographic structure and shape of the nanoparticles are considered as important 
properties affecting the antimicrobial behaviour. Recent works have demonstrated that the 
reactivity is favoured by high atom density facets such as {111}[107]. According to Pal et 
al.[109] truncated triangular nanoparticles display a higher antibacterial activity as compared to 
spherical nanoparticles and ionic silver. 
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Comparing the antibacterial activities of metallic and partially oxidized AgNPs, Lok et al.[110] 
indicated that only partially oxidized particles exhibited antibacterial activities and, since smaller 
AgNPs have a higher surface area-to-mass ratio, they provide higher relative concentration of 
chemisorbed silver ions. 
The matrix where the nanoparticles are dispersed is of primary importance to determine the 
performance of the material; in fact, in the final nanocomposite constructs, stabilizers  play a 
fundamental role to control the formation of nanoparticles as well as their dispersion stability. 
For example, in the case of polymer solutions, the concentration of the stabilizer operates as a 
controller of nucleation, affecting the size of the final nanoparticles as can be monitored by UV-
Vis spectra and TEM observations. Polymeric dispersants or capping agents are generally used 
to stabilize AgNPs, but it must also be considered that they may deactivate the nanoparticles 
functions because the organic wrapping on the metal surface can limit or prevent its surface 
reactivity[111].  
 
1.3.4 Antimicrobial mechanism 
Three main strategies can be pursued to render materials antimicrobial[38], by choosing:   
1. the anti-adhesiveness; 
2. the biocide-release activity; 
3. the activity by contact. 
 
Silver-based systems can be developed both as biocide-releasing systems (Ag+) and as contact-
active materials. Although the toxic effects of silver on bacteria have been investigated for more 
than 60 years, the mechanism by which silver is able to kill bacteria is still only partially 
understood[107;112]. Several investigations have suggested possible mechanisms involving the 
interaction of silver ions with biological macromolecules.  
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   Figure 12:  Interaction sites of silver ions on microorganisms 
 
Most of the Ag+ sensitive sites are likely to be proteins and their alterations will result in cell 
disruption due to structural and/or severe metabolic damage (Figure 12). Silver ions inhibit a 
number of enzymatic activities reacting with electron donor groups containing sulfur, oxygen, or 
nitrogen such as carboxylates, phosphates, hydroxyl, amines, imidazoles, indoles and especially 
sulfhydryl groups[113-116]. In the bacterial cell wall, free sulfhydryl groups are localized on 
transmembrane and outer-membrane proteins, including proteins of the electron transport chain, 
and they protrude in the extracellular portion of the membrane where they represent a very 
accessible interaction site for silver ions[107;117-120].  
The Na+-translocating NADH:ubiquinone oxydoreductase (NQR) has been recognized as one of 
the primary targets for Ag+ ions. It is a component of the respiratory chain of various bacteria 
and it generates a redox-driven transmembrane electrochemical Na+ potential. In two 
independent studies, submicromolar concentrations of Ag+ ions were demonstrated to inhibit 
energy-dependent Na+ transport in membrane vesicles of the NQR-possessing Bacillus sp. 
strain[121] and to inhibit purified NQR of V. alginolyticus[122]. Dibrov et al.[123] showed that 
low concentrations of Ag+ (submicromolar) induce a massive proton leakage through the Vibrio 
cholerae membrane, which results into a complete alteration and elimination of transmembrane 
proton gradient, de-energization, followed by cell death. 
A study performed on E. coli as a bacterial model pointed out that the bactericidal action of 
silver ions is correlated with the interaction with ribosomal subunit proteins and with the 
suppression of enzymes and proteins necessary for ATP production[124]. 
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Ag+ also forms complexes with the DNA bases, inducing DNA condensation. It is known that 
the replication of DNA molecules is effectively conducted only when DNA molecules are in a 
relaxed state. In a condensed form, DNA molecules lose their replicating abilities[107;125;126]. 
Feng et al.[127] have provided a morphological and structural study on the changes that occur on 
bacteria when treated with silver ions. They observed detachment of the cytoplasm membrane 
from the cell and the presence of dense electron granules around the cell wall and in the 
cytoplasm. As explained by Feng, these electron-dense granules, likely formed by the 
combination of silver and proteins, are prevented from permeating through the membrane, 
denying electron transport. Silver ions produce the formation of a low molecular weight region 
in the centre of the bacteria, which is considered a defense mechanism by which the bacteria 
conglomerates its DNA to protect it from toxic compounds when the bacteria senses a 
disturbance of the membrane (Figure 13).  
 
                         
Figure 13: Internal structure of E.coli cells treated with silver ions. Left: Cytoplasm membrane detachment from cell 
wall (arrow). Right:  Electron-dense granules around the cell wall (arrow). From Feng et al. (2000), reproduced with 
permission.  
 
As to silver nanocomposite materials, it is still not clear whether the biocidal mechanism of the 
AgNPs involves only silver ions or it also follows different routes[128]. Various mechanisms 
have been suggested according to the morphological and structural changes of bacteria. 
Generally, silver is believed to interact with the bacterial membrane either by direct contact 
between the nanoparticle and the membrane causing a direct transfer (solvent free) of Ag+ ions, 
or by means of silver ions released into the medium. A combination of the two mechanisms is 
also possible. Stevens et al.[129] suggested that when bacteria are in direct contact with silver 
nanoparticles in the medium they locally encounter high amounts of silver ions resulting in their 
death. In fact, the high surface-to-volume ratio of the nanoparticles accounts for a sustained local 
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supply of silver ions at the material-bacterium interface, preventing bacterial adhesion and 
biofilm formation (Figure 14). It must be also taken into account that if plasma proteins adsorb 
onto the biomaterial surface, the release of Ag+ can be hampered as well as the direct contact 
between nanoparticles and bacteria can be prevented. 
  
                 
 
Figure 14. Schematic representation of the possible antimicrobial mechanisms by ions elution or by contact-
dependent transfer of silver ions following collision with the silver nanoparticle-containing surface. From Stevens et 
al. (2009), reproduced with permission.  
 
Catellano et al.[130] suggested that when metallic silver reacts with the moisture in the wounded 
skin it gets ionized and binds to bacterial membrane proteins, DNA and RNA, leading to bacteria 
death. Lok et al.[131] reported that the antibacterial activity of AgNPs is dependent on surface 
oxidation; in contrast with zeroth-valent nanoparticles, only partially oxidized AgNPs exhibit 
antibacterial activities suggesting that partially oxidized AgNPs may be carriers of chemisorbed 
Ag+ in quantities that are sufficient to cause bacterial damage. A possible way of delivery of Ag+ 
from oxidized AgNPs may involve a direct  interaction with the bacterial membrane.                                                                                    
Su et al.[132] studied the antimicrobial mechanism of AgNPs/Silicate Clay nanocomposites; 
these constructs appear to exert their biocidal effect by means of a direct contact with the 
nanoparticles and not by means of the silver ions released, which indicates that in this system a 
simple contact with AgNPs is sufficient to trigger membrane leakage and cell death. 
One of the main target sites of silver nanoparticles is the bacterial membrane where deep 
morphological changes are induced leading to a significant increase of permeability and to the 
alteration of transport mechanisms through the plasma membrane[133;134]. As reported by the 
authors[135], a colloidal system  based on a lactose-modified chitosan and AgNPs, noticeably 
affects membrane potential and permeability. Morones et al.[107] have tested silver 
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nanoparticles on four types of Gram-negative bacteria: E. coli, V. cholera, P. aeruginosa and S. 
typhus. They observed silver nanoparticles attached to the cell membrane and in the cytoplasm of 
the bacteria (Figure 15). The mechanism by which the nanoparticles are able to penetrate into the 
bacteria is not totally understood, but the observation of silver nanoparticles on the cell surface 
and inside the bacteria is fundamental in the understanding of the bactericidal mechanism. In 
analogy with the mechanism suggested for silver ions, nanoparticles might tend to react with 
sulfur-containing proteins, as well as with phosphorus-containing compounds such as DNA, 
inducing irreversible cellular damages.  
Proteomic data revealed that a short exposure of E. coli cells to antibacterial concentration of 
AgNPs resulted in an accumulation of envelope proteins precursors, indicative of the dissipation 
of proton motive force. Consistent with these proteomic findings, AgNPs were shown to 
destabilize the outer membrane, to collapse the plasma membrane potential and to deplete the 
levels of intracellular ATP[136]. 
 
 
 
Figure 15: (a) Silver nanoparticles on the membrane and inside E. coli bacteria. (b) Magnification of E. coli 
membrane, where the presence of silver nanoparticles is clearly observed. From Morones et al. (2005), reproduced 
with permission. 
 
As free-radicals increase is considered as one of the possible explanation of the antimicrobial 
mechanism[137;138], Su et al.[139]studied the burst of free radicals and reactive species of 
oxygen (ROS) in AgNPs/Clay-treated bacteria by measuring 2,7-dichlorofluorescin-diacetate 
(DCFH-DA) as intracellular-ROS indicator. Results show that 40.3% of the AgNPs/Clay-treated 
bacteria became DCF+, indicating that ROS were generated and played a role in the killing 
mechanism. In addition it was observed that bacteria lost their mobility upon treatment with the 
nanocomposites, meaning that the motor function of the cytoskeleton is hampered with a 
consequent prevention of cytokinesis (Figure 16). Nanocrystalline silver-supported carbon[140] 
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showed kinetics of bacterial inactivation, in the presence of hydroxyl radical scavengers and 
superoxide anion radical inducer that suggest the contribution of the reactive oxygen species 
(ROS) to antibacterial effect. However, these ROS scavengers did not show any inhibition of 
bactericidal activity after approximately 1 hour, suggesting that generated ROS are responsible 
for E. coli inactivation only during the initial hour of the incubation time. The antibacterial 
process was found to be highly increased at higher temperature, which was ascribed to the 
enhanced ROS formation and Ag+ elution.  
 
 
Figure 16. Possible mechanisms of AgNP/Clay-mediated cytotoxicity. (A) AgNPs on synthetic platelet clay show 
electrostatic attraction to bacteria and form AgNP clusters on the bacterial cell wall. (B) Electronic transport through 
the respiratory chain on plasma membrane of E. coli through complex I, ubiquinone oxidoreductase (Q) and 
cytochrome bo/bd ubiquinone oxidase (bo/bd complex). (C) AgNP/Clay on the cell wall interacts with 
transmembrane proteins and consequently interferes with the proton pool in the intermembrane space or the 
electronic flow through the respiratory chain. Accumulated electrons due to a disturbance of complex I are 
transferred to oxygen to form O2 and H2O2, contributing to oxidative damage and membrane leakage in bacteria. 
From Su et al. (2009), reproduced with permission.   
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1.4 BIOLOGICAL HAZARDS OF SILVER NANOCOMPOSITES 
 
Nano-sized materials are currently being used in medicine, biotechnology, energy and 
environmental technology. Given the wide variety and growing number of applications on the 
market, there is a lack of studies and information regarding the effects of nano-sized materials 
(silver nanoparticles included) on general human health and environment. At present silver-
based products are widespread available on the market primarily as formulations for topical 
applications, both in the medical areas such as wound dressing and surgical instruments, coated 
or embedded with AgNPs, and in daily life where consumers have access to silver containing 
detergents and soaps, room sprays, water purificants, textiles, personal care products, handles 
and furniture for public places. Silver-based systems are also used in some food processing 
industry where pipelines are susceptible to biofilm formation. Besides, more recently AgNPs 
have been studied to be exploited for systemic applications and for the preparation of internal 
prosthesis and devices (e.g. bone cement, catheters). Hundreds of silver-based products are 
currently on the market, but there are not specific reporting requirements, risk assessments or 
official government indications for the commercialization of these kinds of products.  
The widespread use of AgNPs and silver ion-based products is partially justified by the fact that 
till few years ago and even nowadays, many researchers associated to ionic silver a low toxicity 
in the human body and expected minimal risk with respect to clinical exposure by inhalation, 
ingestion, dermal application or through the urological or haematogenous routes. Silver is not 
known as a systemic toxic agent for humans, except at extreme doses. The most evident 
secondary effects derived by chronic ingestion or inhalation of silver preparations is the 
deposition of particles in the skin (argyria), eye (argyrosis) and other organs. These conditions 
are generally not considered life-threatening but simply cosmetically undesirable. Silver in form 
of ions is absorbed into the human body and enters the systemic circulation as a protein complex 
to be eliminated by the liver and kidneys with a metabolism modulated by induction and binding 
to metallothioneins. These protein complexes can mitigate the cellular toxicity of silver and 
contributes to tissue repair[141]. Literature does not report cases of people specifically harmed 
by the use or exposure AgNPs: this fact could be attributed to the lack of knowledge about what 
effects to expect.  A recent work by Larese et al., demonstrated the absorption of silver 
nanoparticles through intact and damaged skin, detecting the presence of nanoparticles in the 
stratum corneum and the outermost surface of the epidermis[142]. 
In fact, in sharp contrast with the attention paid to new applications of silver nanocomposites, 
few studies provide insights into the possible interaction of AgNPs with the human body after 
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entering via different routes, and not only through skin. Systemic distribution and translocation, 
organ accumulation, degradation, possible adverse effects and toxicity in human tissues start to 
be considered and open major questions associated with the increased medical use of silver 
nanocomposites. An important and often disregarded aspect to be considered when studying the 
biological effect of silver nanocomposites is that nanoparticles show an impressive array of 
unusual physical-chemical properties that confer them higher and often unpredictable bioactivity 
when compared to the identical bulk materials. For instance, based upon size alone and not upon 
physical or chemical properties, nanomaterials have capabilities (normally attributed to micro-
organisms like viruses) to penetrate circulatory system and to reach and to translocate in all 
living organs including the blood-brain barrier. 
In the last 5 years most of the in vitro studies regarding the exposure of cell lines to silver 
nanoparticles have evidenced the presence of a potential cytotoxic mechanism that is strictly 
dependent on particle size and concentration. In spite of the limited number of cell lines tested, 
all experimental data agree that the mitochondria are the main intracellular target of silver 
nanoparticles. AgNPs mediate their toxicity through an oxidative stress with increase of ROS 
levels and following activation of the apoptotic mitochondrial pathway[143-147]. AgNPs induce 
mitochondrial membrane perturbation, generation of ROS, depletion of antioxidant GSH and 
reduction of mitochondrial function in BRL 3A rat liver cells[148], rat alveolar 
macrophages[149] and  human THP-1 monocytic cells[150]. Furthermore, GSH depletion in 
human skin carcinoma and fibrosarcoma cell lines is associated to expression of apoptotic 
markers[151] and in human hepatoma cells HepG2 to the over expression of oxidative stress-
related genes such us catalase and superoxide dismutase[152]. 
It is to note a report where four commercially available silver dressings were tested in terms of 
cytotoxicity towards keratinocyte HaCaT and fibroblast 142BR cells[153]; the results, as 
similarly observed by  Burd et al.[154], showed that all tested dressings induce, albeit to a 
different degree, apoptotic cell death in a way dependent on the cell line and type of dressing 
investigated. 
Although the molecular mechanism  at the base of silver nanoparticles potential toxicity is yet to 
be completely elucidated, a work by Hsin et al.[155] shed partially light on it. The mitochondria-
dependent apoptotic mechanisms identified in eukaryotic cells constitute an intrinsic and an 
extrinsic pathway characterized by the activation of pro-apoptotic proteins such as Bid, Bad, Bak 
and the inactivation of anti-apoptotic proteins as Bcl-2 e Bcl-Xl. Activation of Bad and Bak 
results in their traslocation and oligomerization on mitochondria membrane, to form ion channels 
allowing exit of cytochome C and other apoptotic factors.  
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By the experimental data so far collected by the researches, the prevailing hypothesis is that 
AgNPs interact with thiol groups of proteins and enzymes after passing through eukaryotic cell 
membrane. Most of those proteins can be involved in the antioxidant defense mechanism, like 
reduced glutathione, catalase, superoxide dismutase, that prevent tissue damage under normal 
conditions neutralizing ROS produced by the aerobic energy metabolism[156;157]. Over 
accumulation of ROS, an inflammatory response is induced and irreversible mitochondrial 
membrane damage and pemeabilization occurs, with following release of cytochrome C and of 
other apoptogenic factors[158].  Besides mitochondrial pathway activation, cell membrane 
destruction and lipoperoxidation can also take place and they represent another aspect of AgNPs 
toxicity (Figure 17).  
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Figure 17. Cytotoxic effect of silver nanoparticles on eukaryotic cells  
 
Silver nanoparticles can be internalized through the membrane by different mechanisms that 
include passive diffusion, receptor-mediated endocytosis and clathrin- or caveolae-mediated 
endocytosis[159-162].  
The mechanism of action of AgNPs described above seems to be shared by silver ions[163], and 
supports the hypothesis that part of the toxic potentiality of silver nanoparticles is due to the Ag+ 
release from them.  
The literature survey clearly shows that, over last years, the studies were mainly focused to asses 
the adverse biological affects of AgNPs by administering them at dose and concentrations that 
lead to cell death or irreversible cellular damage. These studies fail to consider concentrations of 
nanoparticles that may not result in cellular death but may cause sub-lethal cellular alterations 
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leading to serious consequences on human health. The most important examples are DNA 
damage and induction of inflammation processes. Mutation of DNA, induced by genotoxic 
materials, leads to carcinogenesis and has a deep impact on the biology of reproductive cells. As 
recently reviewed by Singh et al.[164], metal nanoparticles can generate DNA damage 
indirectly, by inducing oxidative stress and inflammation responses. ROS, whose increase is 
associated to an oxidative stress and subsequent redox imbalance, react with many biological 
macromolecules, including DNA, enzymes and lipids; in particular, they cause oxidative damage 
on DNA in the form of breaks of single and double-strands, purine, pyrimidine and deoxyribose 
modifications, abasic sites and DNA-DNA coupling[165]. At the same time, nanoparticles can 
gain direct access to the nucleus either though passive diffusion or transport across the nuclear 
pore complexes. Within this site they can trigger aggregation of nuclear proteins with subsequent 
inhibition of transcription, replication and cell proliferation[166-169]. 
Although there is a substantial experimental evidence on the genotoxic potential of many metal-
based nanomaterials, the data accumulated on AgNPs point only very marginally on their 
genotoxicity.  
An initial screen of nanomaterials toxicity must be always accomplished using in vitro studies, 
but they must be always supported by in vivo test, since the in vitro-in vivo gap is associated with 
the complexity of biological interactions in a higher order organism which are not reproducible 
by an in vitro system. In vivo tests require animal models to evaluate markers of inflammation, 
oxidant stress, and cell proliferation in portal-of-entry and selected remote organs and tissues, 
deposition, translocation of the materials and its degradation products, toxicokinetics and 
biopersistence studies, effects of multiple exposures and finally potential effects on the 
reproductive system, placenta, and fetus. In the field of silver nanocomposite materials the 
scarcity of toxicity data obtained on cellular models goes in parallel with the almost lack of 
exhaustive studies performed using in vivo models. In Zebrafish embryos, AgNPs in a 
concentration range between 250 and 0,25 µM caused toxic lethal and sub-lethal (morphological 
malformations) effects albeit in a size-dependent manner for certain concentrations and time 
ranges[170]. Silver nanoparticles administrated via intra-peritoneal injection in adult mice are 
able to traslocate to the circulatory system and reach the brain were they generated neurotoxicity 
by inducing free-radical oxidative stress, by altering gene expression and by producing 
apoptosis[171]. A study performed to compare the effects on liver caused on mice fed with nano- 
and micro-sized silver particles, revealed in both cases induction of liver inflammation[172]. 
Micro- and nano-silver particles implanted into rat's back muscle reveal a good biological effect 
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on days 7 and 14 but an inflammation process at day 30, more serious in AgNPs-treated rats than 
in the micro-silver treated ones[173]. 
All the studies are acute toxicity tests and no information was obtained from more informative 
chronic tests.  
An increasing number of papers take into consideration the development and characterization of 
materials based on silver nanocomposites and their interaction with eukaryotic systems. As 
examples, Fu et al.[174] describe the realization of antibacterial multilayer films containing 
AgNPs via layer-by-layer assembly of heparin and chitosan, lacking of toxic effects on 
osteoblasts. Nanocomposite materials based on acrylic resins and Ag NPs stimulate fibroblast 
and osteoblast aggregation and growth without displaying any toxic effect[175;176], and 
stainless steel orthopaedic materials already commonly used in the biomedical field, when coated 
with silver, efficiently sustain the growth of osteoblasts and do not show genotoxicity[177].  
However, besides the potential toxicity of silver when topically or systematically administrated, 
a general concern must be also considered on the hazardous effects of nanoparticles 
accumulation in the environment. As the scientific literature often points out, there is a great lack 
of knowledge about AgNPs impact on human health but even less is what we know about its 
environmental pathways and its environmental effects. At present, silver is classified by EPA 
(US  Environmental Protection Agency) as an environmental hazard because in some 
circumstances it is toxic, persistent, and bio-accumulative. Nanotechnology is not well 
researched or regulated, so the environmental impact and risks of silver nanoparticles is not 
known. 
Although the scientific community is in agreement to retain that the paucity of data renders it 
premature to formulate any definite risk assessment about silver-based materials, an increasing 
public debate is emerging, and very contradictory opinions and experimental evidences about the 
potential impact of these nanomaterials on health are often presented[178;179]. A central point is 
that silver nanocomposites should not be considered as a uniform group of materials. The 
toxicity of nanocomposite materials may be influenced by particle concentration, size 
distribution, agglomeration state, shape, chemical and physical nature of the matrix, physical 
status of the composite and finally site and time of exposure. The ultimate and main goal in the 
field of silver nanotechnology remains still the development and choice of products with a 
superior profile of functionality (like for instance high infection control) associated to reduced 
host cell cytotoxicity and a moderate environmental risk to fully exploit the potential benefits 
and limit the unnecessary risks of this technology.  
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In general, the rapid proliferation of many different engineered nanomaterials presents at the 
moment a dilemma to regulators regarding hazard identification. The International Life Sciences 
Institute Research Foundation/Risk Science Institute[180] convened an expert working group to 
develop a screening strategy for the hazard identification of engineered nanomaterials. Based on 
the evaluation of the limited data currently available, the report presents only a broad data 
gathering strategy applicable to this very early stage in the development of a risk assessment 
process for nanomaterials. Oral, dermal and inhalation routes of exposure must be considered 
recognizing that, depending on use patterns,  exposure to nanomaterials may occur by any of 
these routes. In particular, three key elements of the toxicity screening strategy have been 
identified: 1) physicochemical characteristics, 2) in vitro assays (cellular and non-cellular), 3) in 
vivo assays. It is common opinion that in the next future every new nanomaterial entering the 
market will need to be screened for toxicity and biopersistence, using low-cost, fast-throughput 
but scientifically rigorous and standardized tests.  
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1.5 POLYSACCHARIDES AS BIOMATERIALS 
 
Polysaccharides constitute an important class of biological materials. They display well 
documented biocompatibility and biodegradability, which are the basic characteristics for 
polymers used as biomaterials[181]. Besides, polysaccharides are involved in cell embedding 
and signalling including tissue addressing and transport mechanisms. 
Polysaccharides in biomaterials are often used in order to manipulate surface properties such as 
wettability, adhesion, and biocompatibility. On a general point of view, polysaccharides are rich 
in –OH functional groups allowing good solvation in aqueous medium and possible chemical 
modifications. Due to their stereoregularity, and to the presence of –OH groups, H-bond 
networks are formed which stabilize intra and inter-polymeric chain interactions; they cause the 
characteristic semi-rigid behaviour of polysaccharides in well defined thermodynamic 
conditions. Polysaccharides can be either neutral polymers (such as cellulose, amylose, and 
galactomannans) or charged ones; carboxylic or sulfate groups are present in hyaluronan and 
alginate or carrageenan respectively; amino groups are naturally present in the only natural 
cationic polysaccharide, i.e. chitosan. The polyelectrolyte character favours the dissolution in 
aqueous solutions, depending on the pH. 
Polysaccharides are usually obtained by biosynthesis in plants (e.g. algae) and animals.  
Polysaccharides can also be synthetized by microorganisms such as bacterial hyaluronan, 
dextran, gellan or xanthan. The large amount of polysaccharides with different chemical 
structures and physical properties constitutes a source of materials for many applications 
especially in the domain of biomaterials for tissue engineering, drug vehicle and 
viscosupplementation. Few polysaccharides reach the level of consideration as good basis for 
biomedical applications: among these, alginate and chitosan will be considered for the aim of the 
present thesis.  
 
1.5.1 Chitosan and Derivatives 
Chitosan is a partially deacetylated derivative of chitin, the second most abundant natural 
biopolymer on earth, which is the main component of the exoskeleton of marine crustaceans and 
cell walls of fungi. Chitosan is a linear polysaccharide consisting of β(1-4) linked D-glucosamine 
residues (GlcNH2) with a variable number of randomly located N-acetylglucosamine groups 
(GlcNAc) (Figure 18). 
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Figure 18. Structure of chitin and chitosan. Chitin is composed predominantly of GlcNAc units (y). Chitosan is 
composed predominantly of GlcNH2 units (x)[182]. 
 
Chitosan is very abundant, and its production is low cost. Nowadays chitosan is receiving a great 
deal of interest for medical and pharmaceutical applications[183]. Chitosan is well known for 
being biocompatible allowing its use in different medical applications such as topical ocular 
application[184], implantation[185] or injection[186]. Moreover, chitosan is considered as 
biodegradable because it is metabolized by several human enzymes, especially lysozyme[187]. 
In addition, it has been demonstrated that chitosan acts as a penetration enhancer by opening 
epithelial tight-junctions[188]. Chitosan was also reported to promote wound-healing[189;190] 
and to display bacteriostatic effects[191].  
One of the most interesting feature of chitosan as biomaterial is connected with the presence of 
amino groups located on the glucosamine units. Chemical derivatization based on the reactivity 
of the glucosamine residues leads to strong modification of the physico-chemical and biological 
properties of the polycation. Derivatization examples include acylation[192;193], 
alkylation[194] and carboxymethylation[195]. Starting from these assumptions, our group has 
modified highly deacetylated chitosan by grafting lactose moieties on the free amino groups of 
the polymer to obtain, by reductive amination, the corresponding lactitol derivative. This low 
charged, highly hydrophilic chitosan derivative was named “Chitlac” (Figure 19). This 
glycopolymer exhibited the ability to induce chondrocyte aggregation leading to the formation of 
nodules of high dimensions (up to 0.5–1 mm) within 12–24 hours; it also stimulates the 
biosynthesis of typical markers of articular cartilage, such as type II collagen and 
glycosaminoglycan[196]. 
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Figure 19: Synthesis of Chitlac via N-alkylation of chitosan with lactose[197]. 
 
These findings seem promising in connection to a possible application of Chitlac in protocols of 
tissue engineering applied to the regeneration of bone and articular cartilage. The localization of 
Chitlac at the plasma membrane of isolated chondrocytes and its permanence at the same site 
also after nodule formation indicate that the process is mediated by a specific binding of Chitlac 
to cells, most likely through its β-galactose residues[198]. Further experiments demonstrated the 
involvement of Galectin-1 as a molecular bridge between Chitlac and chondrocyte cell 
surfaces[199]. Galectin-1 is a member of the S-type galactoside-binding animal lectins 
[200;201]. The discovery that Galectin-1 binds with high affinity to polylactosamine-containing 
ligands (such as laminin) and the co-localization of Galectin-1 with laminin in extracellular 
matrix suggested that its major function could be to promote cell adhesion to 
glycoconjugates[202-204]. 
In general, the polysaccharide biofunctiontality can be enhanced by modifications on different 
levels of complexity, from relatively simple changes in the hydrophilicity of the material to the 
functionalization with charged groups, peptides or proteins. The incorporation of bioactive 
peptide motifs such as Arginine-Glycine-Aspartic acid (RGD), which is recognized by the cell 
transmembrane integrin receptors, is perhaps the most commonly adopted strategy to enhance 
functionality[205]; in fact, integrins are heterodimeric cell surface receptors that mediate 
adhesion between cells and the extracellular matrix by binding to ligands with an exposed RGD 
sequence. These receptors also stimulate intracellular signalling and gene expression involved in 
cell growth, migration, and survival. In the studies discussed in Paper 3[206], Chitlac was 
modified with RGD peptide in order to promote cell attachment and proliferation. For anchoring 
the bioactive peptide onto the Chitlac chain, the biopolymer was treated with the RGD peptide in 
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the presence of 1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide methiodide (EDC) and N-
hydroxysuccimide (NHS) as coupling agents. 
 
1.5.2 Alginate 
Alginate was first described in 1881, by the British chemist E.E.E. Standford[207]. It is 
synthesized in large quantities by marine brown algae (Phaeophyceae)[208], and it can also be 
synthesized by bacteria belonging to the genera Azotobacter and Pseudomonas[209;210]. 
Alginate is an unbranched polysaccharide consisting of the two sugar residues 1-4 linked β-D-
mannuronic acid (M) and α-L-guluronic acid (G) (Figure 20 a). The monomers are arranged in a 
pattern of blocks along the chain, with homopolymeric regions (M and G-blocks) interspersed 
with regions of alternating structure (MG-blocks)[211-213]. A strong correlation between 
structural features and functional properties has been found in alginate. The intrinsic flexibility 
of alginate in solution increases in order MG > MM > GG[214], but the viscosity depends 
mainly on the molecular size[215]. By contrast, the selectivity for binding of cations and the gel 
forming properties varies strongly with the composition[214] and sequence[212;213]. It has been 
reported that divalent cations like Ca2+, Sr2+ and Ba2+ bind preferentially to G-blocks in a highly 
cooperative manner[216]. It is this selective binding to alginate which accounts for its gel 
forming properties (Figure 20 b).  
In fact this complexation with ions has been described by the “egg-box” model in which each 
divalent ion interacts with two adjacent G-residues as well as with two G-residues in an opposing 
chain, giving rise to the junction zone in the gel network [217] (Figure 20 c). 
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Figure 20: a) Chemical structure of alginate; b) Probable Ca-binding site in a GG-sequence and c) ionic cross-
linking of two homopolymeric blocks of G-residues in the egg-box model[217]. Adapted from Strand[218]. 
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Recently, it has been suggested by Donati et al.[219]  that G-blocks are not the only sequences 
involved in junction formation. Based on experiments with polyalternating alginate, mannuronan 
and alginate rich in G-blocks, it could be hypothesized that junction zones in the gel network 
could occur even between MG/MG-blocks and between GG/MG-blocks. 
Alginate from brown algae is the basis for numerous applications in biotechnology and 
biomedicine, due to its water-binding, viscosity and gel-forming properties[220]. At present, 
alginate gels are being employed in several areas of drug delivery and tissue engineering[221]. 
Alginate represents an attractive material for the preparation of “biohybrid organs” and “micro-
bioreactors” because its hydrated three-dimensional (3D) network allows cells to survive and be 
protected by immunosystem[222]. Three-dimensional matrixes are broadly used in tissue 
engineering, in particular for stem cell culturing, as they have high specific surface area and 
support high cell density growth. Moreover, this kind of matrices allows control over 
permeability and mechanical strength. The 3D structure of matrices has the potential to provide 
cells with a biomimetic environment that aims to resemble the in vivo conditions[223]. Alginate 
encapsulation system, exploiting the ability to form cross-linked matrixes involving the use of 
divalent cations, includes the paramount benefit to be a flexible technology allowing variations 
in polymer concentration, composition, bead size and cell seeding density. Alginate-based 
systems have been widely tested for islet encapsulation and have been shown to provide 
immuno-isolation after the system transplantation, thus prolonging the survival of encapsulated 
islets[224-228].  
 
 
1.6 METHACRYLIC THERMOSETS AS BIOMATERIALS FOR 
ORTHOPAEDIC AND DENTAL APPLICATIONS 
 
Methacrylic thermosets are largely employed as biomaterials for different applications like bone 
cements, screw fixation, filler for cavities and skull defects and also vertebrae stabilization in 
osteoporotic patients. They are also used as dental cements, bonding substances that are placed 
in the mouth as a viscous liquid and set to a hard mass[229].  
The structure of polymethylmethacrylate (PMMA) incorporates methyl and methacrylate groups 
on alternate carbon atoms as shown in Figure 21 (left). 
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Figure 21. Chemical structure of PMMA (left), BisGMA (centre) and TEGDMA (right) 
 
PMMA has been extensively used as bone cement since the late 1950s[230]. In bone surgery, 
bone cements based on PMMA are particularly used for their capacity to be moulded into fixed-
design implants or to be polymerized at the time of surgery for tailor-made implant applications 
like as filler material in total-hip insertion[231]. Cement injections help to fix bone screws in 
weak bone and can significantly increase the strength of vertebral bodies or femoral necks even 
if applied without a metallic implant. PMMA is currently used for anchoring cemented 
arthroplasties to the continuous bones; in this application, the main functions of the cement are to 
transfer the body weight and service loads from the prosthesis to the bone and increase the load-
carrying capacity of the prosthesis-bone system. The first use of polymethyl methacrylate 
(PMMA) as a dental device was for the fabrication of complete denture bases[232].  
In the literature there are some conflicting results about the effects of PMMA on bone tissue. In 
several studies, fibrous layer formation around PMMA has been observed due to exothermal 
polymerisation reaction or toxic effect of leachable residual monomers; on the other hand, some 
authors have observed direct bone contacts with PMMA after 15 days to more than 17 years after 
implantation of cemented hip prosthesis[233]. Vallittu et al. have shown that glass or carbon 
fibre reinforced PMMA composite have relatively good biocompatibility in vitro [234]. 
However, experimental results on animal models by Heikkilä et al. revealed disturbed bone 
formation at the surface of PMMA implants loaded with bioactive glass or hydroxyapatite 
particles[235]. Moreover, PMMA displays shrinkage during polymerization and can cause a 
stiffness mismatch between the cement and the contiguous bone. 
Efforts at improving the properties of PMMA-based cements have explored different directions. 
One involves the preparation of composite materials were PMMA is the matrix in which are 
dispersed small quantities of reinforcements like carbon nanotubes[236], graphite, aramid, bone 
particles[237;238], polyethylene, polyethylene terephthalate, titanium[239], ultrahigh molecular 
weight polyethylene or PMMA fibres[240]. 
Alternatively, various methacrylate-based thermosets have been developed in order to overcome 
PMMA limitations and tailor-make the material to match the requirements of the specific 
application. Among these, 2,2-bis[4-(2-hydroxy-3-methacryloxyprop-1-oxy)phenyl]propane 
(BisGMA) has received particular attention  (Figure 21, centre); it is an aromatic dimethacrylate  
 48 
used in photocurable pit and fissure sealants and in composite restorative dental materials. 
BisGMA can be formed by the reaction of bisphenol A with glycidyl methacrylate, it is 
extremely viscous due to intermolecular hydrogen bonding between the hydroxyl groups.  
Today, dental cements usually contain high-viscosity BisGMA as the main component mixed 
with a low-viscosity dimethacrylate, namely triethyleneglycol dimethacrylate (TEGDMA) 
(Figure 21, right). Since BisGMA has five times the molecular weight of methylmethacrylate, 
the density of methacrylate double-bond groups of BisGMA is approximately two-fifth as high 
in these monomers, which results in reduced polymerization shrinkage. The use of 
dimethacrylates also results in extensive cross-linking, which increases the strength and rigidity 
of the polymer and reduces degradation by heat and solvents compared to 
methylmethacrylate[241]. Moreover BisGMA/TEGDMA dental cements display high strength, 
high fracture toughness, low oral solubility and high micromechanical bonding to prepared 
enamel, dentin alloys and ceramic surfaces.  
Methacrylate monomers polymerize by the addition mechanism initiated by free radicals. The 
main system used for the polymerization initiation of BisGMA is light curing. The blue light (λ = 
450 nm) is absorbed by a diketone (e.g. camphorquinone, radical initiator), which, in the 
presence of an organic amine (e.g. dimethylaminoethyl methacrylate, coinitiator), starts 
polymerization reaction. Exposure time of 20 to 40 seconds is needed to start the 
polymerization[242]. 
Thermosets based on light-induced reticulation of BisGMA and TEGDMA have found a large 
use in the biomedical field, in particular, in dentistry. BisGMA-based biomaterials were 
originally developed for dental composites more than 25 years ago and are nowadays used in 
most of the commercial products[243]. A number of brands of BisGMA-based dental cements 
(e.g. Variolink® II from Ivoclar Vivadent, Orthocomp from Orthovita-Malvern) are available in 
the market for the cementation of crowns, bridges, inlays and veneers[244]. The fillers generally 
used for this application are silica, glass particles and colloidal silica. 
BisGMA/TEGDMA materials are also prone to be reinforced with fibers, for example, glass 
fibers, rendering them particularly interesting for load bearing conditions such as in 
dental[245;246], orthopaedic and craniofacial applications[247]. 
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1.7 INFECTION RISKS IN ORTHOPAEDIC IMPLANTS 
 
During last 15 years the advent of modern standards in the control of sterility within the 
operating room environment and the use of adequate protocols of peri-operative antibiotic 
prophylaxis have decreased the incidence of infections associated with orthopaedic implants.  
Nevertheless, the event of infection still represents one of the most serious and devastating 
complications which may involve prosthetic devices. It can lead to complex revision procedures 
and even to the failure of the implant and the need for its complete removal. In orthopaedics, 
given the enormous number of surgical procedures involving invasive implant materials, 
infections have a huge impact in terms of morbidity, mortality, and medical costs. For example, 
in the US alone, total hip and knee arthroplasties currently account for over half a million 
interventions each year. In view of this enormous population of patients with orthopaedic 
implants, even a currently low risk of infection, estimated to be in the range of 0.5–5% for total 
joint replacements, has to be considered very relevant for its serious consequences. 
The chemotherapy treatment with antimicrobial agents is not always effective on infections that 
are already established. Often prosthesis removal and replacement, represent the only salvage 
option to definitively eradicate severe infections. These drastic interventions bear serious 
implications in terms of attendant patient trauma, prolonged hospitalization as well as in terms of 
health and social costs, since it has been estimated that the treatment of each single episode of 
infected arthroplasty costs more than 50000 $. 
In the strategy for the prevention of infections, much has been done to improve the operating 
standards, minimize the possibility of contamination during surgery, reduce the establishment of 
infection by peri-operative antibiotic prophylaxis, and confine pathogenic strains by patient 
isolation; along these directions little advancements in terms of decreased infection rates are 
being expected in return of this type of efforts.  
During the last years increasing attention has been focused on the epidemiology and the 
pathogenesis of the infections, especially associated to implant materials, in order to increase 
knowledge and control over this phenomenon. Many efforts have been directed to investigate 
which are the most important etiologic agents involved, the pathogenetic mechanisms leading to 
microbial adhesion, colonization of implant surfaces, and evasion of the host defenses, the most 
crucial virulence factors and the nature and properties of microbial biofilms. The pathogenesis of 
peri-implant infections differs from that of other post-surgical infections for a series of 
phenomena that are strictly related to the presence of biomaterials because the interstitial milieu 
surrounding prosthetic implants represents a region of local immune depression susceptible to 
 50 
microbial colonization, and favorable to the instauration of infections. Bacteria are initially 
passively adsorbed on the biomaterial surfaces, but the establishment of prosthesis-associated 
infections relies also on specific active interactions of the bacteria with biomaterial surfaces. For 
instance, several microbial species possess adhesins, receptorial proteins which mediate cell 
anchorage and fixation to host extracellular matrix proteins (such as collagen, fibrinogen, 
fibronectin, and elastin) adsorbed on biomaterials. In addition, bacteria elaborate a complex 
polysaccharidic glycocalix, forming adherent biofilms on implant surfaces which increase their 
protection from the host defense and enhance resistance to antibiotic treatments. 
The diagnosis of orthopaedic implant-related infections is a difficoult task since, while early 
post-operative prosthetic joint infections are often characterized by acute onset of symptoms and 
signs of infections, late post-operative prosthetic joint infections (which generally occur after the 
first 3 months following surgery) show more subtle signs of inflammation, chronic persistent 
post-operative pain and/or early loosening of the implant. The vast majority of implant-related 
infections is due to S. aureus and S. epidermidis (Gram+ bacteria), but also other strains are 
involved with the frequency reported in Figure 22. 
 
Figure 22. Frequency of main pathogenic species among orthopaedic clinical isolates of implant-associated 
infections.  
 
The progressive alarming appearance of antibiotic resistant strains (e.g. S. aureus strains) is a 
main issue requiring primary clinical attention. Moreover, bacteria forming biofilms on 
prosthetic surfaces are particularly resistant to antimicrobials and tend to survive to aggressive 
chemotherapy even in the absence of specific antibiotic resistance factors. 
Material chemical properties and superficial topography of implant materials can influence early 
microbial adhesion and the chances of successful colonization of the prosthesis; in fact a 
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modification of the chemistry or the micro/nanotopology of the outer layer of the device 
represents the most convenient way to interfere with the early phases of microbial adhesion. 
Many attempts of superficial chemical modifications include the coating of the device with 
surfactants, proteins such as albumin, hydrophilic negatively charged polysaccharides like 
hyaluronic acid and heparin, with the scope to generate adhesion resistant or even bacteria 
repellent surfaces. Even if for in vitro simplified conditions some of these surfaces result 
effective, up to now little evidence has been produced of a significant reduction in implant 
susceptibility to infection under in vivo conditions deriving from this type of approach. A more 
incisive approach considers the use of bioactive materials and coatings endowed with intrinsic 
large spectrum anti-microbial properties; in this way, a sustained release of disinfectants, drugs 
or antibiotics, can reach critical concentrations directly at the interface of the implant. In the list 
of the bioactive material surfaces, there are coatings able to release metals like copper[248] and 
silver ions[249], or silver sulfadiazine[250], disinfectants such as chlorhexidine[251] or other 
bactericidal chemicals such as nitric oxide and various antibiotics (e.g. gentamicin, 
vancomycin…)[252;253]. Active substances can also be incorporated into bulk materials and 
cavity filling materials, either by simple impregnation or by covalent bonding; for instance, 
antibiotic loaded cements are nowadays frequently applied in orthopaedics, especially in 
association with the replacement of infected prostheses for the high risk of recidive.  
On the other hand, toxicological issues related to systemic metal accumulation or local 
cytotoxicity could limit the broad use of certain anti-microbial chemicals other than antibiotics, 
supporting their utilization only in special circumstances at high infection risk such as in 
percutaneous implants or catheters. In fact, for bone implants, cytotoxicity can be a very crucial 
issue, interfering with optimal osteointegration when not even leading to bone resorption 
phenomena and aseptic mobilization. 
Overall, it is hard to expect that a single strategy among all these just mentioned could represent 
the ideal solution in the fight against infections. More plausibly, depending on the type of 
implant, the anatomic site of implantation, and the circumstances of the intervention (e.g. 
revision with risk of recidive), a number of new valid options should be made available to the 
surgeons. The appropriate choice when not even combination of these expedients will contribute 
both to decrease the chances of implant colonization, and to increase the effectiveness of 
traditional chemotherapy, contributing to further lowering the risks of implant failure. The 
development of anti-infective surfaces is just at a very early stage and, in a near future, efforts 
and investments in this direction are expected to multiply[254]. 
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2. AIMS  
 
The overall scope of these studies has been to develop a nanocomposite coating for a polymer-
based bone prosthesis, with particular focus on its interaction with bacteria and eukaryotic cells. 
 
The specific aims were to: 
 
1. define preparation protocols of antibacterial metal nanoparticles stabilized by 
biocompatible polysaccharides; 
 
2. develop nanocomposite materials based on silver nanoparticles that could exert 
antibacterial activity without showing cytotoxic effects; 
 
3. devise a technique to graft the nanocomposite coating to the substrate material of the 
prosthesis (methacrylic thermoset); 
 
4. evaluate the biological response of the final construct. 
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3. SUMMARY OF PAPERS 
 
PAPER 1: 
 
Polyol Synthesis of Silver Nanoparticles: Mechanism of Reduction                                             
by Alditol Bearing Polysaccharides 
 
 
 
This work tackles the preparation of silver nanoparticles by means of alditol bearing 
polysaccharides derived from natural resources (chitosan), without the addition of exogenous 
reducing agent. In fact, the alditol itself is used to induce the metal reduction thanks to the 
Fetizon reaction. For the first time, alditols, i.e. completely reduced sugars, are shown to be able 
to reduce silver ions in mild conditions. The mechanism of the reaction has been proved using 
different derivatives of chitosan which showed that when the primary hydroxyl group of the 
alditol moiety is involved in glycosidic bonds, silver ion reduction does not take place. Thanks to 
the multivalent arrangement of the alditol on the polysaccharide backbone, a very efficient 
reduction takes place and round shaped silver nanoparticles (Ø ~ 5 nm) are formed. This systems 
proved to give rise to a notable Surface Enhanced Raman Scattering effect (SERS) and, 
depending on the experimental conditions, to lead to the formation of hydrogels. 
The possibility of using alditols to reduce silver ions in mild conditions and their arrangement on 
a polysaccharide backbone to form silver nanoparticles represents the main novelty of this paper.  
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PAPER 2:  
 
Non-Cytotoxic Silver Nanoparticle – Polysaccharide Nanocomposites 
with Antimicrobial Activity 
 
 
 
This paper describes the preparation of a nanocomposite system based on bioactive 
polysaccharides and antimicrobial silver nanoparticles. The use of a lactose-modified chitosan 
(“Chitlac”) as dispersing agent allows for a more effective formation and stabilization of the 
nanoparticles, with respect to unmodified chitosan. Moreover, the miscibility of Chitlac-silver 
nanoparticles (Chitlac-nAg) with the polysaccharide alginate was exploited to obtain 
homogeneous hydrogels that do not exert any cytotoxic effect on eukaryotic cells while 
displaying considerable antimicrobial activity. This is attributed to the fact that the nanoparticles, 
immobilized in the gel matrix, can exert their antimicrobial activity by simple contact with the 
bacterial membrane, while they can not be uptaken and internalized by eukaryotic cells. This 
novel approach could provide new tools to design engineered materials exploiting, to different 
purposes, the cell-stimulating activity provided by the saccharidic component and the properties 
of silver at the nanoscale level. 
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PAPER 3: 
 
Surface Modification and Polysaccharide Deposition on  
BisGMA/TEGDMA Thermoset 
 
 
 
 
 
This work describes the preparation of BisGMA/TEGDMA thermoset whose surface has been 
functionalized by deposition of a bioactive polysaccharide coating (Chitlac) in order to stimulate 
cell proliferation. The coating was characterized by means of AFM, Confocal Laser Scanning 
Microscopy (CLSM) and SEM and its friction properties were evaluated. Biological tests in vitro 
revealed that the presence of Chitlac decorated with an RGD-peptide led to a significant 
enhancement of cell proliferation with respect to the unmodified BisGMA/TEGDMA resin. The 
performance of the coated BisGMA/TEGDMA resin became comparable with that of clinically 
used roughened titanium. The approach presented in this work efficiently combines aspects like 
proper mechanical performances and cell-directed biochemical signaling to upgrade these largely 
used thermosets. This approach could lead to new materials capable to meet the complex 
requirements of biomechanical and biological properties expected for a “third generation” 
biomaterial. 
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PAPER 4: 
 
Silver-Polysaccharide Nanocomposite Antimicrobial Coatings                                                   
for Methacrylic Thermosets 
 
 
 
 
This paper describes the preparation of an antimicrobial non-cytotoxic coating for methacrylic 
thermosets based on Chitlac and silver nanoparticles. The coating was characterized by means of 
UV-Visible spectrophotometry, TEM and SEM, while its antimicrobial properties were 
evaluated with both Gram+ and Gram- strains. Cell proliferation on the coating was studied with 
osteoblasts-like cell lines, primary human fibroblasts and adipose-derived stem cells by means of 
Alamar Blue assays, SEM and Confocal Laser Scanning Microscopy (CLSM).  
This nanocomposite coating is effective in killing bacteria without exerting any significant 
cytotoxic effect towards tested cells, which are able to firmly attach and proliferate on the 
surface of the coating. Such biocompatible antimicrobial polymeric films containing silver 
nanoparticles have good potentials for surface modification of medical devices, especially for 
prosthetic applications in orthopedics and dentistry. 
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PAPER 5: 
 
Cytotoxicity Evaluation of Hydrogels Embedding Gold Nanoparticles                                           
(In preparation) 
 
 
 
 
This paper describes the preparation of a nanocomposite hydrogel based on alginate and Chitlac 
embedding gold nanoparticles. The use of Chitlac allows for the preparation of a homogeneous 
colloidal solution where gold nanoparticles are better stabilized with respect to chitosan. In line 
with the case of Chitlac-nAg, also this gold-based colloidal solution displayed antimicrobial 
activity. Despite the miscibility with alginate that allowed obtaining semi-solid structures (AC-
nAu), in vitro cytotoxicity assays pointed out a gold-related toxicity towards eukaryotic cells 
which are induced into apoptosis, at variance with silver-based hydrogels (AC-nAg). In vivo tests 
in a rat model showed a good biocompatibility of both AC-nAg and AC-nAu materials, but in 
the latter case it was noticed the formation of a thicker fibrous capsule surrounding the implant, 
stemming from its lower biocompatibility. This finding opens up for debate about gold-related 
toxicity and the use of this noble metal for biomedical applications. 
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PAPER 6: 
 
Silver Nanocomposites and their Biomedical Applications 
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This paper represents a chapter of the book entitled “Nanocomposites for the Life Sciences” 
(Wiley-VCH 2010) and overviews the state-of-the-art of silver nanocomposites for the most 
promising pathways in the biomedical field. 
It starts with an introduction about the new class of materials referred to as “silver 
nanocomposites” and the discussion of the main routes of preparation of silver nanoparticles and 
final composite constructs. Subsequently it reports the main results and applications over the last 
few years, with a particular attention to the antimicrobial field. In fact, as the largest efforts aim 
at exploiting the antimicrobial properties of silver, this paper sums up results and hypotheses 
about the details of  the antimicrobial mechanism, which is today only partially understood. 
Moreover it specifically considers the use of silver nanocomposites for applications related to 
wound healing, inflammations and biological sensing. The work on silver nanocomposites also 
tackles the issue of possible biological hazards, which are rarely taken into account and often 
represent a matter of controversy in terms of contradictory results. Finally, this review suggests 
possible upcoming biomedical applications of this class of materials.  
 
Part of this work has been adapted in the Introduction section of this thesis. 
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4. GENERAL DISCUSSION 
 
This work aimed at realizing a nanocomposite coating for the development of a polymer-based 
bone prosthesis. Overall, the objective to prepare a coating endowed with i) antimicrobial 
activity and ii) good biocompatibility was fulfilled. Moreover, this research contributed to shed 
light on a complex interdisciplinary topic that regards the preparation of nanocomposite 
materials and their interaction with the biological world. In fact, as discussed in the Introduction, 
to date little is known about exact mechanisms that involve nano-scale materials and prokaryotic 
or eukaryotic microorganisms; the existence of contradictory results in the literature indicates the 
extreme complexity of these aspects and the numerous variables that may influence the results of 
each study (Paper 6). This is why this thesis aims at improving the knowledge in the field, being 
aware that some issues can be tackled only by hypotheses or suggestions, since much has to be 
done to completely elucidate exact mechanisms and gain a deeper understanding over these 
nano-biotechnolgical techniques. 
 
Choice of the polysaccharides in the preparation of nanoparticles 
For the preparation of metal nanoparticles we took advantage of the “wet chemical synthesis” in 
the presence of a stabilizing agent because this in situ approach allowed the formation of 
homogeneous nanoparticles dispersed within the polymer solution. For both silver and gold 
nanoparticles, the choice of Chitlac as stabilizing agent was due to two main reasons: 
1. the functional groups of Chitlac can interact with metal species (coordination 
interactions); 
2. Chitlac is biocompatible and stimulates cell proliferation, thus being an excellent 
candidate for biomaterial applications. 
Moreover, thanks to the presence of the lactitol side chain, Chitlac overcomes the chemical and 
biological limitations of unmodified chitosan (solubility at physiological pH, miscibility with 
anionic polysaccharides, cell signalling). The colloidal solutions obtained in the presence of 
Chitlac are highly homogeneous in terms of nanoparticle dimensions and degree of aggregation, 
and their stability is maintained over long time scale (years) as discussed in Paper 2. Chitlac is 
also endowed with the functionality to reduce silver ions without requiring additional exogenous 
reactants (Paper 1).  
The miscibility of Chitlac with the anionic polysaccharide alginate was particularly useful in our 
attempt to prepare semi-solid matrixes entrapping the nanoparticles: in fact Chitlac-based 
colloidal solutions were used to obtain soluble binary mixtures with alginate, which eventually 
 62 
were gelified exploiting the properties of the latter polyelectrolyte. The final constructs were 
highly hydrated three-dimensional gels containing well dispersed nanoparticles (Paper 2 and 5). 
 
Preparation of the coating 
The technique adopted to coat the methacrylic thermosets was based on polyelectrolyte 
physisorption driven by electrostatic forces, in analogy to the procedure used for the so called 
“layer by layer deposition” (Paper 6). In particular, we have proposed a novel strategy for the 
coating of a BisGMA/TEGDMA thermoset material based on a chemical modification that 
exposes negative charges (carboxylate groups) on its surface (Paper 3). The formation of a thick 
polysaccharide layer on the thermoset was accomplished by deposition of Chitlac, for the large 
number of positive charges on Chitlac and the amount of negative groups on the methacrylate 
surface ensured cooperative interactions. The stability of this layer was explored by scratch tests 
that indicate a gel-like mechanical behaviour of the coating firmly grafted on the substrate.  
The same preparation technique was successfully applied also in the case of Chitlac-nAg (Paper 
4); in this case the silver nanocomposite layer attached on the thermoset surface was able to exert 
considerable antimicrobial effects without being harmful to eukaryotic cells. Stability tests in 
water demonstrated that electrostatic forces suffice to prevent the dissolution of the 
nanocomposite layer, at least over a short time scale. 
 
Antibacterial mechanism of silver nanoparticles 
An important aspect in the characterization of metal-based antimicrobial systems regarded the 
study of the mechanisms involved in bacteria inactivation induced by the nanoparticles. As 
discussed in the Introduction section, in the literature the exact antibacterial mechanism has not 
been reported yet, despite the wide use of silver for many applications; the most popular 
explanation is that the main molecular targets in bacteria are the thiol groups (-SH) of the 
membrane proteins exposed to the extracellular portion of the membrane, although it is still not 
clear whether the active species is metallic or ionic silver. In our cytofluorimetry studies we 
demonstrated that the potent bactericidal activity of Chitlac-nAg is associated with bacteria 
membrane depolarization and permeabilization, thus confirming that the nanoparticles induce 
damages at bacteria membrane level (Paper 2). It was also important to prove that bacteria 
inactivation persists when the nanoparticles are entrapped in the polymer matrix (Paper 2 and 4), 
which suggests that nanoparticles can exert their antimicrobial activity by simple contact with 
the bacteria. 
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The contact mechanism proposed was confirmed also in the case of the nanocomposite layer 
deposited on the methacrylic thermoset, where silver nanoparticles are embedded in the Chitlac 
matrix attached onto the resin surface; also in this case, bacteria are killed upon direct contact 
with the silver-containing material, while the metal release is negligible and does not cause any 
biological effect (Paper 4). 
 
Cytotoxicity issues 
The issue of possible adverse effects and toxicity of nanoparticles toward eukaryotic cells was a 
central point in the development of our nanocomposite biomaterials.  
Although in the literature a widely accepted consensus on the detailed molecular mechanism of 
nanoparticles toxicity is still missing, it is possible to state that a lack of physical barriers to 
nanoparticle diffusion into cells determines their generalized availability, with the risk of a 
massive uptake by cells, which eventually leads to their death. In this work we have verified that 
nanoparticles in the colloidal solution state exerted cytotoxicity effects (Paper 2, Paper 5); at 
variance, the grafting of silver nanoparticles in the hydrogel (Paper 2) or coating (Paper 4) 
structures ruled out any risk of toxicity while keeping the antimicrobial properties unaltered. 
This was ascribed to the fact that, while in bacteria the main molecular targets of silver are thiol 
groups of proteins exposed to the extracellular portion of the membrane, eukaryotic cells do not 
have exterior proteins with thiol groups; thus, silver ions or nanoparticles must first permeate 
through cell membranes to react with thiol groups of intracellular proteins and enzymes, which 
can happen only upon nanoparticles internalization. In light of this explanation, our strategy of 
incorporating silver nanoparticles on the surface of the polysaccharide matrix was effective to 
overcome cytotoxicity issues.   
 
Preliminary evaluation of gold nanocomposites 
The study of gold nanoparticles was preliminary tackled because this metal is also widely 
employed for biomedical applications and its use in the antimicrobial field has been proposed 
(Paper 5). We managed to prepare homogeneous and stable colloidal solutions of gold 
nanoparticles formed in Chitlac; the antimicrobial activity was proved both in solution and in the 
form of hydrogels obtained in association with alginate (AC-nAu). Nevertheless, these 
nanocomposite hydrogels displayed cytotoxic effects towards eukaryotic cells exerted due to 
apoptosis mechanisms, at variance with silver-based gels. Additional work is needed to further 
elucidate the cause of this biological effect. 
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5. CONCLUDING REMARKS 
 
In spite of extensive research over the recent years in the field of antimicrobial biomaterials 
based on metal nanocomposites, further studies on the antibacterial mechanism and on possible 
cytotoxicity towards eukaryotic cells are needed in order to develop new materials that can 
exploit the peculiar properties of noble metals at the nano-scale without representing a threat for 
human health. The present work aimed at realizing a coating for a new generation bone 
prosthesis, whose surface should be able to prevent infections without being harmful to cells of 
the tissues surrounding the implant. 
In this respect, we have shown that natural polysaccharides can be successfully employed to 
prepare homogeneous nanocomposite systems which, depending on their physical status 
(colloidal solution, hydrogel, coating) and on the nature of the nanoparticles (silver or gold), can 
be used to realize biocompatible materials for antimicrobial applications. Since the most 
important results were obtained in the case of silver nanoparticles, the main part of the work was 
based on this metal, while the studies on gold nanoparticles can be considered a preliminary 
investigation.  
 
In particular, it was demonstrated that: 
 
• the polysaccharide Chitlac can be efficiently used as a reducing agent for silver ions as 
well as a stabilizer of the nanoparticles. This “green synthesis” is based on a particular 
mechanism (Fetizon reaction) that brings to the preparation of colloidal solutions for 
biological and optical applications; 
 
• silver nanoparticles prepared in Chitlac solutions display remarkable antibacterial activity 
due to the interaction between metal and bacteria membranes; such colloidal solution is 
toxic also for eukaryotic cells, which suggests the need to prevent the cellular 
internalization of nanoparticles;  
 
• the miscibility of Chitlac-silver colloidal solution with the polysaccharide Alginate led to 
the preparation of homogeneous hydrogels (AC-nAg) that entrap the nanoparticles and 
inactivate bacteria upon direct contact with the nanocomposite material;  
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• AC-nAg hydrogels are able to exert a broad spectrum antibacterial activity without being 
harmful to mammalian cells both in vitro and in vivo;  
 
• methacrylic thermosets (BisGMA/TEGDMA), which represent the substrate material of 
the prosthesis (when reinforced with glass fibres), can be coated with Chitlac-based 
systems by a deposition technique that exploits electrostatic forces between the 
polyelectrolyte and the activated thermoset surface, leading to cell proliferation rates 
comparable to clinically used titanium; 
 
• this deposition technique can also bring to the preparation of a nanocomposite coating 
where silver nanoparticles are grafted within the Chitlac matrix; such material endows 
the thermoset surface with potent antimicrobial properties while, at the same time, 
allowing for adhesion and proliferation of eukaryotic cells; 
 
• the techniques devised follow a non-demanding chemical approach based on reliable and 
reproducible procedures. 
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Alditol bearing chitosans have shown the ability to reduce silver ions in mild conditions and without addition of
exogenous reducing agents. The ion reduction induces the formation of a lactone moiety on the polysaccharide
(Fetizon reaction) without causing C-C bond cleavage on the polyol. The close and multivalent arrangement of
the endogenous reducing agent (alditols) on the polysaccharide backbone resulted in the formation of silver
nanoparticles (L < 10 nm), which induced a considerable SERS effect and led to hydrogel formation.
Introduction
Stable and well dispersed nanoparticles can be obtained by
adding the metal precursor (like metal salts) to a polymer
solution followed by reduction with an exogenous reducing
agent. Stabilizers (like polymers) play an important role in
controlling the formation and dispersion stability1 of nanopar-
ticles, while avoiding their aggregation. In particular, polymers
containing amino groups like chitosan2 and poly(ethyleneimine)3
efficiently coordinate metal ions, enabling the formation of
particles of small dimensions. In addition, exogenous reducing
agents are used such as ascorbic acid,4,5 sodium borohydride,6
sodium citrate,7 polyols, hydroxyalkyl radicals, and aldehyde
groups of reducing sugars.8,9 In particular, in the case of polyols,
the silver-reduction mechanism typically involves heat treatment
and could lead to C-C bond cleavage.10-14
Lactit-1-yl chitosan (Chitlac) is an engineered polysaccharide
characterized by multifunctional properties modulating its
chemical and biological features. In fact, the presence of the
lactitol side chains on the polysaccharide backbone endows such
a weak polycation with a very high solubility over a wide pH
range and with the ability to efficiently disperse silver nano-
particles formed from AgNO3 by the addition of an exogenous
reducing agent (i.e., ascorbic acid). This particular aspect points
to the possibility of using Chitlac in the preparation of
antibacterial and noncytotoxic films and hydrogels for bioma-
terial applications.15 Moreover, the presence of a large number
of galactose moieties arranged on the polymer side chain triggers
chondrocytes adhesion and proliferation by the interaction with
S-type lectins: this galectin-mediated cell stimulation enhances
production of type-II collagen and GAGs production.16-18
Because of the presence of the lactitol side chain, Chitlac
overcomes the chemical and biological limitations of the parent
polysaccharide, chitosan.
In the present contribution, Chitlac was used as both
dispersing and reducing agent for silver nanoparticles. In
particular, the alditol group linked on the chitosan backbone is
shown, for the first time, to be able to reduce silver ions in
mild conditions following the Fetizon oxidation mechanism.
Experimental Section
Materials. Chitosan was purchased from Aldrich Chemical Co.
(U.S.A.) and purified as reported elsewhere.16 The residual degree of
acetylation was 11.3 ((0.3)%, as assessed by 1H NMR. The molecular
weight of the sample was 650000, as estimated from viscosity
measurements. Silver nitrate, ascorbic acid, and 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) were purchased from Sigma
Chemical Co (St. Louis, MO). All other chemicals were of analytical
grade.
Synthesis of Saccharide Derivatives of Chitosan. Chitosan (300
mg) was dissolved in 21 mL of a 1:1 mixture of methanol and 1%
acetic acid (pH 4.5); 12 mL of the same methanol/acetic acid mixture
containing a saccharide (2.5 equiv) and sodium cyanoborohydride (6
equiv) were then added. The solution was stirred at room temperature,
diluted with water, and dialyzed against deionized water. The polymer
solution was filtered through 0.45 µm Millipore filters and freeze-dried.
The composition of the modified chitosans is reported in Table 1 of
the Supporting Information.
Oxidation of Glucitol by the Tollens Assay. Sodium hydroxide (2
M, 2 mL) is poured into a silver nitrate solution (5%, 2 mL).
Ammonium hydroxide solution (10%) is then added until the precipitate
is completely dissolved. A few drops of this solution are then dropwise
added to a solution containing glucitol (1%). The formation of a silver
mirror is immediate.
Chitlac-Silver Nanoparticles (Chitlac-nAg) Preparation.
Preparation without Ascorbic Acid. Silver nanoparticles were obtained
by reducing silver ions in Chitlac solutions according to the following
procedures: freeze-dried Chitlac was dissolved in deionized water to
obtain solutions with different concentrations (2 g/L and 4 g/L). Chitlac
solutions were mixed with AgNO3 solutions to achieve final concentra-
tions of 1, 5, 10, and 14 mM. The solution was vigorously stirred at
25 °C and its color immediately turned to dark-orange.
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Preparation with Ascorbic Acid. Silver nanoparticles were obtained
by reducing silver ions with ascorbic acid in Chitlac solutions according
to the following procedures: freeze-dried Chitlac was dissolved in
deionized water in order to obtain solutions with different concentrations
(2 g/L and 4 g/L). Chitlac solutions were mixed with AgNO3 solutions
to achieve final concentrations of 0.5 and 1 mM; then ascorbic acid
(C6H8O6) solutions were added to final concentrations of 0.25 and 0.5
mM, respectively. The solution was vigorously stirred at 25 °C and its
color immediately turned to dark-orange.
Chitlac-Silver Nanoparticle (Chitlac-nAg) Hydrogels. Chitlac (4
g/L) was dissolved in HEPES buffer (10 mM) at pH 7 and mixed with
AgNO3 (final concentration, 14 mM). The solution was stirred
vigorously and incubated at room temperature. Hydrogel formation was
noted few hours after mixing of the components.
UV-vis Spectroscopy. UV-visible spectroscopy measurements
were performed with a Cary 400 spectrophotometer (data interval: 0.5
nm; scan speed: 300 nm/min). All sample solutions were diluted 1:10.
Transmission Electron Microscopy (TEM). TEM images were
taken by means of a PHILIPS EM 208 microscope; the solutions were
deposited onto Nickel grids coated with a carbon film and dried
overnight.
Raman Spectroscopy. Raman spectra were collected using an inVia
Raman system (Renishaw plc, Wotton-under-Edge, U.K.). The laser
(514.5 nm argon-ion laser, LaserPhysics, West Jordan UT, U.S.A.) was
focused on the sample by a 20× objective (0.4 NA). Laser power at
the sample was 3 mW; to minimize laser-induced photodegradation of
the sample, the laser power density was lowered by defocusing the
beam by 10%. The exposure time was 5 accumulations of 10 s for
each spectrum, for a total exposure time of 50 s per spectrum.
NMR. NMR spectra were recorded in D2O with a 270 MHz Jeol
instrument using 3-(trimethylsilyl) propanesulfonate as internal standard.
Figure 1. (a) Schematic representation of chitosan and of the alditol containing structure of Chitlac, Chitcel, Chitglc, and Chitmel. (b) UV-vis
spectra of Chitlac (2 g/L in deionized water) in the presence of 1 mM (black), 5 mM (red) and 10 mM (green) AgNO3. For comparison, the
UV-vis spectrum obtained from a 2 g/L Chitlac solution in the presence of 1 mM AgNO3 and 0.5 mM ascorbic acid (blue) is also reported. Inset:
evolution with time of the surface plasmon resonance peak at 403nm. (c) UV-vis spectra of 2 g/L solutions of chitosan (black), Chitlac (red),
Chitmel (green), and Chitglc (blue) treated with AgNO3 (10 mM).
Scheme 1. Fetizon Oxidation in the Case of Chitlac, Chitcel, and
Chitglc
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1H NMR spectra of the modified chitosans were recorded at 90 °C,
while 13C NMR spectra of ascorbic acid, glucitol, and silver-oxidized
glucitol were recorded at 25 °C.
FT-IR. Infrared spectra of silver-treated Chitlac in KBr were
recorded with a FT-IR Perkin-Elmer 2000 System spectrometer.
Mechanical Spectroscopy. Dynamic viscoelastic characterization
was carried out on a Stress-Tech general-purpose rheometer (Reologica
instruments AB, 22363 Lund, Sweden). The experiments were per-
formed at 25 °C with a serrated plate-plate (d ) 40 mm) measuring
geometry with a gap of 1.00 mm. Frequency sweeps were performed
at a constant strain (0.001) in the frequency range 0.01-5 Hz. The
sample was sealed with a low-density silicon oil to avoid adverse effects
associated with evaporation of the solvent.
Results and Discussion
In the present paper, we focus on the possibility of exploiting
the glucitol-component of the side chain of Chitlac, that is, the
open-chain polyol part, as Ag+ reducing agent for the formation
of silver nanoparticles. In this sense, Chitlac could be granted
of an additional functionality, that is, the ability to “auto-reduce”
the metal ions without requiring additional exogenous reactants.
This idea springs from the observation of the reducing properties
of alditols toward silver ions. As such, alditols do not conform
to the classic definition of “reducing sugars” and are not
expected to give rise to a positive Tollens assay. In fact, Ag+
belongs to a group of oxidizing agents that are unable to oxidize
alcoholic groups under mild conditions (i.e., room temperature).
However, according to the Fetizon oxidation mechanism, diol-
containing molecules could be efficiently oxidized by silver ions,
provided that five- or six-membered rings are formed.19 To
prove the applicability of the above-reported oxidation mech-
anism, glucitol was treated under the Tollens conditions with
silver ions, instantaneously leading to the formation of a silver
mirror and to a complex mixture of oxidation products of
glucitol (see Supporting Information). The peak at ∼173 ppm
in the 13C NMR of the oxidized mixture likely stems from the
presence of a lactone group much like in another lactone-
containing oxidized sugar derivative, namely ascorbic acid. As
such, these results seem to point (for the first time to the best
of the authors’ knowledge) to the ability of alditols to reduce
silver ions by means of the Fetizon oxidation mechanism.
Prompted by these results, the silver-reducing ability of the
glucitol moiety entrapped in the side chain of the lactit-1-yl
chitosan was assessed (Figure 1b). Upon addition of silver ions
to the polysaccharide solution, a sharp and intense surface
plasmon resonance peak, arising from the formation of metallic
nanoparticles, is displayed without requiring exogenous reducing
agents. The shape of the surface plasmon resonance peak at
403 nm suggests a narrow size distribution of the silver
nanoparticles obtained through this approach.3,20 The presence
and the close arrangement of the Ag+-coordinating amino group
and of the reducing component (glucitol) in a polyvalent
assembly account for a strong enhancement of reactivity, as
nonpolymer-linked glucitol is ineffective at the same alditol
molar concentrations. Moreover, they produce a very fast
kinetics of the reduction (Figure 1b inset), as the maximum
intensity of the surface plasmon resonance was reached a few
minutes after
the addition of silver ions to the polymer solution. Finally, the
polymer component also allowed the stabilization of the silver
nanoparticles toward coalescence, maintaining them stable over
several months.
To gain a more detailed insight into the mechanism of silver
ion reduction, different oligosaccharide derivatives of chitosan
have been prepared, all being characterized by the presence of
a glucitol in the side chain (Figure 1a). Chitlac, Chitcel, and
Chitglc were all able to efficiently reduce silver ions in aqueous
solution in mild conditions without the addition of exogenous
reducing agents (Figure 1c), as revealed by the presence of a
surface plasmon resonance band at 403 nm. In all cases, the
formation of silver nanoparticles is traced back to an oxidation
process involving the glucitol moiety in the modified polysac-
charide. In fact, neither native chitosan nor other nonglucitol-
containing polyols like dextran (data not reported) were able to
lead to a plasmon resonance band once treated with silver nitrate.
The first step of the Fetizon oxidation mechanism is the
oxidation of a primary alcohol to an aldehyde group. This is
followed by the formation of a cyclic hemiacetal, which is
further oxidized to lactone. These requirements are met by the
chitosan samples modified with glucose, lactose, and cellobiose
where the Ag+ treatment can lead to the formation of a lactone
intermediate involving the C6 and C2 (six-membered ring) or
C3 (five-membered ring) of the glucitol moiety (Scheme 1).
As a negative control, in melibiose-modified chitosan (Chitmel)
the primary alcohol at C6 is not available for the oxidation by
silver ions: no reduction was observed (Figure 1c). Because
chitosan and all its oligosaccharide derivatives tested have been
prepared as hydrochloride salts, a direct effect of the counterion
(chloride) in the formation of the nanoparticles21,22 can be ruled
out. Moreover, it is important to underline that the present
mechanism, at variance with previous reports on the use of
Figure 2. (a) Raman-SERS spectra of Chitlac ( · · · · , 50 g/L) and Chitlac treated with 14 mM AgNO3 (s, 4 g/L). (b) TEM micrograph of silver
nanoparticles in Chitlac (4 g/L, AgNO3 14 mM).
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polyols for silver ion reduction, requires mild conditions and
does not cause C-C bond cleavage.
The lactone group formed after treatment of Chitlac, Chitcel,
and Chitglc with silver ions is surrounded by water molecules
and by several hydroxyl groups from the modified polysaccha-
ride itself. It follows that the lactone groups can undergo (i)
hydrolysis or (ii) trans-esterification reactions. The former case
is likely to occur when the treatment with silver ions is
performed under slightly acidic media. This hypothesis was
corroborated by the appearance of a IR peak at around 1384
cm-1 and of a SERS peak around 1390 cm-1 (Figure 2a), which
can be assigned to the vibrational frequency of the carboxylic
moiety upon AgNO3 treatment of Chitlac in deionized water.
The peak at 1390 cm-1 is considered to be characteristic of
carboxylic acids adsorbed on silver and corresponds to the
symmetric stretching mode of a carboxylate.23,24
In the trans-esterification reaction the lactone group can react
with hydroxyl groups located on different polysaccharide chains
leading to a chemically cross-linked network. Hence, the silver-
induced oxidation of the polysaccharide results in a chemical
hydrogel. In the case of Chitlac, the gel formation process upon
treatment with silver ions at pH 7 is very effective and a
semisolid system (albeit a weak one) is achieved even with a
relatively low concentration of polysaccharide (4 g/L), as
qualitatively confirmed by shear rheology (see Supporting
Information). Although further analysis is required to character-
ize the kinetics of gel formation and dissolution, it can be
anticipated that a complete degradation of the ester bonds in
water environment spans over 1 week. This latter aspect points
to a possible and very appealing application of branched
chitosans for the preparation of silver containing antibacterial
hydrogels with programmed erosion for topical use.
Overall, the Chitlac molecule represents a polyvalent system
containing both a coordinating group and the reducing agent in
spatial proximity for the production of silver nanoparticles. From
these considerations, it can be foreseen that nanoparticles of
very small dimensions and in close contact with the polysac-
charide chain are obtained. Transmission electron microscopy
confirmed the presence of well dispersed nanoparticles with an
average diameter smaller than 10 nm, together with few larger
particles (∼ 30 nm) (Figure 2b). Such close arrangement of
electron dense metal particles allows obtaining a very strong
SERS effect (Figure 2a) when the Raman spectrum of this
polymer is recorded. In fact, the intensity of the signals arising
from the polysaccharide is enormously enhanced when these
small silver nanoparticles are present. Given the biological
significance of Chitlac and its ability of interacting with different
carbohydrate-binding proteins, the SERS effect becomes par-
ticularly appealing in designing novel and specific biosensors.
Conclusion
In the present manuscript, we propose a new mechanism for
the formation of stable silver nanoparticles based on the presence
of alditols in an engineered polysaccharide; this integrated
system displays multivalent properties that can be exploited in
biological and optical applications. The reduction of silver ions
is achieved through the Fetizon oxidation mechanism that, for
the first time, is shown to work on alditols. An insight on the
detail of the mechanism proposed and on the complete
characterization of the different products will be tackled in a
future work.
Supporting Information Available. A complete description
of materials and methods. This material is available free of
charge via the Internet at http://pubs.acs.org.
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In this work we study (i) the formation and stabilization of silver nanoparticles in a bioactive chitosan-derived
polysaccharide solution, (ii) the antimicrobial properties, either in solution or in 3D hydrogel structures, obtained
by mixtures with the polysaccharide alginate, and (iii) the cytotoxicity of the latter nanocomposite materials on
different eukaryotic cell lines. Antimicrobial results show that these nanocomposite systems display a very effective
bactericidal activity toward both Gram+ and Gram- bacteria. However, the hydrogel does not show any cytotoxic
effect toward three different eukaryotic cell lines. This is due to the fact that the nanoparticles, immobilized in
the gel matrix, can exert their antimicrobial activity by simple contact with the bacterial membrane, while they
can not be uptaken and internalized by eukaryotic cells. This novel finding could advantageously contribute to
responding to the growing concerns on the toxicity of nanoparticles and facilitate the use of silver-biopolymer
composites in the preparation of biomaterials.
1. Introduction
Since ancient times, silver has been extensively used to
control infections. At present, silver as an antimicrobial agent
is gaining increasing appeal for medical applications because
antibiotic-resistant bacterial strains have become a major issue
in public health care.1-3 Silver-based medical products, ranging
from topical ointments and bandages for wound healing to
coated stents, have been proven to be effective in retarding and
preventing bacterial infections.4 Improvements in the develop-
ment of novel silver nanoparticles-containing products are
continuously sought. In particular, there is an increasing interest
toward the exploitation of silver nanoparticles technology in
the development of bioactive biomaterials, aiming at combining
the relevant antibacterial properties of the metal with the peculiar
performance of the biomaterial.5-9
However, a widely accepted consensus on the detailed
molecular mechanism of silver nanoparticles toxicity is still
missing. It is possible to state that a lack of physical barriers to
nanoparticle diffusion into cells determines their generalized
(bio)availability, with the risk of a massive uptake by eukaryotic
cells, which eventually leads to their death.10 A critical survey
of the present nanotechnology literature suggests that the drive
toward new formulations often overwhelms the interest for a
better assessment of the cytotoxicity of the nanoparticles. In
fact, the issue of possible adverse effects and toxicity of
nanoparticles for the human body is progressively recognized
as central by a still limited, albeit increasing, number of
studies.11 So far, water-based biomaterials able to successfully
combine antibacterial properties of silver nanoparticles with
demonstrated absence of cytotoxicity have not yet been reported
in the literature. At the nanometric level, a crucial issue about
silver nanoparticles is their tendency to aggregate, thus losing
the peculiar properties associated with the nanoscale. Conse-
quently, the preparation and stabilization of metal nanoparticles
represent to date an open challenge. To this scope, polyelec-
trolytes in small concentration, such as polyphosphate, poly-
acrylate, poly(vinyl-sulfate), poly(ethylene-imine),12-14 poly(allyl-
amine),8 and chitosan,7,15,16 have been used with variable results
to stabilize the nanoparticles preventing the growth of ag-
gregates, in addition to the more widely used poly(vinyl-
pyrrolidone),17 a neutral polymer. The stabilization of metal
nanoparticles is explained by the electronic interaction of the
polymer functional groups with the metal particles. In fact, their
(albeit minor) nucleophilic character is sufficient to bind the
metal particles by donating electrons.14 Protective polymers can
coordinate metal ions before reduction, forming a polymer-metal
ion complex; such a complex can then be reduced under mild
conditions, resulting in a smaller size and a narrower size
distribution than those obtained without protective polymers.18
Once the reduction occurred, the stabilizing effect of these
macromolecules is attributable to the fact that either the particles
are attached to the much larger protecting polymers or the
protecting molecules cover or encapsulate the metal particles.8
To find applications in the biomaterials field, both the stabilizing
and the reducing agents must not represent a biological hazard.19
Chitosan, a natural saccharidic polybase composed of -(1f4)-
linked glucosamine residues interspersed with residual N-acetyl-
glucosamine moieties, has been previously used to prepare and
stabilize metal nanoparticles.7,15,16 However, the limitations of
such polysaccharide are connected with its pH-dependent
solubility (limited to low pH only, as a polycation), immiscibility
with other oppositely charged polyelectrolytes and lack of cell-
specific molecular signals. To overcome these problems, we
decided to use a lactose-substituted chitosan, 1-deoxylactit-1-
yl chitosan, short-named “Chitlac”. Chitlac is a highly branched
polymer devoid of pH limitations as to aqueous solubility; it is
both biocompatible and bioactive, owing to the terminal
galactose unit on the side chain.20 In addition, at neutral pH
the moderately cationic Chitlac can give rise to soluble binary
mixtures with alginate, an anionic polysaccharide composed of
(1f4)-linked R-L-guluronic acid and -D-mannuronic acid
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residues. These mixtures were shown to be able to form stable
hydrogels in cell-friendly conditions.21,22
The aim of this work is (i) to characterize the formation and
stabilization of silver nanoparticles in Chitlac solutions, (ii) to
assess the antimicrobial properties, either in solution or in 3D
hydrogel structures, obtained by mixtures with the polysaccha-
ride alginate, and (iii) to evaluate the cytotoxicity of the latter
nanocomposite materials on different eukaryotic cell lines.
2. Materials and Methods
2.1. Materials. Chitlac (1-deoxylactit-1-yl chitosan, CAS registry
number 85941-43-1) sample was prepared according to the procedure
reported elsewhere23 starting from a highly deacetylated chitosan
(residual acetylation degree ) 11.3%, Aldrich Chemical Co. (U.S.A.)).
The molecular weight of Chitlac was estimated to be approximately
1.5 × 106. Alginate (Mw ∼ 130000, FG ) 0.65, FGG ) 0.53) was
provided by FMC Biopolymers. Silver nitrate, ascorbic acid, lead citrate,
uranyl acetate, 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid,
CaCO3 (mean particle size 3 µm), glucono-D-lactone (GDL), and LDH
(lactate dehydrogenase)-based TOX-7 kit (Sigma-Aldrich) were pur-
chased from Sigma Chemical Co (St. Louis, MO). Mueller Hinton (MH)
was from Difco Microbiology (Sparks, MD).
2.2. Chitlac-Silver Nanoparticles (Chitlac-nAg) Preparation.
Silver nanoparticles were obtained by reducing silver ions with
ascorbic acid in Chitlac solutions according to the following procedures:
freeze-dried Chitlac was dissolved in deionized water to obtain solutions
with different concentrations (1, 2, and 4 g/L). Chitlac solutions were
mixed with AgNO3 solutions to achieve final AgNO3 concentrations
of 0.5 and 1 mM; then ascorbic acid (C6H8O6) solutions were added at
final concentrations of 0.25 and 0.5 mM, respectively. For antibacterial
tests 20% Mueller-Hinton broth was added to Chitlac-nAg solutions.
2.3. Hydrogels Preparation. 2.3.1. AC-Gel. For the preparation of
alginate-Chitlac hydrogels (AC-Gel), an in situ calcium release
approach was used. Briefly, a Chitlac solution was added to an alginate
solution (final concentrations: alginate 15 g/L, Chitlac 2 g/L, NaCl 0.15
M, HEPES buffer 0.01 M, pH 7.4) and the mixture was blended with
an inactivated form of Ca2+ (CaCO3, 15 mM) followed by the addition
of the slowly hydrolyzing D-glucono-δ-lactone (GDL; [GDL]/[Ca2+]
) 2). Aliquots of this gelling solution were poured into well tissue
culture plates. Finally, the gels were washed with CaCl2 solution 5
mMtoremoveresidualGDL.Forantibacterial tests,20%Mueller-Hinton
broth was added to both Chitlac and alginate solutions.
2.3.2. AC-nAg-Gel. Alginate-Chitlac hydrogels containing silver
nanoparticles were prepared according to the procedure of the AC-
Gels using Chitlac-nAg instead of Chitlac solutions. For antibacterial
tests, 20% Mueller-Hinton broth was added to both Chitlac and alginate
solutions.
2.4. UV-Vis Spectroscopy. UV-visible spectroscopy measure-
ments were performed with a Cary 400 spectrophotometer (data interval,
0.5 nm; scan speed, 300 nm/min). All samples solutions were diluted
1:10.
2.5. Transmission Electron Microscopy (TEM). TEM images
were taken by means of a PHILIPS EM 208 Microscope; the solutions
were deposited onto Nickel grids coated with a carbon film and dried
overnight. In the samples in which the polymer was stained, a mixed
solution of lead citrate (5 g/L) and uranyl acetate (5 g/L) was added
1:1 to the Chitlac-silver nanoparticles (nAg) solutions.
2.6. Bacterial Killing Kinetics Assays. The killing kinetics assays
were performed using cultures of E. coli (ATCC 25922), S. epidermidis
(clinical isolate), S. aureus (ATCC 25923), and P. aeruginosa (ATCC
27853) diluted in 20% Mueller-Hinton broth to give 1 × 106 CFU/mL
(CFU ) colony forming units) in the presence or absence of Chitlac-nAg.
The bacterial suspensions were then incubated in a shaking water bath at
37 °C. At the indicated times, samples were removed, serially diluted with
buffered saline solution, plated in duplicate on Mueller-Hinton agar, and
incubated for 24 h to allow colony counts. Data are the mean of at least
four independent determinations with comparable results.
2.7. Growth Inhibition Assays in Solid Medium. The growth
inhibition in solid medium was evaluated after smearing, with sterile
cotton swabs, of bacterial suspensions at final concentrations of 106
and 105 CFU/mL on Petri dishes prepared as described above (hydrogel
preparation). After overnight incubation at 37 °C, the presence of visible
colonies was evaluated. Growth controls were carried out on
Mueller-Hinton agar plates and AC gels in the presence of
Mueller-Hinton medium.
2.8. Evaluation of Bacterial Membrane Alteration by Flow
Cytometric Assays. Flow cytometric assays were used to evaluate the
transmembrane potential and the membrane permeabilization of bacte-
rial cells treated with the system Chitlac-nAg. For these analyses,
midlogarithmic phase bacterial cultures were diluted in 20% MH broth
to 1 × 106 CFU/mL. Aliquots of the bacterial suspension were then
incubated with or without (controls) the system Chitlac-nAg for 10 or
30 min at 37 °C. At the end of the incubation time, the bacterial
suspensions were incubated in the dark for 4 min at 37 °C with bis-
(1,3-dibutylbarbituric acid)-trimethine oxonol (DiBAC4(3); Molecular
Probes Inc., Eugene, OR) at a final concentration of 1 µM to evaluate
alterations in the transmembrane potential. The fluorescence intensity
was detected with a Cytomics FC 500 instrument (Beckman-Coulter,
Inc., Fullerton, CA) equipped with an argon laser (488 nm, 5 mW)
and using a photomultiplier tube fluorescence detector for green (525
nm) filtered light. The detectors were set on logarithmic amplification.
Optical and electronic noise were eliminated by setting an electronic
gating threshold on forward scattering detector, while the flow rate was
kept at a data rate below 200 events/second to avoid cell coincidence.
For each sample, at least 10000 events were acquired and stored as list
mode files. Membrane permeabilization following treatment with the
system Chitlac-nAg was determined by means of a flow cytometer,
measuring the propidium iodide (PI; Sigma-Aldrich) uptake by bacterial
cells. For the analyses, bacterial suspensions of 1 × 106 cells/mL were
incubated in 20% MH broth with the system Chitlac-nAg at 37 °C for
different times. A filtered solution of propidium iodide was then added
to the bacterial suspensions at a final concentration of 10 µg/mL, and
the cells were analyzed in the flow cytometer after 4 min incubation at
37 °C. The fluorescence intensity was detected as reported above using
a detector for red light (610 nm). All the experiments with the
fluorescent probes were conducted in triplicate and the analysis of data
was performed with the WinMDI software (Dr. J. Trotter, Scripps
Research Institute, La Jolla, CA, U.S.A.).
2.9. LDH Cytotoxicity Assay. In vitro cytotoxicity of AC-nAg-
Gels was evaluated by using the lactate dehydrogenase assay (LDH
assay, TOX-7, Sigma) on the mouse fibroblast-like (NIH-3T3), human
hepatocarcinoma (HepG2), and human osteosarcoma (MG63) cell lines,
respectively. Cylindrical gel samples, with a length of 5 mm and a
diameter of 4 mm, were used and the tests were performed by direct
contact with the gel or with liquid extract of the gel material. For a
direct contact test, 70000 cells were plated on 24-well plates and, after
complete adhesion, culture medium was changed with 250 µL of fresh
medium. Tested materials (in quadruplicate) were directly deposited
on the cell layer. After 24 and 72 h, medium was collected and the
LDH assay was performed according to the manufacture’s protocol.
In an extraction test, samples were incubated in extraction medium
(Dulbecco’s modified Eagle’s medium, inactivated fetal bovine serum
10%, penicillin 100 U/mL, streptomycin 100 µg/mL, and L-glutamine
2 mM) for 24 h at 37 °C and 5% pCO2. The surface/volume ratio of
the samples and the medium was 1.25 cm2/mL. After incubation,
extraction media were added on cells seeded on 24-well plates (70000
cells/well). The LDH assays were performed after 24 and 72 h as
described above. Each material test was performed in quadruplicate.
Evaluation of cytotoxicity was calculated according to the formula: %
LDH released ) [(A - B)/(C - B)] × 100%, with A ) LDH activity
in the culture medium of gel-treated or extraction medium-treated cells;
B ) LDH activity of culture medium from untreated cells; and C )
LDH activity after total cell lysis).
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2.10. Preparation of Microspheres and ICP-MS Analysis. Cal-
cium microspheres from AC-nAg mixtures (final concentrations:
alginate 15 g/L, Chitlac 2 g/L nAg, NaCl 0.15 M, HEPES 0.01 M, pH
7.4) were obtained by dripping the polymer blend into a gelling solution
(0.05 M CaCl2). The droplet size was controlled by use of a high-
voltage electrostatic bead generator (7 kV, 10 mL/h, steel needle with
0.7 mm outer diameter, 1 cm distance from the needle to the gelling
solution). The gel beads obtained were stirred for 30 min in the gelling
solution prior to use.
To evaluate the amount of silver released from the AC-nAg gel, the
microspheres were vigorously stirred for 5 weeks in a saline solution
(NaCl 0.015 M) with a volume ratio microspheres/solution of 4; after
incubation, supernatants from the microsphere suspensions were
analyzed by ICP-MS (inductively coupled plasma mass spectrometry).
2.11. MTT Assay. Cytotoxicity of AC-nAg gel microspheres
external solutions was evaluated by the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) reduction assay using mouse
fibroblast (NIH-3T3), human hepatocarcinoma (HepG2), and human
osteosarcoma (MG63) cell lines, respectively. Cells (5000 cells/well)
were seeded into 96-well plates and allowed to adhere for 16 h. Extracts
from the microspheres were then added to cell cultures for 72 h at 37
°C in the presence of DMEM culture medium and 10% fetal bovine
serum. Cell cultures treated with 1% (v/v) Triton-X 100 in complete
DMEM medium or with a solution of 0.015 M NaCl supplemented
with DMEM culture medium and fetal bovine serum were used,
respectively, as positive and negative controls. Finally, MTT (5 mg/
mL in PBS) was added to the medium in each well to obtain a final
concentration of 0.5 mg/mL, and the cell cultures were incubated for
a further 4 h. Cell viability was determined by measuring the cellular
reduction of MTT to the crystalline formazan product, which was
dissolved by addition of 100 µL of DMSO. The formazan concentration
was determined spectrophotometrically at 570 nm.
3. Results and Discussion
Chitlac nanocomposites containing silver were prepared by
chemical reduction of corresponding metal ions to zeroth-valent
metal nanoparticles; the reduction was performed using ascorbic
acid, a nontoxic reagent which can form metallic silver
according to the following stoichiometry:6
2Ag+ + C6H8O6 a 2Ag
0 + C6H6O6 + 2H
+
The formation of nanoparticles, their shape, distribution and
dimensions have been evaluated by means of transmission
electron microscopy (TEM) imaging and analyses. Figure 1a,b
shows the nanoparticles dispersed in Chitlac at two different
magnifications; they are mostly round-shaped and well-
dispersed. TEM images have been analyzed to evaluate the
dimensional distribution, as the size affects the antimicrobial
properties of the nanoparticles.24 The histogram shows a narrow
distribution of the silver nanoparticles dispersed in Chitlac with
a maximum frequency at around 30 nm (Figure 1c) and a mean
Figure 1. (a,b) TEM images of silver nanoparticles dispersed in Chitlac at different magnifications (Chitlac 4 g/L, AgNO3 1 mM, C6H8O6 0.5
mM); (c) silver nanoparticles size distribution histogram based on the TEM image in Figure 1a; the mean particle size is 33.6 ( 7.6 nm; (d) TEM
image of silver nanoparticles formed on the polymeric chains of Chitlac (Chitlac 2 g/L, AgNO3 1 mM, C6H8O6 0.5 mM). Chitlac chains have been
stained with a mixed solution of lead citrate (5 g/L) and uranyl acetate (5 g/L); (e) schematic representation of the polymeric chains of Chitlac
providing the nitrogen atoms for the coordination and stabilization of silver nanoparticles.
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diameter of 33.6 ( 7.6 nm. TEM analyses were conducted also
to visualize the polymeric chains using staining agents (i.e.,
Pb2+, UO22+). As revealed by Figure 1d, Chitlac chains (“gray
threads”) efficiently coordinate the silver nanoparticles (“black
dots”), thus hampering their large scale collapsing (Figure 1e);
the image shows a vein-like structure formed by different
polysaccharide chains, which likely associate as a consequence
of the drying process during sample preparation for TEM
analysis.
The formation of silver nanoparticles was verified also by
means of UV-vis absorption spectroscopy (Figure 2a), where
an intense band centered at about 400 nm was clearly detected.
This band, identified as a “surface plasmon resonance band”,
is due to a collective excitation of the free electrons in the
nanoparticles. The shape of the plasmon band is almost
symmetrical, suggesting that the nanoparticles are well dispersed
and spherical. At variance, the aggregation of nanoparticles
would lead to a broader plasmon band, with a red-shifted
maximum.
The effect of concentration in solution of both polymer and
silver nitrate was explored (Figure 2b). The changes in UV-vis
absorption indicate that the size and dispersion of silver
nanoparticles were affected by both the concentration of Chitlac
(which operates as a controller of nucleation as well as a
stabilizer) and of AgNO3. The highest plasmon peaks were
recorded for Chitlac at 2 and 4 g/L in the presence of AgNO3
1 mM and C6H8O6 0.5 mM. The kinetics of the reduction
process was monitored for 4 h immediately after the addition
of ascorbic acid (Figure 2c). It can be seen that the intensity of
the plasmon resonance peak increases with time; for reaction
times exceeding 4 h no significant increase in the absorption
peak was found. As previously noted, long-term stability of
silver nanoparticles in solution is an important goal to be
reached. In fact, agglomeration of particles may occur upon
aging of solutions which initially contained isolated particles.
Figure 2d shows that the presence of Chitlac allows the
stabilization of silver nanoparticles in solution up to several
months, thus preventing colloidal instability. In view of this
result, it can be safely stated that Chitlac acts as an efficient
stabilizing ligand for silver ions and silver nanoparticles thanks
to the presence of amino groups. Esumi18 demonstrated that
metal nanoparticles can be protected by the exterior amino
groups of dendrimers which act as stabilizers. When AgNO3 is
mixed with Chitlac solutions, Ag+ ions probably give rise to a
localized binding to Chitlac macromolecules via amino groups
chelation persisting also with the formed silver nanoparticles.
The hydrophilic side-chains also play a fundamental role in
the stabilization by embedding the silver nanoparticles bound
in the proximity of the polymer backbone and isolating them
from the surrounding species (Figure 1e). In fact, it is known
that chitosan, which shares with Chitlac the same backbone
chemical structure, is able to stabilize silver nanoparticles
according to the same mechanism proposed above. However, a
comparison of the UV-vis spectra arising from the reduction
of silver ions in the presence of Chitlac or chitosan points to a
marked difference in behavior of the two polysaccharides under
the same experimental conditions (Figure 2a). In fact, a broader,
less intense and nonsymmetrical peak was detected for chitosan,
suggesting the formation of more aggregated nanoparticles. The
better performance of Chitlac must be traced back to the
presence of the highly hydrophilic and bulky lactitol groups
decorating the modified polysaccharide; they provide silver
nanoparticles with coordination (amino groups) and protection
(steric hindrance), thus preventing their aggregation.
In order to study the antimicrobial activity of Chitlac-nAg,
killing kinetics assays were performed with S. epidermidis, E.
Figure 2. (a) UV-vis spectra of silver nanoparticles formed in chitosan (dashed line) and Chitlac (solid line) solutions under the same conditions
(polymer concentrations 2 g/L; AgNO3 1 mM; C6H8O6 0.5 mM). (b) Effect of polymer and AgNO3 concentrations on UV-vis spectra of silver
nanoparticles. In each sample, the AgNO3/C6H8O6 concentration ratio is 2, according to the reaction stoichiometry. (c) Time dependence of
UV-vis spectra variations of Chitlac 2 g/L + AgNO3 1 mM after the addition of ascorbic acid. d) UV-vis spectra of silver nanoparticles in Chitlac
after 1 day (black dashed line) and after 90 days (orange solid line).
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coli, S. aureus, and P. aeruginosa to determine the amount of
viable cells after treatment with Chitlac-nAg solutions. Bacteria
were incubated with Chitlac-nAg for different times and then
plated on Mueller-Hinton agar to allow counting of colony
forming units (CFU). Overall, the Chitlac-nAg system showed
a remarkable bactericidal effect against all four bacterial strains
with a very fast killing kinetics: as representative data, Figure
3a reports the results for the S. epidermidis strain. The number
of viable cells drastically decreased (a drop of 3 log units in
CFU/mL) after only 30 min of incubation with the Chitlac-
nAg system and, after 2 h of treatment, a complete inactivation
of bacterial cells was found.
To study the mechanism by which the system Chitlac-nAg
inactivates bacterial cells, the effect on membrane potential was
evaluated by flow cytometry. Cell membrane depolarization was
assessed by addition of DiBAC4(3), a fluorescent probe able
to selectively enter and fluorescently label the cells whose
membrane potential has collapsed, resulting in an increase of
the mean fluorescence intensity (MFI). The fluorescence inten-
sity of S. epidermidis was shifted toward higher channel numbers
with respect to untreated cells after only 10 min of incubation
with the system Chitlac-nAg, revealing a remarkable depolar-
ization of the cell population (97.5 ( 3.9% of fluorescent cells
vs 2.5 ( 0.8% of the control; Figure 3b-d).
The depolarization effect shown by the use of the DiBAC4(3)
probe suggests that the system Chitlac-nAg interacts with the
bacterial membranes. To evaluate the membrane damage caused
by the system Chitlac-nAg, untreated and treated bacterial cells
were labeled with the fluorescent probe propidium iodide (PI),
which is excluded from cells with an intact plasma membrane
and thus used as a marker of membrane integrity. A remarkable
permeabilizing effect was observed after treatment of S.
epidermidis; when the cells were incubated with Chitlac-nAg
for 10 min, the percentage of PI-positive cells was of 80% versus
<5% of the control. The membrane damage is even more evident
after 30 and 60 min of treatment (>90% PI-positive cells; Figure
3e). Similar results of antibacterial activity were obtained with
all the bacterial strains tested.
LDH tests carried out on the system Chitlac-nAg in solution
pointed out a cytotoxic effect on mouse fibroblast (NIH-3T3),
human hepatocarcinoma (HepG2), and human osteosarcoma
(MG63) cell lines leading to cell death after 24 h (data not
shown). This observation prompted us to focus our attention
toward the preparation of Chitlac-based 3D structures entrapping
the silver nanoparticles. If successful, such hydrogels could
possibly be used in the preparation of bioactive biomaterials.
To this end, the gel forming properties of alginate were exploited
allowing the production of a highly hydrated system in a mixture
with Chitlac-nAg. The rationale of this approach is that the 3D
system could prevent nanoparticles from being available for
eukaryotic cellular uptake but, at the same time, preserve its
antimicrobial activity allowing the direct interaction of the
nanoparticles with the proteins localized on the bacterial surface.
In fact, in bacteria the thiol groups (-SH) of membrane proteins,
exposed to the extracellular portion of the membrane, are the
main molecular targets of the silver antibacterial activity.25-29
At variance, eukaryotic cells do not have exterior thiol groups,
thus silver ions or nanoparticles must first permeate through
cell membranes to react with -SH groups of intracellular proteins
and enzymes, such as inner membrane mitochondrial proteins
and the enzymes of the antioxidant defense mechanism.30-36
The use of alginate allows casting of different gel shapes
(cylinders, slabs, microcapsules, etc.), which makes it possible
to tailor-make different semisolid systems for various applica-
tions. The advantage of the presence of Chitlac over chitosan
Figure 3. (a) Killing kinetics of Chitlac-nAg (solid line) against S.
epidermidis. The dashed line indicates control runs in the absence
of Chitlac-nAg. Results are mean values ((SD) of at least four
independent determinations; (b-d) Dual-parameter dot plot of the side
scatter intensity versus DiBAC4(3) fluorescence relative to S. epi-
dermidis after incubation with Chitlac-nAg; (b) CTRL ) control at 10
min, (c) Chitlac-nAg treated sample after 10 min, (d) Chitlac-nAg
treated sample after 30 min. The table reports the percentage of
depolarized cells and the corresponding mean fluorescence intensity
(MFI) values in nontreated and Chitlac-nAg treated samples; (e) effect
of Chitlac-nAg on the membrane integrity of S. epidermidis. Bacteria
were incubated for 10, 30, and 60 min with Chitlac-nAg in 20% MH
broth. The percentage of PI-fluorescent cells after treatment is shown.
Background values obtained with untreated samples (<5% of per-
meabilized cells) were subtracted to each nAg-treated sample. Results
are the mean ((SD) of 3 independent experiments.
Figure 4. (a) Mixed alginate-Chitlac cylindrical hydrogel containing
silver nanoparticles (AC-nAg gel). (b) AC-nAg microspheres. (c)
Cytotoxicity analysis (MTT assay) on mouse fibroblast (NIH-3T3),
human hepatocarcinoma (HepG2), and human osteosarcoma (MG63)
cell lines of AC-nAg gel microspheres external solutions (S1 and S2,
external solutions not diluted and 1:10 diluted, respectively; T,
cytotoxicity positive control, cells treated with Triton 1%; CTRL,
cytotoxicity negative control, cells treated with 0.015 M NaCl solution).
(d) Growth of S. epidermidis on 20% Mueller-Hinton AC gel (upper
Petri dish) and on 20% Mueller-Hinton AC-nAg gel (lower Petri dish).
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in the preparation of three-dimensional gels is connected with
the ability of the former to allow complete miscibility between
the two oppositely charged biopolymers, as already pointed
out,21 at variance with the latter polycation. This process can
thus be efficiently exploited to entrap silver nanoparticles
stabilized by polycations within a homogeneous gel construct
avoiding coacervation. The final nanocomposite structure arising
from the treatment of the binary mixture of alginate and Chitlac-
nAg with calcium was a yellow-orange yet transparent hydrogel.
(Figure 4a). It is important to underline that neither nanoparticles
aggregation nor polymer phase separation was observed during
and after gel formation. Homogeneous highly swollen micro-
spheres (Ø ) 500 µm) were obtained37 (Figure 4b), which
ensure a high surface/volume ratio. The amount of silver
released by AC-nAg gel microspheres[0] was evaluated from
two independent measurements. The microspheres were kept
under vigorous stirring for 5 weeks in saline solution with a
microspheres/solution volume-ratio of 4; the external solution
was eventually analyzed by ICP-MS to evaluate the amount of
silver released by the microspheres. The concentration of silver
released was 58 µg/L, which corresponds to 2.6% of the total
silver amount inside the microspheres, pointing out that a very
low amount of silver had been released from the gel. The MTT
tests showed that such low concentration of silver released from
the microspheres was not cytotoxic for three different cell lines:
fibroblasts (NIH-3T3), osteoblasts (MG63), and hepatocytes
(HepG2; Figure 4c).
The possibility of obtaining three-dimensional highly hydrated
structures results particularly appealing for tissue engineering
applications in which an ideal candidate biomaterial must
associate antibacterial properties with lack of cytotoxicity. To
assess the extent of bacterial growth on semisolid system, two
different concentrations of the four bacterial strains (106 and
105 CFU/mL, respectively) were smeared on the surface of
nanocomposite AC-nAg gel. Both agar and alginate-Chitlac
gels (AC gels) were used as controls. After overnight incubation,
bacterial colonies were clearly visible on control plates, while
they were completely absent on the silver nanoparticles-
containing gels. Figure 4d shows the case of S. epidermidis;
similar results were obtained with all the strains tested (data
not reported).
We evaluated the cytotoxicity of the nanocomposite system
also in the form of gel (AC-nAg). As reported in Figure 5, AC-
nAg gels did not exert any cytotoxic effect on the cell lines
used. In fact, there was no significant difference in the release
of lactate dehydrogenase between the AC-nAg treated cells and
control groups after 24 and 72 h.
The combination of these results shows that the AC-nAg
hydrogels, besides providing for an efficient stabilization of the
silver nanoparticles against aggregation, are able to display
antibacterial activity without being harmful to mammalian cells.
In the AC-nAg gels, nanoparticles coordinated to Chitlac are
firmly grafted and immobilized in the gel matrix and therefore
do not diffuse into the surrounding environment, as demonstrated
by the ICP-MS analysis.
4. Conclusions
In this work we have successfully obtained new nanocom-
posite systems based on polysaccharides and silver nanoparticles.
The role of the branched polysaccharide Chitlac is fundamental
in the formation and stabilization of well-dispersed silver
nanoparticles having a mean diameter of about 35 nm. Repro-
ducibility of size distribution together with a demonstrated
stability of the nanoparticles over time have been successfully
achieved. Moreover, the use of a nondemanding chemical
approach adds a considerable appeal to the results obtained. The
simultaneous presence, in the final system, of a sugar-based
bioactive polymer for cell stimulation22 and of silver nanopar-
ticles for antibacterial activity represents a major achievement
of the present work. This novel approach arises at the crossover
of nanotechnology and glycobiology. It might pave the way (i)
to facilitate the use of silver nanoparticle-biopolymer composites
in the preparation of bioactive biomaterials and (ii) to provide
new tools to design engineered materials exploiting, to different
purposes, the bioactivity provided by the carbohydrate compo-
nent and the properties of silver at the nanoscale level.
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Bisphenol A glycidylmethacrylate (BisGMA)/triethyleneglycol dimethacrylate (TEGDMA) thermosets and
composites are well-known examples of biomaterials for dental applications that are receiving growing interest
for orthopedic applications. While mechanical bulk properties are guaranteed by the presence of reinforcing fibers,
in vitro and in vivo performances of these materials are ultimately driven by their ability to establish proper
interactions between their surface and the surrounding tissues. Hence, the development of novel chemical processes
enabling the introduction of bioactive molecules on the surface of these methacrylate-based thermosets is of
particular interest. In the present work, we have devised a chemical strategy to expose carboxylic groups on the
surface of the BisGMA/TEGDMA thermoset. The presence of negative charges was confirmed by Fourier transform
infrared-attenuated total reflectance and by UV-vis spectrophotometry. Bulk mechanical properties and surface
morphology of the thermoset were only slightly affected upon chemical functionalization. The activated material
was further refined by the deposition of a lactose-modified chitosan (chitlac) driven by strong electrostatic
interactions. The presence of the bioactive polysaccharide was confirmed by fluorescence spectroscopy and by
confocal laser scanning microscopy measurements. Scratch tests were performed to evaluate the mechanical behavior
of the coating. Finally, in vitro tests revealed that the presence of chitlac led to a slight enhancement of cell
proliferation with respect to the unmodified BisGMA/TEGDMA thermoset. This effect was more pronounced
when chitlac decorated with an arginine-glycine-aspartic acid (RGD) peptide was used in the preparation of the
coating. In the latter case, the in vitro performance of the coated BisGMA/TEGDMA thermoset became comparable
with that of clinically used roughened titanium.
1. Introduction
The reconstruction of large bone defects represents an
extraordinary challenge for biomaterial design and manufactur-
ing as it requires a balanced combination of biochemical,
biophysical, and material science concepts. In particular, an ideal
biomaterial should be able to merge an advanced technological
approach (like design of the implant by aid of computer
tomography and rapid prototyping) with an appropriate bio-
chemical focus on its interaction with the surrounding tissues.
Metallic implants, such as titanium compression plates and
femoral nails, have been largely used for fixing different bone
fractures. Apart from the numerous advantages, such materials
do present limitations with respect to formability and compat-
ibility with advanced imaging techniques (e.g., MRI).1,2 In
addition, the mismatch in mechanical properties between the
metallic implant and the surrounding tissue causes the so-called
“stress shielding” effect leading ultimately to periprosthetic bone
loss.3
Thermosets based on the light-induced reticulation of Bis-
GMA and TEGDMA have found a large use in the biomedical
field, in particular, in dentistry. BisGMA-based biomaterials
were originally developed for dental composites more than 25
years ago and are nowadays used in most of the commercial
products.4 These thermoset materials are prone to be reinforced
with fibers, for example, glass fibers (FRC, fibers reinforced
composite), rendering them particularly interesting for load-
bearingconditionssuchasindental5,6andorthopedicapplications.7–10
Apart from the considerations on the bulk properties of the
materials (mostly due to the fiber component), it is important
to stress the fundamental role played by the material surface in
triggering the interaction with the surrounding tissues.11 Pro-
cesses like protein adsorption and cell adhesion, which are
fundamental steps in the biological integration of the implant,
are promoted or prevented depending on electric charge,
hydrophilicity/hydrophobicity, and the presence of specific
signals on the surface of the material. As an example, BisGMA
composite materials coated with bioactive glass have been
proposed in the reconstruction of critical size calvarial bone
defects12 and in frontal bone defect repair.13 In both cases, the
bioactive FRC-implant promoted the healing of critical size bone
defects and it has shown the potential to become a feasible
alternative to bone grafts.
Among the different biomolecules used to decorate the surface
of biomaterials, polysaccharides possess unique properties. They
compose the natural highly hydrated structure embedding cells,
known as “extracellular matrix” (ECM). Polysaccharides provide
for the biomechanical performances of the ECM, enabling both
biological recognition and proper viscoelastic responses to
stresses. These biomolecules have raised notable interest in the
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field of biomaterials as their physical-chemical characteristics,
as well as the chemical composition, influence their interaction
with biological systems.
Several reports have focused on the ability of positively
charged polyelectrolytes to stimulate cell adhesion. Chitosan is
a polycation derived from the deacetylation of chitin, and its
cationic nature increases upon decreasing the residual degree
of acetylation. Different authors have argued for a direct
correlation between the presence of amino groups on the
polymer chain and the proliferation of keratinocytes, fibro-
blasts,14 gliosarcoma cells,15 and primary chicken dorsal root
ganglion neurons.16 Finally, multilayer coatings based on a
combination of chitosan and hyaluronate or chondroitin sulfate
have shown to boost cell proliferation, providing, at the same
time, for their protection.17 A lactose-modified chitosan (chitlac)
has been recently reported18,19 to have biological properties
toward articular chondrocytes, stimulating cell growth and
chondro-specific glycosaminoglycans and collagen production
in tissue-engineered biomaterials.
Aside from the use of natural polysaccharides, another
common strategy for improving cell/biomaterial interactions
resides in the functionalization of the material surface with
biomimetic peptides such as arginine-glycine-aspartic acid
(RGD) and laminin adhesion peptides.
RGD is the well-known integrin recognition site embedded
within many cell attachment proteins, including fibronectin,
vibronectin, and fibrinogen.20–25 Numerous studies have shown
that the RGD peptide promotes increased binding of cells
(including mesenchymal stem cells) to many types of bioma-
terials and that this activity is modulated by the pattern
distribution of the signal.26,27 RGD containing peptides are often
covalently coupled to bioactive polysaccharides. Hyaluronan,
dextran, chitosan, and alginate have largely been used as
backbone structures to be decorated with this peptide.28–34 As
an example, chitosan-based scaffolds modified with RGD
showed an increase in ROS cell attachment onto the substrate
with respect to the unmodified material.31 In addition, poly-
electrolyte complexes, obtained from the combination of op-
positely charged polysaccharides containing the RGD motif,
promoted the attachment of immortalized rat chondrocytes as
well as primary cultures and displayed an enhanced healing rate
of rabbit joint cartilage defect.28 In particular, alginate represents
a very interesting example of modulation of biological properties
upon addition of cell signals. In fact, this otherwise nonbioad-
hesive polysaccharide resulted to regulate myoblast proliferation
and differentiation once the RGD motif was inserted in its
backbone.35
The present work reports a novel strategy for the coating of
a BisGMA/TEGDMA thermoset material based on a chemical
modification that exposes carboxylic groups on its surface. The
formation of a polysaccharide layer on the thermoset was then
accomplished by means of a polycation, that is, chitlac. Due to
this feature, electrostatic interactions will take place between
the negatively charged surface of the treated BisGMA/
TEGDMA thermoset and the cationic polysaccharide. The large
number of positive charges on chitlac (due to its large molar
mass) and the almost unlimited size (on a molecular scale) of
the negative methacrylate surface ensure highly cooperative
interactions with a very high energy stabilization. The ensuing
polyelectrolyte complex (PEC) can be visualized as an ionomer.
This is the rationale behind the hypothesis of the formation of
a strongly adherent bioactive polymer coating. Moreover, the
production of repelling anionic groups over several surface
layers very likely produces an overall loosening of the thermoset
surface compactness allowing for some polycation penetration,
adding the contribution of entanglement to the attractive
interactions of the PECs.
2. Materials and Methods
Chitlac(lactose-modifiedchitosan,CASregistrynumber85941-43-1)
was prepared according to the procedure reported elsewhere18 starting
from a highly deacetylated chitosan (residual acetylation degree
approximately 11%). The (viscosity average) relative molar mass of
chitosan was estimated to be approximately 7 × 105. The composition
of chitlac was determined by means of 1H NMR and resulted to be
glucosamine residue ) 24%; N-acetylglucosamine ) 11%; and 2-(lactit-
1-yl)-glucosamine ) 65%. The relative molar mass of chitlac was
estimated to be approximately 1.5 × 106. Bisphenol A glycidyl-
methacrylate (Bis-GMA), triethyleneglycol dimethacrylate (TEGDMA),
2-[N-morpholino]ethanesulfonic acid (MES), 1-ethyl-3-[3-(dimethy-
lamino)propyl] carbodiimide (EDC), N-hydroxy-succinimide (NHS),
7-amino-1,3-naphtalene disulfonic acid (7-ANA), and fluorescein
isothiocianate (FITC) were purchased from Aldrich. Camphorquinone
(CQ) and 2-dimethylamino ethylmethacrylate (DMAEMA) were pur-
chased from Fluka. E-glass fibres were from Ahlstro¨m (Karhula,
Finland). Alamar blue was purchased from BiosourceTM (Invitrogen).
Titanium disks (Ti6Al4V) with roughened surface (Ra ) 3 µm) were
kindly provided by Medacta Int. (Lugano, Switzerland).
2.1. Preparation of the BisGMA/TEGDMA Thermosets (TS
and fTS). BisGMA (70% w/w) and TEGDMA (30% w/w) were mixed
under vigorous stirring at 37 °C. CQ (0.7% w/w) and DMAEMA (0.7%
w/w) were added and the solution was protected from light and degassed
for 12 h in vacuum oven at 40 °C. The solution was poured in Teflon
mold (L )14 mm, h ) 2.5 mm) and the wells were covered with a
PET film. The polymerization was light initiated with a hand cure light
device (Optilux 501, λ: 400-505 nm, light power: 850 mW/cm2) for
20 s. The postcuring was performed with a Photopol IR/UV Plus oven
(Dentalfarm, Italy) equipped with eight lamps and two spots operating
in the wavelength range 320-550 nm following the procedure: 20 min
in light oven (eight lamps), 20 min in light oven (eight lamps) on a
rotating plate, 60 min in light oven (eight lamps) under vacuum, and
7 min in light oven (eight lamps plus two spots). The thermosets were
then sandpaper polished (granulometry: 1200). This sample is indicated
as TS in Table 1 (Supporting Information). For ultraflat samples (fTS,
Table 1, Supporting Information), quartz molds (L ) 14 mm, h ) 2.5
mm) were employed without final polishing. In the case of fiber
containing composites (BarTS), thermoset bars (20 mm length × 2
mm width × 2 mm thickness) were reinforced by adding 50% (w/w)
of longitudinally oriented E-glass fibers in the mold.
2.2. Synthesis of Glycine-Arginine-Glycine-Aspartic Acid-Serine
(GRGDS) Peptide. Solid phase peptide synthesis was performed by
using Fmoc-chemistry on Liberty Microwave Peptide Synthesizer (CEM
Corporation, Matthews, NC) with a computer-assisted operation system
at a 0.12 mmol scale (500 mg of PEG-PS resin, 0.24 meq/g). Couplings
were carried out with HCTU as an activator. GRGDS peptide was
cleaved from the thermoset and deprotected using a mixture consisting
of trifluoroacetic acid, water, and triisopropylsilane (95:2.5:2.5, by
volume). The crude peptide was precipitated by the addition of tert-
butylmethyl ether, washed several times with the same ether and its
mass was confirmed by ESI-MS spectrometer Bruker Esquire 4000
(Bruker Daltonics, Billerica, MA). No further purification of the peptide
was necessary.
2.3. GRGDS Functionalized Chitlac (RGD Chitlac). Chitlac (0.26
mmol; expressed as average repeating unit) was dissolved in 20 mL of
25 mM MES buffer (pH 6.5). The peptide GRGDS (0.14 mmol) was
dissolved in 1 mL of buffer and activated with 0.35 mmol of EDC and
0.07 mmol of NHS. The solution containing chitlac was then added
and the mixture was stirred overnight at room temperature. The polymer
was dialyzed (cutoff molecular weight of the membrane: approximately
10000) against deionized water until the conductivity was below 2 µS
B Biomacromolecules, Vol. xxx, No. xx, XXXX Travan et al.
at 4 °C. The polymer was filtered through 0.45 µm Millipore filters
and freeze-dried.
To determine the degree of substitution, 2 mg of functionalized
polymer were dissolved in 2 mL of 6 M HCl and stirred at 110 °C for
20 h under reflux. After evaporation of the hydrochloric acid, the residue
was redissolved in 500 µL of capillary electrophoresis running buffer
(100 mM borate buffer pH 8.95). The obtained solution was then filtered
and the degree of substitution was evaluated by the quantification of
Arginine derived from the peptide degradation. Quantitative analysis
was performed by capillary electrophoresis (CE-UV conditions: buffer
borate 100 mM, pH 8.95; 15 kV; fused silica capillary total length 64
cm, effective length 56 cm, internal diameter 50 µm; wavelength 195
nm). The degree of polymer functionalization was equal to 0.45% with
respect to the average repeating unit, corresponding to 2% of primary
amines.
2.4. Hydrolysis of the Methacrylate Esters on the Surface of
the BisGMA/TEGDMA Thermosets. TS, fTS, and BarTS (Table 1,
Supporting Information) were treated with 12 M HCl at 80 °C for
different times. Eventually, a treatment for 7 h was selected for all the
specimens used in the present work. The thermosets were removed
and rinsed with deionized water (2 × 50 mL), NaOH (0.1 M, 50 mL),
and water again (50 mL). The thermosets were finally air-dried
overnight. The sample thus obtained is indicated as HCl-TS, HCl-fTS,
and HCl-BarTS in Table 1 (Supporting Information).
2.5. ATR-FTIR Analysis of Acid-Treated Thermosets. FT-IR was
performed on TS and HCl-TS (Table 1, Supporting Information) with
aBrukerHYPERION3000instrumentequippedwithaMercury-Cadmium-
Telluride detector MCT D316 working in ATR mode.
2.6. Indirect Quantification of the Carboxylic Groups Density
on the Surface of the BisGMA/TEGDMA Thermosets. HCl-TS was
immersed in MES buffer (1 mL, pH 5.5) containing 7-ANA (2 × 10-4
M). EDC (20 mg) and NHS (10 mg) were added and the reaction
mixture was gently stirred for 24 h prior to the analysis. The residual
concentration of 7-ANA in the supernatant was evaluated at 350 nm
by means of UV-vis spectroscopy (Cary 4E) through a calibration
curve.
2.7. Coating of the Thermoset Surface with a Positively
Charged Polysaccharide (Chitlac or RGD chitlac). HCl-TS was
immersed in 1 mL of polycation (chitlac or RGD chitlac) dissolved in
water (2 mg/mL or 4 mg/mL), and the system was gently stirred for
24 h. The thermosets were rinsed extensively with water and air-dried.
The samples obtained have been indicated as chitlac-TS and RGD
chitlac-TS (Table 1, Supporting Information) when chitlac and RGD-
chitlac were used for the coating, respectively. For confocal laser
scanning microscopy (CLSM) experiments and for fluorimetric deter-
minations, a fluorescein-labeled chitlac, prepared as previously reported,
was used.18,36 In the case of HCl-fTS, 4 mL of chitlac solution (4 mg/
mL) were used.
2.8. Atomic Force Microscopy. Surface morphology studies were
conducted on TS and chitlac-TS samples by means of an atomic force
microscope (AFM) using a Perception (Assing, Rome, IT) instrument
in contact mode. Silicon cantilevers with a nominal resonance frequency
of 100 kHz, force constant of 5 N/m, and tip radius of <10 nm (Veeco,
Santa Barbara, CA) were used. For the tip, proportional (pGain) and
integral (iGain) feedback parameters were optimized. The feedback
parameters were adjusted to provide maximum possible feedback
performance while avoiding ringing due to feedback instability. Image
processing of the 10 × 10 µm area was done using the software
Gwyddion (Czech Metrology Institute, Brno, Czech Republic). A
second-order polynomial plane correction was carried out to reduce
waviness due to scanner bow and variations of the film thickness, and
a line-wise leveling was performed to reduce a possible line-by-line
repetition error. AFM analyses were performed also on fTS and chitlac-
fTS thermosets prepared according to the procedure reported in section
2.1. Images were taken in noncontact mode with an A100 APE Research
AFM. XY scanner mounted a closed loop scanner with capacitive
sensors that ensure subnanometric resolution, with a 1 × 1 µm scan
range. Mikromasch NSC15 probes (tip radius < 10 nm) were employed
and the same tip was for both images. Tip oscillation amplitude was
used in the range of a few tens of nanometers. RMS values obtained
by Gwyddion software are calculated on original data without any tip
deconvolution.
2.9. Spectrofluorimetry. The fluorescence of fluorescein-labeled
chitlac was measured with a Perkin-Elmer LS50B spectrofluorimeter
(T ) 25 °C). A calibration curve was performed prior to quantitative
analyses (R2 ) 0.98). A 498 nm excitation wavelength was used and
the emission spectrum was recorded in the range 460-600 nm. Both
the excitation and the emission bandwidths were set to 4.5 nm.
2.10. Confocal Laser Scanning Microscopy (CLSM). Fluorescein-
labeled chitlac was used for the visualization of the coating on the
thermoset samples by means of CLSM. The wet specimen was placed
on a coverslip and mounted on the stage of an inverted microscope
LEICA TCS SP2 associated with a confocal argon-ion laser scanning
microscope. Confocal data have been processed by means of Image
Pro Plus 6.2 software extended with the 3D Constructor package. Laser
excitation light was provided at 488 nm and fluorescent emissions were
collected in the wavelength range between 510 and 580 nm. For image
acquisition, an exposure time of 0.8 s was adopted with a binning of
2 × 2 on the charge-coupled device camera, yielding a pixel size of
1.46 µm. The lens magnification was 10×.
2.11. Scratch Test on Chitlac-Coated Thermosets. The scratch
tests were performed in a ball-on-flat contact configuration using a
microrange surface tester (MUST Falex Tribology NV, Belgium).37
The measuring element of this device is a 25 by 50 mm cantilever
with a given tangential (kt) and normal stiffness (kn).
In this study, a 2 mm Ø ruby ball was used as the scratch probe. A
compressive normal load of 25-100 mN was applied during the test.
The scratch speed was kept constant at 0.5 mm/s, while the scratch
length was 1 mm. All the tests were carried out in ambient air at 20 (
2 °C and 45 ( 3% Relative Humidity. For the scratch tests a sensitive
steel cantilever with normal stiffness of 800 N/m and tangential stiffness
of 1400 N/m was used. During scratch tests, friction force between the
ball and the surface is measured as a function of time. From this data,
the coefficient of friction is determined by dividing the same with the
applied normal load. Two square samples were tested and compared,
namely, sTS (square thermoset) and chitlac-sTS (Table 1, Supporting
Information). A surface microtester, equipped with a cantilever, was
used. The deflections of this cantilever are detected with a set of optical
sensors (FOS) placed in the normal and the tangential direction of the
cantilever, which transmits and receive light. On deflection of the
cantilever, either in the tangential or normal direction, the intensities
of the received light change, leading to subsequent changes in the
voltage. These differential voltages are converted to forces using the
prerecorded sensor calibration files in the instrument. Before testing,
the counterbody is glued at one end of this cantilever and the coated
sample is placed on a moveable table. During a scratch test, the
cantilever is loaded on the sample and by measuring the cantilever
deflection, dz, the magnitude of the applied normal force is controlled.
After reaching the destination load, the sample containing table moves
causing some tangential deflection on the cantilever due to friction.
By recording the deflections in tangential direction, the friction force
or shear force between the material couple is calculated.
2.12. Three Points Bending Tests. Mechanical tests were performed
on fiber reinforced bars (BarTS) and HCl-BarTS samples by means of
a universal mechanical testing machine (Galdabini Sun 500, Galdabini,
Varese, Italy). Three points bending tests were performed according
to the ISO10477 standard. The probe speed was maintained constant
to 5 mm/min. The force-deformation profile was recorded and the
flexural modulus (Ef) and strength (σf) were calculated. For each
measurement, results from 10 samples were averaged.
2.13. Biological Tests on Chitlac and RGD Chitlac-Coated
Thermosets. TS, chitlac-TS, HCl-TS, and RGD chitlac-TS (Table 1,
Supporting Information) were prepared and sterilized by exposure to a
UV lamp for 1 h. Approximately 20000 cells (Osteosarcoma MG-63,
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ATCC number: CRL-1427) suspended in 50 µL of culture medium
(Dulbecco’s modified Eagle’s medium added of inactivated fetal bovine
serum (10%), penicillin (100 units/mL), streptomycin (100 µg/mL),
and L-glutamine (2 mM)) were added in the center of the materials
and incubated for 4 h at 37 °C and 5% pCO2. A total of 0.85 mL of
culture medium was added and the thermoset samples were further
incubated for 18 h under the same conditions. 0.1 mL of Alamar blue
solution was then added and the cells were incubated for an additional
6 h. Media was removed from each sample and its fluorescence was
measured at the excitation wavelength of 530 nm and at the emission
wavelength of 590 nm. The thermoset samples were washed with PBS
(2 × 1 mL), 0.9 mL of fresh culture medium was added, and the
incubation was protracted for 16 h before the alamar blue assay was
repeated. Alamar blue test was performed for four consecutive days.
Six replicates were used for each coating, two cell-free coated
thermosets were used as blanks, and the average signal was subtracted
to the signal of the samples.
2.14. Scanning Electron Microscopy Analysis. The samples were
analyzed using a scanning electron microscope (XL 30 ESEM FEG)
after sputter-coating with gold.
3. Results and Discussion
3.1. Chemical Modification on the Surface of BisGMA/
TEGDMA Thermoset Samples. To expose carboxylate moi-
eties on the surface of the samples, BisGMA/TEGDMA
thermosets were treated with HCl (12 M) at 80 °C (HCl-TS),
followed by neutralization (Table 1, Supporting Information).
An indirect quantitative evaluation of the carboxylate moieties
formed on the surface was obtained by reacting the treated
thermosets with 7-ANA and measuring the residual dye in the
supernatant. Figure 1a reports the UV-vis spectrum of the
solution containing 7-ANA after the exposure to the acid-treated
thermoset samples in the presence of the coupling reagents EDC/
NHS. For comparison, the UV-vis spectrum of the amino
containing dye was recorded in the presence of untreated sample.
The reduction of the amount of dye in solution observed in the
former case stems from its anchoring to the acid-treated
thermosets via an amide linkage. This allowed the quantitative
determination of the carboxylic groups exposed which resulted
to depend on the time exposure to the acid solution (Figure
1b). In particular, after 7 h the concentration of carboxylate
moieties was found to be ∼5.5 × 10-2 µmol/cm2. This number
corresponds to about 300 COO- groups/nm2, which can be
explained invoking the penetration of the hydrolyzing H+ ions
down to several molecular layers of the thermoset surface. In
view of these results, 7 h of exposure to hydrochloric acid were
considered sufficient for introducing enough carboxylate moi-
eties without compromising the integrity of the material. It
should be mentioned that longer treatments, namely, 12 h,
caused the formation of small milky-white droplets in the bulk
of the thermoset.
A direct evidence of the presence of carboxylic groups on
the surface of the sample was obtained from the comparison of
the first derivative of the ATR-FTIR spectrum of the HCl-TS
and of the TS samples (Supporting Information). A newly
formed peak at ∼1620 cm-1 was detected in the case of HCl-
TS, which can be safely attributed to the stretching mode of
the carboxylate anion on the surface of the thermoset.
These results show that the treatment with hydrochloric acid
is an efficient and simple approach for the chemical function-
alization of these thermoset materials.
The harshness of the acid treatment used might cast doubt
about its suitability for biomaterials design. If fact, the hydrolytic
effect of the acid exerted on the surface might ultimately result
in a loss of mechanical properties for the whole specimen
hampering its potential applications in the orthopedic field. In
the latter, the mechanical properties of the implant should meet
those of the bone tissue. For this reason, it was decided to focus
on fiber reinforced composites, as the sole thermoset does not
perform adequately well from the mechanical point of view.
To evaluate the bulk mechanical properties of the BarTS and
HCl-BarTS (Table 1, Supporting Information), three-points
bending tests were performed according to the ISO 10447
standard. The flexural modulus (Ef) of the BarTS and of the
HCl-BarTS samples were 31.2 ( 1.2 and 25.9 ( 1.6 GPa,
respectively (relative decrease 17%). Similarly, the flexural
strength (σf) was 790 ( 29 MPa for the untreated sample
(BarsTS) and 650 ( 82 MPa for the acid-treated sample (HCl-
BarTS; relative decrease 18%). These results show that the
treatment with hydrochloric acid only slightly affects both the
flexural modulus (Ef) and the flexural strength (σf).
The effect of acid treatment on the morphology of the surface
of the TS and HCl-TS samples was preliminary assessed by
means of scanning electron microscopy (SEM). Figure 2 shows
that no considerable topography modification was noticed upon
acid treatment allowing to conclude that the treatment so far
described does not significantly affect the BisGMA/TEGDMA
thermoset.
3.2. Coating with Bioactive Polysaccharides. The second
step considered in the present work was the coating of the
modified thermosets with a bioactive polysaccharide. To this
end, chitlac was selected both for its biological activity and for
the presence of positively charged amino groups.18,19,38,39 To
Figure 1. (a) UV-vis spectrum of a 7-ANA solution upon exposure
to TS (straight line) and HCl-TS (12 M HCl, 80 °C, 7 h; dotted line)
samples. (b) Dependence of the amount of carboxylic moieties in the
thermoset samples on the time exposure to HCl (12 M, 80 °C). Values
are reported as mean ( sd (n ) 3). Line is drawn to guide the eye.
See Table 1 (Supporting Information) for legend.
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evaluate quantitatively the amount of chitlac deposited on the
surface of the thermosets, a fluorescent tag, namely, fluorescein
isothiocyanate, was chemically linked to the polycation. The
very low degree of tag grafting (maximum 1 amino group is
modified over 2000 available) did not modify the overall
properties of chitlac (solubility, hydrophobic character, charge),
allowing, at the same time, the monitoring of the deposition of
the polymer on the acid-treated thermosets. Dried or wet HCl-
TS samples were put into contact with a solution containing
the fluorescein-labeled polycation at different concentrations,
namely, 2 and 4 g/L. The decrease of the fluorescent signal in
the supernatant, quantified by means of spectrofluorimetry, was
assessed after 24 h (Figure 3). The coated samples obtained
were indicated as chitlac-TS (Table 1, Supporting Information).
In all cases, the wet HCl-TS samples showed a lower chitlac
adsorption when compared to the dried ones. In particular, when
a 2 mg/mL chitlac solution was used for the coating of the dry
HCl-TS, a surface concentration of the polysaccharide of
approximately 4.5 µg/mm2 was reached. At variance, a 2 µg/
mm2 surface concentration of chitlac was noted when wet HCl-
TS sample was used. The use of a 4 mg/mL concentration led
to an increase of adsorbed bioactive polysaccharide with respect
to the 2 mg/mL solution. In fact, in this latter case a surface
concentration of 5.25 and 3.75 µg/mm2 was obtained for the
chitlac-TS when starting from dried and wet HCl-TS, respec-
tively. It should be noted that TS samples (nonfunctionalized
thermosets) adsorbed only a very low amount of chitlac (∼0.2
µg/mm2) compared to the functionalized ones. The stability of
the coating of the chitlac-TS sample (Table 1, Supporting
Information) was assessed upon treatment with a solution of
sodium chloride (0.5 M) to shield electrostatic interactions. No
release of the fluorescent polysaccharide was detected in the
supernatant after 24 h (data not shown). At variance, the TS
sample (i.e., nonfunctionalized thermoset) released even the low
amount of chitlac deposited as proof of a weak interaction with
the surface.
The use of fluoresceine-labeled polysaccharide in the chitlac-
TS sample allowed the visualization of the coating on the surface
of the sample by means of confocal laser scanning microscopy
(CLSM). This technique has been used by different researchers
to quantitatively determine the thickness of biofilms40,41 and
polymers coatings.42,43 The coating was laser-scanned through-
out its entire height and its three-dimensional reconstruction,
reported in Figure 4, allowed estimating a layer of thickness
80-100 µm, resulting in a hydrated polysaccharide “cushion”.
The morphology of the surface of the uncoated and coated
thermosets was assessed by means of atomic force microscopy
(AFM; Figure 5): in the case of the TS sample, polishing causes
deep scratches to appear on the surface (Figure 5a), which are
partially filled once the thermoset is coated with the cationic
polysaccharide (Figure 5b). In fact, the morphological param-
eters, obtained from AFM analysis, reveal that the chitlac-TS
sample displays, with respect to the TS sample, a lower
maximum peak height (hmax) as well as a lower average
roughness (Ra); similarly, the surface area excess (Sdr) parameter
shows that the overall surface area is reduced upon coating of
the TS samples with chitlac (Table 2, Supporting Information).
An insight at the nanometer scale on the morphology of the
polysaccharide on the surface of the BisGMA/TEGDMA
thermosets was obtained by means of AFM measurements on
ultraflat disks (fTS and chitlac-fTS). They both are completely
devoid of scratches introduced by the polishing which might
give rise to artifacts in the interpretation of the result; they can
thus be used to highlight the specific morphological features of
the polysaccharide coating. At the nanometer scale, the AFM
image of the fTS sample displays round-shaped thermoset
particles (<10 nm) homogeneously arranged on the surface of
the material and a root-mean square roughness (Rrms) of 1.2 nm
(Figure 5c, Table 2, Supporting Information). At variance, in
the case of chitlac-fTS (Figure 5d, Table 2, Supporting
Information), Rrms increased to 3.6 nm and the surface is
characterized by grainy particles with a diameter of about 20
nm, which is attributed to the coiled polysaccharide chain after
air drying and represents the roughness of the outer layer of
Figure 2. Scanning electron microscopy of TS (a) and HCl-TS (b)
samples. Magnification ) 1200×. See Table 1 (Supporting Informa-
tion) for legend.
Figure 3. Amount of chitlac adsorbed on HCl-TS sample upon
exposure to a solution of polysaccharide at a concentration of 2 or 4
mg/mL, respectively. Open and striped bars correspond to dried and
wet HCl-TS, respectively. The control is represented by TS sample
(full bars). Values are reported as mean ( s.d. (n ) 3). See Table 1
(Supporting Information) for legend.
Figure 4. Chitlac-TS (Table 1, Supporting Information) prepared with
fluorescein-labeled chitlac: 3D reconstruction of the coating layer
covering the underlying thermoset. Magnification lens: 10×.
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the polysaccharide cushion. This is the typical morphology found
when using biopolymers in the layer-by-layer (LbL) technique44
and, in particular, a grainy morphology has been reported for
chitosan on gold surfaces45 and in a LbL structure with
hyaluronan.46
Scratch tests were performed on thermosets coated with
chitlac (chitlac-sTS sample, Table 1, Supporting Information),
using the acid-treated thermoset samples as control (HCl-sTS).
The scratch tests are commonly used in determining mechanical
integrity of coatings based on both organic and inorganic
formulations.47,48 This technique is widely used for quantifying
various properties of coatings and thin films, such as critical
load bearing, adhesion strength, coating durability, and failure
mechanisms,49 although the performance of the coating in
physiological conditions cannot be directly inferred from these
measurements. In this study of gel-like chitlac coatings, low
load sensitive scratch tests would help detect the overall response
of this coating under combined compression and shear forces.
A schematic illustration of the setup and of the test is reported
in Figure 6.
A plot of coefficient of friction against the sliding distance
for the two tested materials is shown in Figure 7a,b. The four
curves are the results of scratch tests at different normal loads
measured on different locations of the sample. The coefficient
of friction recorded on HCl-fTS sample seems to vary with the
sliding distance. This variation could be due to the surface
roughness or waviness of the surface. In general, the coefficient
of friction seems to drop with the increasing compressive force
or contact pressure.
The coefficient of friction recorded on the chitlac-sTS sample
exhibited a chaotic stick-slip behavior. The stick-slip is
commonly observed when the static friction between the contacts
is high and when surface slides at low speeds.50 This event is
analogous to pushing a mass with a weak spring, which has to
be first loaded until the block overcomes the friction force and
then relaxes as the mass stops and the sequence repeats. This
stick-slip phenomenon exists even at atomic scale as explained
using the so-called Tomlinson model.51 In the present case, the
coefficient of friction is not high and it is believed that the origin
of stick-slip is due to the structure of the polysaccharide coating
which might resemble a gel on this observation scale. During
sliding, the ball may plow the network structure of the gel, and
once excess material is formed on the sliding front, the ball
stops. As the specimen continues to move, the cantilever spring
loads until sufficient energy is gathered and finally moves again
creating a drop in friction (slip). This action repeats causing
this chaotic stick-slip pattern in the signal.
The same stick-slip behavior was noticed in multiple pass
scratch test performed at contact load of 75 mN. In all, 20
repeated scratches were performed on the same location. For
clarity, four scratch curves recorded at regular intervals are
shown in Figure 7c,d. The magnitude of stick-slip (noise level)
in this measurement seems lower than Figure 7b, which could
be attributed to possible irregularities of the chitlac coating.
An interesting feature was noticed in the evolution of the
normal load during the multipass scratch test (Figure 8). On
the HCl-sTS sample, the normal load during 20 scratches is
shown by the jigsaw pattern. Every test starts at 75 mN and
normal force drops as the test progresses. This average drop of
13.7 mN in normal force corresponds to 17 µm inclination over
1000 µm length or 1° slope which causes relaxation of the
cantilever. The evolution of normal force for the chitlac-sTS
surface is completely different and shows no fixed pattern.
Moreover there was always some shoot-up of the force from
Figure 5. Atomic force Microscopy of TS (a), chitlac-TS (b), fTS (c), and chitlac-fTS (d) samples. Scanned area of 10 × 10 µm for (a) and (b)
and of 1 × 1 µm for (c) and (d). See Table 1 (Supporting Information) for legend.
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the set point normal load indicating some sort of a resistance
from the surface. This aspect is illustrated in Table 3 (Supporting
Information) where a deviation from set point loads for both
HCl-sTS and chitlac-sTS are recorded. In the case of uncoated
thermosets, the error in normal load was within (1.2%, whereas
on chitlac there was always a higher load up to +34% of the
set point. This overshoot is physically equivalent to deflecting
the cantilever more than the minimum. It is hypothesized that
the network structure of the polysaccharide layer responds under
compression, which causes some mismatch in the piezo-
displacement of the instrument. It is interesting to note that this
overshoot is not the same for all the scratch cycles, which may
be due to changes in the coating thickness during every scratch.
This unusual effect will be investigated further through some
systematic studies on the structural strength, mechanical proper-
ties like elastic modulus, creep, and so on, of the chitlac coating.
Figure 6. (a) Microrange surface tester and its components; (b) schematic illustration of the test.
Figure 7. (a, b) Evolution of coefficient of friction with sliding distance during scratch test against 2 mm Ø ruby ball on HCl-sTS (a) and chitlac-
sTS (b). (c,d) Evolution of coefficient of friction with sliding distance during constant load multipass scratch test against 2 mm Ø ruby ball on
HCl-sTS (c) and chitlac-sTS (d). See Table 1 (Supporting Information) for legend.
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At any event, one should always take into account that the
chitlac layer can be depicted as a highly concentrated hyper-
entangled solution of the cationic polysaccharide.
In this respect, it is tempting to correlate the present
observations with an unusual rheological behavior of chitlac
reported by Yalpani et al.52 who observed a low shear
Newtonian behavior, a medium shear viscosity increase (dila-
tancy), and a high shear viscosity drop (pseudoplasticity) of the
polysaccharide; at the transition point between the dilatant and
the pseudoplastic regimes, a semiconcentrated chitlac solution
(2%) exhibits unique oscillatory behavior under steady shear.
3.3. Biological Tests. The final aim of the surface modifica-
tion deals with the possibility of introducing, on the outer layer
of a TS sample, a biopolymer that would promote and facilitate
biological events like cell adhesion and proliferation. In fact,
when such synthetic thermosets are considered for orthopedic
applications, the bioactive coating interacts with the surrounding
tissue (bone), facilitating biological integration and interlocking.
The proper and guided interface-tissue interaction is the key
issue for the design of a successful biomaterial.
A standard cell proliferation test (Alamar blue essay) was
conducted on coated thermosets to detect and highlight the effect
of the different bioactive molecules added on the surface. The
results were normalized with respect to day 1 to obtain a relative
cell proliferation rate which allows a direct comparison between
the different coatings. Standard titanium disks, with a roughened
surface (Titanium, Table 1, Supporting Information), were used
as control.
From the graph reported in Figure 9, it can be seen that the
exposure of carboxylic moieties (HCl-TS sample) reduces cell
proliferation with respect to untreated thermosets. This is
attributed to the modification of the physical properties of the
surface, such as charge density or wettability, which can alter
the mechanism of cellular adhesion and spreading and, conse-
quently, the subsequent processes of cell growth and prolifera-
tion.53 This is also in line with the general consideration that
negative charges hamper cell adhesion and proliferation.54–56
The presence of chitlac coating stimulates cell proliferation
with respect to the acid-treated (polyanionic) sample, reaching
a result similar to that of the untreated thermoset. Very likely
this could be attributed to the slightly positive charge on the
surface of the material given by the presence of the polysac-
charide. However, coating with chitlac is not sufficient to bring
the observed cell growth rate to the level exhibited by the
standard material considered, that is, roughened titanium.
The strategy presented in this work for the modification of
the surface of the BisGMA/TEGDMA thermoset aims especially
at using polysaccharides whose bioactivity can be further
modified and modulated by anchoring additional specific
biological signals to boost and facilitate tissue formation and
integration.
In this perspective, chitlac was decorated with the cell
adhesion sequence arginine-glycine-aspartic acid (RGD) via
coupling reaction with EDC/NHS. The ligand-coupled polymer
was prepared with a low degree of substitution (approximately
2% of the residual primary amines) so that the polysaccharide
still contains enough positive charges to bind with the thermoset
surface by means of electrostatic interactions (RGD chitlac-
TS). The degree of substitution is in line with the RGD-modified
alginate reported by Mooney and co-workers.57 The amount and
distribution of RGD peptides are important parameters influenc-
ing cell adhesion, which shows a sigmoid increase indicating
that there is a critical density for cell response. Moreover, several
aspects are correlated to the attachment of cells, namely, the
different cell lines, the sequence of the RGD peptide, the peptide
distribution at the surface, and the polysaccharide composition.58
As can be seen in Figure 9, RGD ligands upregulate the
proliferation rate of MG63 cells with respect to uncoated and
chitlac-coated thermoset samples. In this case, the cell growth
rate is fully comparable with that displayed by titanium alloy
used as control.
In view of these results, it can be concluded that the
physical-chemical characteristics of the polysaccharide, to-
gether with the presence of biological signals arranged on a
polymeric backbone, likely allows the RGD peptide to extend
over the layer of adsorbed serum proteins and to interact with
integrin molecules of the osteoblast membrane.
4. Conclusions
The present work tackled the problem of the coating of a
BisGMA/TEGDMA thermoset with bioactive polysaccharides.
In the first step, the functionalization of the thermoset has been
achieved through an acid treatment that enables the introduction
of carboxylate moieties on its surface. It is noteworthy that the
acid treatment does not significantly affect the bulk mechanical
properties of the construct. The introduction of such versatile
chemicalgroupsopensupforseveralchemicalandphysical-chemical
routes, allowing further modifications of the thermoset surface.
Figure 8. Fluctuations in the normal load during multiple scratch test
on HCl-sTS and chitlac-sTS. See Table 1 (Supporting Information)
for legend.
Figure 9. Relative MG63 cell growth (with respect to day 1) on TS
(blue diamonds), HCl-TS (purple triangles), chitlac-TS (green tri-
angles), RGD chitlac-TS (red circles), and titanium (control, black
squares) samples (Table 1, Supporting Information). The dotted lines
are drawn to guide the eye. The straight black line represents the
limit of no cell proliferation.
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In the present work, we have exploited electrostatic interactions
to coat the BisGMA/TEGDMA surface with a bioactive
derivative of chitosan (chitlac). This approach led to a well-
anchored deposition of a soft, hydrophilic positively charged
layer on the thermoset surface, showing physical-chemical
properties that are likely not far from those of the hydrated
extracellular matrix. The biological properties of the biopolymer
on the thermoset surface can be further enhanced by chemical
incorporation on the polysaccharide backbone of bioactive
signals (e.g., RGD-peptides). In principle, this system could be
used also for the creation of a polyelectrolyte multilayer coating
through a layer-by-layer approach.59,60 In both cases, the
bioactivity of the BisGMA/TEGDMA thermoset can be finely
tuned to meet the requirements for cell adhesion and tissue
integration of the BisGMA/TEGDMA implant. In this sense,
the results on cell proliferation reported, although preliminary,
are quite promising as they clearly show that the in vitro
biological performances of the methacrylate based thermosets
can be boosted to reach or even to overcome those of the
standard material used in orthopedic applications, that is,
roughened titanium. Factors like optimal spacing between the
biological signals and their clustering are expected to bring about
a further gain in performance as to biological responsiveness
of the coated material.
The approach presented in this work efficiently combines
aspects like proper mechanical performances and cell-directed
biochemical signaling to upgrade the largely used BisGMA
based thermosets. This could lead to new materials which can
meet the complex requirements of biomechanical and biological
properties expected for a “third generation” biomaterial.
Finally, the demonstrated feasibility of a chemical activation
for the introduction of functional groups on the thermoset surface
can be a key point to extend the present work well beyond the
limit of methacrylate-based thermosets and toward more chal-
lenging materials like PET, PU, and PLLA.
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Abstract 
Bisphenol A glycidylmethacrylate (BisGMA)/triethyleneglycol dimethacrylate (TEGDMA) 
thermosets are receiving a growing interest as biomaterials for dental and orthopaedic applications; 
for both these fields, bacterial adhesion to the surface of the implant represents a major issue for the 
outcome of the surgical procedure. Moreover, the biological behavior of these materials is 
influenced by their ability to establish proper interactions between their surface and eukaryotic cells 
of the surrounding tissues which accounts for a good implant integration. The aim of this work was 
to develop an antimicrobial non-cytotoxic coating for methacrylic thermosets by means of a 
nanocomposite material based on a lactose-modified chitosan and ancitbacterial silver 
nanoparticles. The coating was characterized by UV-Visible spectrophotometry, optical 
microscopy, transmission electron microscopy (TEM) and scanning electron microscopy (SEM). In 
vitro tests were employed for a biological characterization of the material: antimicrobial efficacy 
tests were carried out with both Gram+ and Gram- strains. Osteoblasts-like cell lines, primary 
human fibroblasts and adipose-derived stem cells were used for LDH cytotoxicity assays and 
Alamar Blue cell proliferation assays. Cell morphology and distribution analyses were evaluated by 
SEM and Confocal Laser Scanning Microscopy (CLSM). The results showed that the 
nanocomposite coating is effective in killing both bacteria strains and that this material does not 
exert any significant cytotoxic effect towards tested cells, which are able to firmly attach and 
proliferate on the surface of the coating. Such biocompatible antimicrobial polymeric films 
containing silver nanoparticles may have good potentials for surface modification of medical 
devices, especially for prosthetic applications in orthopaedics and dentistry. 
 
Keywords: Biomaterials, Silver nanoparticles, Polysaccharides, Methacrylic thermosets, 
Antimicrobial activity, Cytotoxicity, Stem cells. 
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Introduction 
In the field of biomaterials, the issue of infections associated with the material surface is of 
overriding relevance. When the microbial adhesion to surfaces is followed by bacterial growth and 
colonization, the outcome is the formation of a compact biofilm matrix which protects the 
underlying bacteria from the action of antibiotics and host defense mechanisms. In the case of 
biomedical devices, such as prosthetic implants, this phenomenon can result in serious infection 
leading to the failure of the implant (Sambhy et al., 2006). Nowadays there is an increasing demand 
for antimicrobial materials that do not allow microbes to adhere and proliferate on material surfaces 
(Ho et al., 2004). Many efforts have been made to design a coating that can prevent or eradicate 
occurring infections (Grunlan et al., 2005). For biomaterials applications, antimicrobial coatings 
need to combine antibacterial efficacy and low toxicity to eukaryotic cells.  
Different strategies have been used to endow coatings with antimicrobial properties (Ho et al., 
2004;Sambhy et al., 2006): a) addition of anti-adhesive components (Ignatova et al., 2005), b) 
controlled release of biocides (Kohnen et al., 2003) and c) use of contact-active systems (Lee et al., 
2004), where the antimicrobial agent is incorporated within the matrix and is not supposed to be 
released. The advantage of using a contact-active material is that microorganisms can be killed 
upon direct contact without releasing compounds that might be toxic not only to bacteria but also to 
mammalian cells. Among contact-active agents, silver-based coatings are of great interest. In fact, 
silver, in form of nanoparticles (Panacek et al., 2006;Travan et al., 2009), ions (Balogh et al., 
2001;Rhim et al., 2006) and salts (Sambhy et al., 2006), is widely used as antimicrobial agent for 
different applications like wound-healing devices (Ip et al., 2006;Tian et al., 2007), chatheters 
(Hachem et al., 2003), dental materials {Hernandez-Sierra, 2008 584 /id}, and stents (Multanen et 
al., 2000) due to its ability to kill a broad spectrum of bacteria (Grunlan et al., 2005;Rhim et al., 
2006). Although the antibacterial mechanism is not totally understood (Morones et al., 2005), the 
main molecular targets of the silver antibacterial activity are supposed to be the thiol groups (-SH) 
of proteins exposed to the extracellular portion of the bacterial membrane (Elechiguerra et al., 
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2005;Feng et al., 2000;Furr et al., 1994;Gupta et al., 1999;Morones et al., 2005); conversely, 
eukaryotic cells lack these exterior binding sites, so the nanoparticles are supposed to interact with 
them only upon metal internalization. The issue of possible adverse effects and toxicity of 
nanoparticles for eukaryotic cells is now recognized as central by an increasing number of studies; 
these indicate that the lack of physical barriers to nanoparticle diffusion into cells represents a risk 
of uptake by eukaryotic cells, which can lead to their death (Chen and Schluesener, 2008;Geiser et 
al., 2005;Hussain et al., 2005) in a dose-dependent manner (Lee et al., 2007). 
Silver nanoparticles are usually prepared in the presence of a stabilizing agent in order to avoid their 
aggregation, which could lead to the loss of the high antimicrobial activity associated with the 
nanoscale (Huang and Yang, 2004;Kuo and Chen, 2003); typically, polyelectrolyte solutions can be 
used to control the formation and the long-term stability of nanoparticles (dos Santos et al., 
2004;Dotzauer et al., 2006). Silver nanoparticles formed and stabilized in a lactose-modified 
chitosan (1-deoxylactit-1-yl chitosan, shortly named “Chitlac”) were previously employed as 
antimicrobial agents effective towards both Gram+ and Gram- bacteria (Travan et al., 2009). 
Convenient and effective ways of preparing and embodying silver nanoparticles in polymeric 
materials are continuously sought (Wang et al., 2006). A widely employed strategy is based on the 
dehydration of the polymer solution containing nanoparticles, to obtain a nanocomposite material 
where the nanoparticles are embedded in the polymer matrix (Fu et al., 2006;Huang et al., 
2004;Rhim et al., 2006). Since the nanocomposite is supposed to get in contact with both bacteria 
and eukaryotic cells, the choice of the polymer is crucial in order to obtain a biocompatible 
antimicrobial system. 
Currently, the biocompatibility of nanoparticles-based systems is quite often not well-characterized 
(Lee et al., 2007;Chen and Schluesener, 2008). It would be desirable to firmly incorporate silver 
nanoparticles into a biocompatible polymeric film so that the nanoparticles can directly interact 
with the bacterial membrane without being uptaken by eukaryotic cells. Moreover the preparation 
of homogeneous coatings containing nanoparticles is an ongoing challenge; a crucial feature is to 
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prepare stabilized nanoparticles before film construction (Dai and Bruening, 2002). Recently the 
application of silver-binding membranes has been suggested to further reduce the silver toxicity 
towards eukaryotic cells minimizing the metal absorption (Yu et al., 2006). The film construction 
can be made by means of different techniques like dehydration (Rhim et al., 2006) or alternating 
adsorption of oppositely charged polyelectrolytes (Dotzauer et al., 2006;Grunlan et al., 2005). After 
choosing the proper materials for the nanocomposite film, an effective technique must be used to 
graft firmly the coating onto the substrate material. One approach (the “layer by layer” technique) is 
to obtain a polymeric film by dipping the substrate material with a charged surface in a 
polyelectrolyte solution of opposite charge in order to exploit electrostatic bonds (Grunlan et al., 
2005). This is a simple procedure that can be adapted to almost any type of surface and regardless 
the shape of the solid (Fu et al., 2006). As a result, since nanoparticles are stabilized within the 
polyelectrolyte solution, this approach allows obtaining a nanocomposite film electrostatically 
bound to the substrate material. 
For this study, the substrate material is a thermoset based on Bisphenol A glycidylmethacrylate 
(BisGMA) and triethyleneglycol dimethacrylate (TEGDMA). Such polymeric material finds wide 
application as biomaterial for dental applications (Ballo et al., 2008;Lehtinen et al., 2008) and is 
being studied for prosthetic purposes (Ballo et al., 2007;Ballo et al., 2009); in fact Fiber Reinforced 
Composites (FRC) based on BisGMA/TEGDMA are promising alternatives for metallic implants 
since FRC can be tailored to closely match the mechanical properties of bone. Moreover diagnostic 
imaging of FRC implants with suspected mechanical loosening or infection might be easier if 
compared to metallic implants (Zhao et al., 2009). In any case it would be desirable to render the 
surface antimicrobial by means of a biocompatible coating. In this work we report the preparation 
of a coating for a BisGMA/TEGDMA thermoset material by means of a physisorption of a 
nanocomposite system based on Chitlac and silver nanoparticles (Travan et al., 2009) (hereafter 
“Chitlac-nAg”). Biological tests are performed in order to assay the interaction of the coating with 
both bacteria and eukaryotic cells. 
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Materials and methods 
 
Materials 
Chitlac (lactose-modified chitosan, CAS registry number 85941-43-1) was prepared according to 
the procedure reported elsewhere (Donati et al., 2005) starting from a highly deacetylated chitosan 
(residual acetylation degree approx. 11 %): briefly, 300 mg of chitosan were dissolved in 21 mL of 
a 1:1 mixture of methanol and 1 % acetic acid (pH 4.5); 12 mL of the same methanol/acetic acid 
mixture containing 1.6 g of lactose and 660 mg of sodium cyanoborohydride were then added. The 
solution was stirred for 24 h at room temperature and after dilution with water (30 mL), 
exhaustively dialysed against deionized water. The polymer solution was filtered through 0.45 mm 
Millipore filters and freeze-dried. The composition of Chitlac was determined by means of 1H-
NMR and resulted to be: Glucosamine residue = 24%; N-Acetylglucosamine = 11 %; 2-(lactit-1-
yl)-glucosamine = 65 %. The molecular weight of Chitlac was estimated to be approximately 1.5 x 
106. Bisphenol A glycidylmethacrylate (Bis-GMA), triethyleneglycol dimethacrylate (TEGDMA) 
and Triton x-100 were purchased from Aldrich. Camphorquinone (CQ) and 2-dimethylamino 
ethylmethacrylate (DMAEMA) were purchased from Fluka. Alamar blue was purchased from 
BiosourceTM (Invitrogen). Polyurethane films containing 0.25% zinc dibuthyldithiocarbamate 
(ZDBC) (8 mm discs) were from Hatano Research Institute / Food and Drug Safety Center 
Reference Material Office (JAPAN). Plastic sheets (8 mm discs) were from Wako Pure Chemical 
Industries, Ltd., Cat.No.160-08893). Basic fuchsine was from “Società Italiana Chimici”, 
cod.11260. 
 
Preparation of the BisGMA/TEGDMA thermosets (“uncoated samples”) 
BisGMA (70% w/w) and TEGDMA (30% w/w) were mixed under vigorous stirring at 37 °C. CQ 
(0.7% w/w) and DMAEMA (0.7% w/w) were added and the solution was protected from light and 
degassed for 12 hours in vacuum oven at 40 °C. The solution was poured in Teflon mould (∅ =14 
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mm, h = 2.5 mm) and the wells were covered with a PET film. The polymerization was light 
initiated with a hand cure light device (Optilux 501, λ: 400-505 nm, light power: 850 mW/cm2) for 
20 seconds. The post-curing was performed with a Photopol IR/UV Plus oven (Dentalfarm, Italy) 
equipped with 8 lamps and 2 spots operating in the wavelength range 320-550 nm following the 
procedure: 20 minutes in light oven (8 lamps), 20 minutes in light oven (8 lamps) on a rotating 
plate, 60 minutes in light oven (8 lamps) under vacuum, 7 minutes in light oven (8 lamps plus 2 
spots). The thermosets were then sandpaper polished (granulometry: 1200).  
 
Preparation of the colloidal solution Chitlac-silver nanoparticles (Chitlac-nAg ) 
Silver nanoparticles were obtained by reducing silver ions with ascorbic acid in Chitlac solutions 
according to the following procedures (Travan et al., 2009): Chitlac was dissolved in deionized 
water at the concentration of 4 g/L. Chitlac solution was mixed with AgNO3 solution to a final 
AgNO3 concentrations of 1 mM. Ascorbic acid (C6H8O6) solution was added at final concentration 
of 0.5 mM. After 4 hours, a yellow-orange stable colloidal solution was obtained.  
 
BisGMA/TEGDMA thermosets surface activation 
In order to expose on the surface of the material COO- functional groups by hydrolysis of the 
methacrylate esters, the samples where immersed in HCl 12 M at 80 °C for 7 h. The thermosets 
were then removed, rinsed with deionized water (2 x 50 mL), with NaOH 0.1 M (50 mL) and with 
water again (50 mL) and finally air dried overnight (Travan et al., 2010). 
 
Coating of the thermoset surface with Chitlac-nAg 
The activated samples where immersed for 24 hours in wells containing Chitlac-nAg and 
subsequently rinsed in deionized water for 60 min under agitation. The absorption of Chitlac-nAg 
was followed by UV-Vis spectroscopy (dilution 1:10, Spectrophotometer Cary 400) . The samples 
were dried under hood overnight and sterilized by means of UV light. 
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Antimicrobial efficacy test 
The antimicrobial efficacy was evaluated by means of a slightly modified protocol of the Japanese 
Industrial Standard method (JIS Z 2801:2000). Mid-log phase culture in Mueller Hinton (MH) 
broth of S. aureus ATCC25923 and P. aeruginosa ATCC27853 were centrifuged at 1000 x g for 5 
min and resuspended in Phosphate Buffered Saline (PBS) at the final concentration of 1÷5 x 108 
CFU/mL. 10 µL of each bacterial suspension were deposed on Chitlac-nAg coated and uncoated 
disks samples, and covered with UV sterilized plastic sheets (14 x 14 mm) (from Wako Pure 
Chemical Industries, Ltd., Cat.No.160-08893). The “sandwich” was incubated for 3 h at 37°C at 
saturation humidity. At the end of incubation, the samples were immersed in 2 mL of high salt 
solution (10 mM Na-phosphate, 400 mM NaCl and 10 mM MgCl2) and vigorously vortexed for 30 
seconds to allow the detachment of bacteria from the support. After proper serial dilutions in PBS, 
the bacterial suspensions were plated on MH agar and incubated overnight at 37 °C to allow the 
viable colony counts. The values reported are the mean ± standard deviation of three independent 
experiments with comparable results. 
 
Cell cultures 
Primary human skin fibroblasts, human adipose-derived stem cells (ADSCs) and human 
osteosarcoma cell-lines (MG63 cell line, ATCC number: CRL-1427 and Saos-2 cell line, ATCC 
number: HTB-85TM) were used for the in vitro experiments. MG63 cells and fibroblasts were 
cultured in Dulbecco's Modified Eagle's medium (Sigma), 10 % heat-inactivated fetal bovine serum 
(Sigma), 100 U/mL penicillin, 100 µg/mL streptomycin and 2 mM L-glutamine in a humidified 
atmosphere of 5 % CO2 at 37 °C. Saos-2 cells were grown in McCoy's 5A medium (Sigma) 
supplemented with 15 % heat-inactivated fetal bovine serum (Sigma), 20 U/mL penicillin and 20 
µg/mL streptomycin at 37°C in a humidified 5 % CO2, 95 % air. Human adipose-derived stem cells 
(ADSC) were purchased from Invitrogen (STEMPro® cells). ADSCs were expanded in MesenPRO 
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Basal RS Medium (Invitrogen) supplemented with 10 % MesenPRO RS™ Growth Supplement and 
2 mM L-glutamine at 37°C in a humidified 5 % CO2, 95 % air. 
 
Cell Proliferation Assay (Alamar Blue) 
Coated and uncoated thermosets were prepared and sterilized by exposure to a UV lamp. 
Approximately 20000 fibroblasts and osteoblast-like cells or 7500 ADSCs suspended in 50 µL of 
culture medium were dropped in the center of the sample surface and incubated for 4 hours at 37 °C 
and 5 % pCO2. After incubation, 0.85 mL of culture medium were added and the thermoset samples 
were further incubated for 18 h under the same conditions. 0.1 mL of Alamar Blue solution was 
then added and cells were incubated for additional 6 hours. Then the medium was removed from 
each sample and its fluorescence was measured (excitation wavelength = 530 nm, emission 
wavelength = 590 nm). The thermoset samples were then washed with PBS (2 x 1 mL), added of 
0.9 mL of fresh culture medium and the incubation protracted before the Alamar Blue assay 
repeated. Six replicates were used for each coating and two cell-free coated thermosets were used as 
blank and the average signal was subtracted to the signal of the samples.  
 
Cytotoxicity (LDH) assay 
In vitro cytotoxicity of the samples was evaluated by using the lactate dehydrogenase assay (LDH 
assay, TOX-7, Sigma). Each cylindrical sample (∅ = 14 mm; h = 2.5 mm) was cut into 4 equal 
parts used for direct contact test with the cells or for the extraction test. For the direct contact test, 
50000 cells/well were plated on 24-well plates and, after complete adhesion, culture medium was 
replaced with 500 µL of fresh medium. Tested materials (in quadruplicate) were directly deposited 
on the cell layer. After 24 and 72 hours, medium was collected and the LDH assay was performed 
according to the manufacture’s protocol. As a positive control material, polyurethane films 
containing 0.25% zinc dibuthyldithiocarbamate (ZDBC) (8 mm discs) were used. As negative 
control material, plastic sheet (8 mm discs) were used.  
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For the extraction test, each sample (in quadruplicate) was incubated in cell culture medium (1 mL) 
for 24 h at 37 °C and 5 % pCO2. After incubation, the extraction media were added on cells seeded 
on 24-well plates (50000 cells/well). As positive control, Triton 1% was used.  
The LDH assays were performed after 24 and 72 hours as described above. Each material test was 
performed in quadruplicate. Evaluation of cytotoxicity was calculated according to the formula: % 
LDH released = [(A - B)/(C - B)] × 100, with A = LDH activity in the culture medium of material-
treated or extraction medium-treated cells, B = LDH activity of culture medium from untreated cells 
and C = LDH activity after total cell lysis. 
 
Optical microscopy 
The sample was included in epoxy resin (Electron Microscopy Sciences, DER 332) and 
transversally cut by means of a Leica Ultracut UCT Ultramicrotome in order to obtain slices with a 
thickness between 80 and 120 nm. The slices were dyed to allow the visualization of the 
polysaccharide layer: a fuchsine stock solution (1 % basic fuchsine dissolved in 50 % water-ethanol 
solution) was diluted to the concentration of 5 % in water and incubated with the samples for 5 min 
at 50-60 °C. Finally the samples were air dried and observed by means of an Optical Microscope 
Leitz Dialux 20 EB equipped with the recording system Leica DC300 (Leica Microsystems S.p.A.). 
 
Transmission Electron Microscopy (TEM) 
The microtomed samples were deposited onto Nickel grids coated with a carbon film. TEM images 
were recorded by means of a PHILIPS EM 208 Microscope operating at 100 kV equipped with the 
recording system Olympus Soft Imaging Solutions GmbH (Software: iTEM; TEM Camera: Morada 
4008 x 2672 pixel max). 
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Scanning Electron Microscopy (SEM) 
Sputtered samples: gold-sputtered samples were analyzed by means of a Environmental Scanning 
Electron Microscope (ESEM) Philips XL30 ESEM equipped with a Field Emission Gun (FEG): 
FE-SEM. In the case of cells cultured on the surface, the samples were prepared according to the 
following procedure: after removal of the culture medium, samples were rinsed with Phosphate 
Buffered Saline (PBS), and cells were fixed in 1.5 % glutaraldehyde, sodium cacodylate 0.1 M, pH 
7.4 for 1 hour. After cell fixation the samples were rinsed with sodium cacodylate 0.1 M (pH 7.4) 
for 12 hours, dehydrated in ethanol solutions of increasing concentrations (20, 30, 40, 50, 60, 70, 
80, 90, and 100 %) for 5 min at each concentration and then dried under hood.  
Non-sputtered samples: non-sputtered samples were observed by means of a FE-SEM ZEISS 
SUPRA operating at 15.00 kV and equipped with an Energy Dispersive X-Rays (EDX) 
spectrometer. 
 
Inductively Coupled Plasma - Atomic Emission Spectrometry (ICP-AES) 
The quantitative analysis of the silver released from the coating was performed by means of ICP-
AES Spectroflame Modula E optical plasma interface (OPI) instrument (SpectroTM, Germany). The 
following samples were analyzed: 1) Chitlac-nAg (colloidal solution), 2) supernatant solution (1 
mL) after incubation with the activated thermoset for 24 hours, 3) rinsing solution after washing the 
dried coated sample with deionized water (1 mL) for 1 hour under agitation. The metal 
concentrations were evaluated after centrifugation and filtration with a 0.42 µm membrane 
(Millipore, USA) using calibration curves obtained by dilution of Silver ICP/DCP standard solution 
10,000 µg/mL in HNO3 (Sigma Aldrich). The emission wavelength used was 328.068 nm, the limit 
of detection 0.03 mg/L. Calibration curves obtained by means of 5 standard solutions had 
correlation coefficients higher than 0.998.  
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Confocal Laser Scanning Microscopy (CLSM) 
The cells were fixed with paraformaldehyde 4% in PBS, rinsed with PBS, incubated in glycine    
0.1 M in PBS, rinsed again in PBS and incubated in blocking buffer solution (Saponine 0.05 % w/v, 
BSA 0.2% w/v in PBS). Subsequently, cells were treated with DAPI for nucleus visualization, 
phalloidin alexafluor 488 for actin filaments staining and with anti-human vinculin (mouse) and 
sheep anti-mouse CY3 for vinculin immunostaining. The samples were then rinsed in sequence with 
blocking buffer, PBS and distilled water, and finally cover-slipped with a mounting medium 
(Mowiol). The samples were analyzed by means of a confocal laser microscopy LEICA DM     
6000 B. 
 
Results and Discussion 
 In the field of biomaterials, thermosets based on light-initiated reticulation of BisGMA and 
TEGDMA are being widely employed due to their good mechanical properties and biocompatibility 
(Tezvergil et al., 2005;Vakiparta et al., 2006). Since such materials do not display any biochemical 
feature that prevents bacteria adhesion and the formation of biofilms, modifications of their surface 
properties are of primary importance. To this end, a surface of these thermosets has been activated 
according to the procedure reported elsewhere (Travan et al., 2010). Briefly, the material was 
immersed in HCl and subsequently rinsed in NaOH to expose negative charges (COO- groups) on 
the surface; then, the activated thermoset was immersed in a polysaccharide-silver nanoparticles 
colloidal solution (Chitlac-nAg) in order to promote the grafting of the nanocomposite coating on 
the thermoset substrate by exploiting electrostatic interactions between the carboxylate moieties and 
the positive chains of the polysaccharide.  
The deposition process was indirectly monitored by recording the variations of the UV-Vis spectra 
of the supernatant colloidal solution in contact with the activated thermoset. In fact, the Chitlac-nAg 
solution is characterized by an absorption peak at about 400 nm (plasmon resonance absorption 
band) (Donati et al., 2009) and thus a decrease in the plasmon peak intensity over time accounts for 
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a deposition process of the metallic nanoparticles from the solution onto the substrate; Figure 1a 
shows that the peak intensity decreases considerably after 24 hours, which indicates a time-
dependent adsorption of Chitlac-nAg on the activated thermoset. Moreover, a 6 nm blue-shift of the 
plasmon peak was observed pointing to a smaller size of the particles remaining in solution, which 
means that larger nanoparticles tend to be incorporated in the coating somewhat more easily than 
smaller ones. A non-activated thermoset was used as a control and in this case no change in the 
absorption peak was noticed (data not shown).  
 
Figure 1. a) UV-Vis spectra of Chitlac-nAg freshly prepared (solid line) and after incubation with 
the activated thermoset for 24 h (dotted line). b) Optical image of the cross section of the 
nanocomposite coating. Inset: TEM image of the coating at higher magnifications showing the 
presence of electron-dense domains. 
 
The concentration of total silver in the colloidal suspension was monitored by ICP-AES during each 
step of the coating preparation in order to quantitatively estimate the deposition of the nanoparticles 
on the substrate; after incubation with the activated thermoset for 24 hours, the silver amount in the 
supernatant solution decreased by about 85 %, thus confirming the silver deposition on the 
substrate. The dried coated sample was then rinsed in 1 mL of deionized water for 1 hour under 
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constant stirring and the silver concentration measured in the rinsing solution; the silver release was 
below the detection limit (< 0.01 ppm), showing that the nanocomposite film formed on the acrylic 
thermoset has a good stability in water, at least for short times. 
A further characterization of the nanocomposite coating was carried out by direct imaging the cross 
section of Chitlac-nAg coated samples. The optical image in Figure 1b points to the presence of a 
Chitlac-nAg layer about 10÷15 µm thick, grafted onto the underlying thermoset substrate. TEM 
images of the cross section of the coating confirmed the presence of electron-dense domains buried 
inside, or protruding from, the surface of the polysaccharide matrix, which can be safely attributed 
to silver-nanoparticles clusters (Figure 1b, inset).  
The location of silver nanoparticles both on the surface and inside the coating could be particularly 
beneficial for long-term in vivo applications, since this thick antimicrobial and biodegradable layer 
is expected to be slowly remodeled and adsorbed from the surrounding tissues, acting like a 
reservoir of the biocidal agent. 
Since the coating is supposed to exert its antimicrobial activity mainly by means of a direct contact 
between silver nanoparticles and bacteria membranes (Stevens et al., 2009), examination of the 
distribution and organization of the nanoparticles emerging from the outer nanocomposite layer has 
been undertaken. To this end, FE-SEM was employed to explore the surface of the coating: Figure 2 
collects top-views of the Chitlac-nAg layer at various magnifications. In Figure 2a it is possible to 
notice the presence of white spots spread all over the surface; these zones are polysaccharide 
domains particularly enriched with round-shaped silver nanoparticles kept together by the polymer 
matrix and appear like clusters of nanoparticles and Chitlac. The clusters are homogeneously 
dispersed over the sample surface and display irregular shapes. The average size is about 1 µm, but, 
occasionaly, both larger (up to 5 µm) and smaller clusters (hundreds of nanometers) can be found. 
The chemical composition of the clusters was analyzed by means of EDX measurements that 
confirmed the presence of silver (Figure 2a, inset). Figure 2b shows a single cluster, Figure 2c is a 
magnification of the nanoparticles entrapped within the polymer matrix. The smoothness of the 
Nanocomposite Antimicrobial Coatings in Orthopaedics 
nanoparticles indicates that a Chitlac film seems to wrap the particles around. Figure 2d shows 
smaller clusters of isolated particles embedded in the polysaccharide layer and protruding through 
its surface.   
 
Figure 2. FE-SEM images of the nanocomposite coating (top views) at various magnifications. a) 
Surface distribution of Chitlac-nAg clusters and EDX spectrum showing the presence of silver on 
the surface (inset). b) Single cluster. c) Silver nanoparticles entrapped in the polymer matrix. d) 
Smaller clusters of nanoparticles on the surface layer. 
 
These FE-SEM images confirmed the presence of silver nanoparticles, attached to the 
polysaccharide matrix, able to directly interact with bacteria when they come into contact with the 
biomaterial surface. 
Antibacterial efficacy tests were carried out with two different bacteria strains, namely S. aureus 
(Gram+) and P. aeruginosa (Gram-); each bacterial strain was smeared on the surface of the 
Chitlac-nAg coated thermoset while the uncoated thermoset was used as control. After 3 hours of 
incubation, the bacteria were detached from the samples and the number of Colony Forming Units 
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(CFU)/mL was evaluated. Figure 3 indicates that both bacteria strains were effectively inactivated 
by the nanocomposite coating, with a drop of almost 6 orders of magnitude in the CFU/mL, while 
the uncoated thermoset does not display any remarkable antibacterial activity. 
 
Figure 3. Antimicrobial efficacy tests on S. aureus (a) and P. aeruginosa (b) in direct contact with 
Chitlac-nAg coated and uncoated thermoset. The values are the mean ± standard deviation of three 
independent experiments. 
 
It should be noticed that the biocidal activity of silver nanoparticles is not impaired by their 
incorporation in the polymer layer (Travan et al., 2009), which implies that their immobilization 
does not significantly restrict access to bacteria. This means that the electrostatic deposition on 
acrylic supports represents an effective method to immobilize silver nanoparticles keeping their 
antibacterial activity. 
Since antimicrobial biomaterials need to combine bactericidal activity with the lack of toxicity 
towards eukaryotic cells, LDH cytotoxicity tests were carried out with a osteoblasts-like cell line 
(MG63) and with primary human fibroblasts. Figure 4 (a,b) reports the percentage of lactate 
dehydrogenase released by cells in contact with both coated and uncoated thermosets, with the 
corresponding extracts and with control materials; the results show that Chitlac-nAg coated 
thermosets did not exert any considerable cytotoxic effect on the tested cells. In fact, although 
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MG63 cells exhibit after 24 h a minor increase of the LDH release for the coated samples in direct 
contact with cells, there was no considerable difference between silver-treated cells and control 
groups after 72 h. The slightly toxic effect observed in the case of MG63 cells during the first few 
hours could be presumably ascribed to an initial burst release of silver followed by recover of cell 
viability. 
 
Figure 4: a, b) Cytotoxicity of osteoblast-like cells (MG63) (left) and primary fibroblasts (right). 
Ad = adhesion control on multiwell, UTE = uncoated thermoset extract, CTE = coated thermoset 
extract, UTC = uncoated thermoset contact, CTC = coated thermoset contact, PU = polyurethane 
positive control, PS = plastic sheet negative control. c, d) Cell proliferation of osteoblast-like cells 
(MG63) (left) and primary fibroblasts (right) on uncoated (circle symbols, dashed line) and coated 
thermosets (square symbols, dotted line); lines are drawn to guide the eye.  
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This result indicates that, despite the presence of silver nanoparticles, the nanocomposite coating 
does not represent a threat in terms of toxicity towards eukaryotic cells. Nevertheless, this 
information is not sufficient to state that mammalian cells can grow and proliferate on such 
material. Thus, in order to evaluate the cell proliferation, both osteoblasts and fibroblasts were 
plated on Chitlac-nAg coated and uncoated thermosets and their proliferation rate was evaluated by 
means of Alamar Blue assay over 4 days. Figure 4 (c,d) shows that for both osteoblasts MG63 and 
primary fibroblasts the proliferation rate is practically the same on uncoated and Chitlac-nAg coated 
thermosets, which indicates that the antimicrobial coating does not hamper cell proliferation with 
respect to the supporting biomaterial. 
SEM and confocal characterizations were used in order to gain more information about the 
distribution and morphology of the eukaryotic cells cultured on the nanocomposite coating. Figure 5 
refers to the tests carried out with MG63 cells: rows a) and b) display SEM images of the different 
surfaces without or with cell cultures, respectively, while row c) reports the confocal images at 
higher magnifications. SEM images indicate that the cells proliferate uniformly resulting in a layer 
well adhered to the substrate on both coated and uncoated surfaces. Confocal images clearly show 
that cells keep the same healthy morphology in the presence of the nanocomposite coating as on the 
uncoated surface. The actin filaments are seen to align along the grooves introduced with the 
polishing of the raw thermoset.  
 
 
 
 
 
 
 
Nanocomposite Antimicrobial Coatings in Orthopaedics 
 
UNCOATED THERMOSET CHITLAC-nAg COATED THERMOSET 
a) 
  
b) 
  
c) 
  
 
Figure 5. Micrographs of uncoated (left column) and Chitlac-nAg coated (right column) 
thermosets. a) SEM images of thermosets without cells. b) SEM images of MG63 cells grown for 
72 h on thermosets. c) Confocal images of MG63 cells grown for 72 h on thermosets (ruler = 50 
µm). 
 
In order to assess if these qualitative results are not dependent on the cell line selected, SEM and 
confocal characterization were carried out also with another osteoblasts cell line, i.e. Saos-2. Figure 
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6 shows that also in this case the cells display an elongated morphology (Figure 6a and 6b) which 
follows the underlying ribbed structure (Figure 6c). The osteoblasts are firmly attached and spread 
on the polysaccharidic matrix as pointed out by the presence of numerous focal adhesions stained in 
red (Figure 6d). Cytoskeleton, in particular actin fibres appear well organized in the chitlac-nAg 
coated samples such as in uncoated samples. In the centre of Figure 6d it is possible to notice the 
chromosomes rearrangements that characterize cell mitosis, thus confirming the healthy condition 
of the cells in direct contact with the silver containing coating. 
 
Figure 6. Saos-2 cell morphology and proliferation on uncoated and coated thermosets. Top: SEM 
images of cells grown on the uncoated thermoset (a), and on Chitlac-nAg coated thermoset (b).  
Bottom: confocal images of Saos-2 cell distribution over the Chitlac-nAg coating showing the 
underlying nanocomposite surface finishing (c), and highlighting the vinculin, a focal adhesion 
marker of cells (red spots) (d).  
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In analogy to what observed for osteoblast cell lines, also the morphology of primary fibroblasts 
grown on Chitlac-nAg coating does not appear modified in comparison with that of cells grown on 
uncoated samples; the cells appear uniformly spread and well adhered with a highly organized actin 
network (Figure 7a,b).    
 
Figure 7. Top: Confocal images of human primary fibroblasts proliferated for 72 hours on uncoated 
(a) and Chitlac-nAg coated (b) thermosets. Bottom: c) Alamar Blue proliferation assay on human 
adipose-derived stem cells on Chitlac-nAg coated (striped bars) and uncoated (white bars) 
thermosets. d) Confocal image of human adipose-derived stem cells proliferated for 7 days on 
Chitlac-nAg coated thermoset. 
 
Human adipose-derived stem cells were tested in order to preliminary evaluate the effect of the 
silver-containing nanocomposite coating on undifferentiated cells. Since these cells were expected 
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to have a lower proliferation rate with respect to the cell-lines tested, the Alamar Blue assay was 
performed on longer time range (seven days); the results reported in Figure 7c show that stem cells 
were able to attach and proliferate on Chitlac-nAg coating (striped bars) as well as on uncoated 
thermoset (white bars). Confocal images of stem cells grown on Chitlac-nAg coated thermoset 
confirmed the presence of well adhered cells all over the coating in direct contact with the substrate 
and also in overlapping layers (Figure 7d). Further studies are planned to study the differentiation of 
the stem cells proliferated on the nanocomposite coating. 
 
Conclusions 
A polysaccharide film containing silver nanoparticles was successfully prepared to coat a 
surface-hydrolyzed methacrylic thermoset exploiting electrostatic interactions. The nanocomposite 
film is effective in killing both Gram+ and Gram- bacteria; FE-SEM and TEM images reveal the 
presence of silver nanoparticles located on the surface of the coating allowing the direct contact 
between the metal and bacteria, while the considerable thickness of the nanocomposite layer could 
account for a long-term reservoir of the antimicrobial agent in vivo. This material does not exert any 
significant cytotoxic effect towards eukaryotic stem cells, primary cells and cell-lines, which are 
able to firmly attach and proliferate on the surface of the coating. Such biocompatible antimicrobial 
polymeric films containing silver nanoparticles may have good potentials for surface modification 
of medical devices, especially for prosthetic applications in orthopaedics and dentistry. The 
preparation technique is easy and inexpensive: in particular, the polyelectrolyte layer provides a 
convenient matrix for immobilizing accessible antimicrobial nanoparticles on methacrylic supports. 
The procedure can be adapted to almost any type of material as long as proper surface charges are 
present or can be produced thereon; such possibility to combine the system with other 
polyelectrolytes with specific biological properties could make this technique even more appealing.   
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Abstract 
A nanocomposite hydrogel based on natural polysaccharides and gold nanoparticles (AC-nAu) has 
been prepared and its biological effects were tested in vitro with both bacteria and eukaryotic cells. 
Antimicrobial tests showed that AC-nAu gels are effective in killing both Gram+ (S. aureus) and 
Gram- (P. aeruginosa) bacteria. LDH assays pointed at a toxic effect towards eukaryotic cell-lines 
(HepG2 and MG63), at variance with silver-based hydrogels; cytofluorimetry studies demonstrated 
an apoptosis-related mechanism that leads to cell death after 24 hours of direct contact with AC-
nAu gels. In vivo biocompatibility has been evaluated in a rat model: this study aimed at 
investigating the soft tissue peri-implant reaction after 1 month of implantation. The results show 
that silver-containing samples induced a soft tissue capsule of the same average thickness of the 
control sample (devoid of nanoparticles) (~50 µm), while in the case of gold-containing materials 
the fibrotic capsule was thicker (~100 µm), confirming a higher biocompatibility for silver-based 
samples than for gold-based ones.   
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Bulk gold is the most noble of all metals and as such considered inert[1]. This behaviour is found 
only at a macroscopic level, since this metal exhibits different properties when moving to nanoscale 
structures that find increasing attention in plasmonics-related field. For instance, gold nanoparticles 
are being employed for molecular imaging applications[2], Surface Enhanced Raman 
Scattering[3;4], as catalyzing agents[5], tracers in diagnostics[6] and antimicrobial agents[7-
10;10;11]. Gold compounds are also used for the treatment of rheumatoid arthritis[12] and were 
referred to inhibit bone-resorbing osteoclasts[13]. 
However, once reaching the nanoscale, certain materials (e.g. carbon) do exhibit significant toxicity 
to mammalian cells even if they are biochemically inert and biocompatible in bulk size[6;14-17]. 
When dealing with metal nanoparticles, only a few studies have provided insights on their 
interactions with eukaryotic cells and their relevant toxicological implications, in contrast to the 
attention paid to their applications [18]. In the last few years, despite the great excitement about the 
potential uses of gold nanoparticles, researchers have become increasingly aware that potential 
nanoparticle toxicity must be investigated before any in vivo applications of gold nanoparticles can 
move forward[6].  
The recent literature contains conflicting data regarding the cytotoxicity of gold nanoparticles[19]. 
Shukla et al.[16] showed that gold nanoparticles are not cytotoxic to macrophage cells, reduce the 
production of reactive oxygen and nitrite species, and do not elicit secretion of proinflammatory 
cytokines TNF-R and IL1-α, underlining their non-immunogenic and biocompatible properties with 
the potential for application in nanobiotechnology and molecular medicine therapies. On the other 
hand,  nanoparticles cytotoxicity directly related to their dimensions has been reported[20]. Jan et 
al.[21] pointed to the inhibitory effect of gold nanoparticles on HepG2 cell growth and Pan et 
al.[19] discussed the issue of size-dependence on the mechanism of gold nanoparticles cytotoxicity. 
Mitchell et al.[22] reported the toxicity of gold nanoparticles against a yeast (Saccharomyces 
cerevisiae). 
Within this debate, metal nanoparticles like gold and silver have also been explored for their broad-
spectrum antimicrobial activity[7]. Colloidal gold and silver (AuNPs and AgNPs) were successfully 
used to treat both Gram+ and Gram- bacteria[11]. Ray et al.[9] studied the antimicrobial efficacy of 
metallopharmaceutical agents based on gold complexes and Nomyia et al.[23] discussed the 
antimicrobial and antifungal activity of gold complexes. 
A general way to prepare metal nanoparticles is by reducing metal ions in the presence of a 
stabilizing agent such as a polymer in order to prevent aggregation. Polymers like chitosan[24;25], 
methylcellulose[26] and amphiphilic block copolymers[27] have been used to stabilize gold 
nanoparticles. Yang et al.[28] reported a method to prepare gold nanoparticles using chitosan as 
both reducing and capping agent. Dinda et al.[29] reported a method for the formation of gold 
nanoparticles by using ionic liquids based on ascorbic acid. Esumi et al.[30]demonstrated that 
hydroxyl groups of Sugar-Persubstituted Poly(amidoamine) dendrimers reduce Au(III) to Au(0). 
In the antimicrobial field, many efforts are aimed at the preparation of biocompatible and hydrated 
materials endowed with broad spectrum antibacterial activity for topic applications like the 
treatment of burns and chronic wounds; in this perspective, hydrogels appear as the ideal matrix for 
the selected biocidal agent. Recently, the in vivo evaluation of noble metal coatings (Ag, Au, Pd 
coated catheters) has pointed out a higher biocompatibility for silver coatings, while the addition of 
gold or palladium induced the formation of a thicker fibrotic capsule surrounding the implants[31]. 
A recent study of the authors[17] discussed the preparation of a nanocomposite hydrogel based on 
biocompatible polysaccharides (a lactose-modified chitosan, named “Chitlac”, and alginate) and 
silver nanoparticles that displays considerable antimicrobial efficacy without exerting any cytotoxic 
activity towards eukaryotic cells in vitro.  
In the present study we describe the preparation of 3D hydrogels structures based on 
polysaccharides and gold nanoparticles and we assess their antimicrobial properties and 
cytotoxicity.  The results obtained in the case of hydrogels containing gold nanoparticles are 
compared with those loaded with silver nanoparticles in order to evaluate the biological effects of 
the two nanocomposite systems based on different metal nanoparticles; in vitro studies were carried 
out to elucidate antimicrobial activity and cytotoxic mechanism, while in vivo tests evaluated 
interfacial soft tissue response in a rat model. 
 
Materials and methods 
Materials 
Chitosan was purchased from Sigma Chemical Co (St. Luois, MO) and purified according to the 
procedure reported elsewhere[32]. Chitlac (1-Deoxylactit-1-yl chitosan, CAS registry number 
85941-43-1) sample was prepared according to the procedure reported elsewhere[33] starting from 
a highly deacetylated chitosan (residual acetylation degree = 11.3%, Aldrich Chemical Co. (USA). 
The relative molar mass of Chitlac was estimated to be approximately 1.5 x 106. Ultrapure alginate 
(FG = 0.65, FGG = 0.53) was purchased from Novamatrix. Chloroauric acid (HAuCl4), Ascorbic acid, 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, CaCO3 (mean particle size 3 µm), Glucono-d-
lactone (GDL) and LDH based TOX-7 kit (Sigma-Aldrich) were purchased from Sigma Chemical 
Co (St. Luois, MO). The colloidal solution of Chitlac and with silver nanoparticles (Chitlac-nAg) 
was prepared as reported elsewhere[17].  
Gold nanoparticles  preparation in the presence of Chitlac or chitosan  
Gold nanoparticles were obtained by reducing gold ions in polysaccharides solutions according to 
the following procedures: freeze-dried Chitlac or chitosan was dissolved in deionized water at 
different concentrations (2, 4, 8 and 12 g/L). Chitlac and chitosan solutions were mixed with 
HAuCl4 solutions to achieve the final concentration of 1 mM HAuCl4; the samples were then heated 
for 24 hours at 55°C and a red-violet colloidal solution was obtained. When the polysaccharide 
concentration was 4 g/L the colloidal solution is referred to as “Chitlac-nAu” or “chitosan-nAu”. 
For antibacterial tests 20% Muller-Hinton broth was added to the colloidal solutions.  
 
 
Hydrogel preparation 
Alginate-Chitlac (AC) hydrogel: for the preparation of alginate-Chitlac hydrogels an in-situ calcium 
release approach was used. Briefly, a Chitlac solution was added to an alginate solution (final 
concentrations: alginate 15 g/L, Chitlac 2 g/L, NaCl 0.15 M, HEPES 0.01 M, pH 7.4) and the 
mixture was blended with an inactivated form of Ca2+ (CaCO3, 15 mM) followed by the addition of 
the slowly hydrolyzing       D-glucono-δ-lactone (GDL) ([GDL]/[Ca2+] = 2). Aliquots of this gelling 
solution were poured in well tissue culture plates. Finally, the gels were washed with CaCl2 solution 
5 mM to remove       residual GDL.  
Alginate-Chitlac-nAu (AC-nAu) hydrogel: alginate-Chitlac hydrogels containing gold nanoparticles  
were prepared according to the procedure of the AC-Gels using Chitlac-nAu instead of Chitlac 
solutions. For antibacterial tests, 20% Muller-Hinton broth was added to both Chitlac and alginate 
solutions.  
Alginate-Chitlac-nAg (AC-nAg) hydrogel: alginate-Chitlac hydrogels containing silver 
nanoparticles  were prepared according to the procedure of the AC-Gels using Chitlac-nAg instead 
of Chitlac solutions, as previously reported[17]. 
UV-Vis spectroscopy 
UV-Visible (UV-Vis) spectroscopy measurements were performed with a Cary 400 
Spectrophotometer (data interval: 0.5 nm; scan speed: 300 nm/min). All samples solutions were 
diluted 1:2. 
Transmission Electron Microscopy (TEM) 
TEM images were taken by means of a PHILIPS EM 208 Microscope; the solutions were deposited 
onto Nickel grids coated with a carbon film and dried overnight.  
Bacterial growth Inhibition Tests 
Bacterial growth Inhibition Tests were performed using bacteria stains of S. aureus (ATCC 25923) 
and P. aeruginosa (ATCC 27853) diluted in 20% Muller-Hinton broth to give 1 x 106  Colony 
Forming Units (CFU/mL),  in presence or absence of Chitlac-nAu. Bacteria growth was monitored 
for 4 hours by measuring the absorbance at 620 nm 10 min with a microtiter plate reader (Tecan 
Trading AG, Switzerland).  
Growth Inhibition Assays in Solid Medium  
The growth inhibition in solid medium was evaluated by smearing with sterile cotton swabs 
bacterial suspensions (106 CFU/mL) on Petri dishes prepared as described above (Hydrogel 
preparation). After overnight incubation at 37°C, the presence of visible colonies was evaluated. 
Growth controls were carried out on Muller-Hinton agar plates and AC gels in the presence of 
Muller-Hinton medium. 
LDH cytotoxicity assay  
In vitro cytotoxicity of AC-nAu gels was evaluated by using the lactate dehydrogenase assay (LDH 
assay- TOX-7 Sigma) on human hepatocarcinoma (HepG2) and human osteosarcoma (MG63) cell 
lines. Cylindrical samples with a length of 5 mm and a diameter of 4 mm were used and the tests 
were performed by direct contact and on liquid extract of material. For direct contact test, 50000 
cells were plated on 24-well plates and after complete adhesion, culture medium was changed with 
250 µL of fresh medium. Tested materials (in quadruplicate) were directly deposited on the cell 
layer. After 24 and 72 hours, medium was collected and the LDH assay was performed according to 
the manufacture’s protocol. In extraction test, samples were incubated in extraction medium 
(Dulbecco’s modified Eagle’s medium, inactivated fetal bovine serum 10%, penicillin 100 U/ml, 
streptomycin 100 µg/ml and  L-glutamine 2 mM) for 24 h at 37 °C and 5% pCO2. The 
surface/volume ratio of the samples and the medium was 1.25 cm2/mL. After incubation, extraction 
media were added on cells seeded on 24-well plates (50000 cells/well). Tested materials (in 
quadruplicate) were directly deposited on the cell layer. After 24 and 72 hours, medium was 
collected and the LDH assay was performed according to the manufacture’s protocol. As a positive 
control material, polyurethane films (PU) containing 0.25% zinc dibuthyldithiocarbamate (ZDBC) 
(8 mm discs) were used. As negative control material, plastic sheet (8 mm discs) were used (PS). 
For the extraction test, each sample (in quadruplicate) was incubated in cell culture medium (1 mL) 
for 24 h at 37 °C and 5 % pCO2. After incubation, the extraction media were added on cells seeded 
on 24-well plates (50000 cells/well). As positive control, Triton 1% was used. The LDH assays 
were performed after 24 h and 72 hours as described above. Each material test was performed in 
quadruplicate. Evaluation of cytotoxicity was calculated according to the formula:  % LDH released 
= [(A-B)/(C-B)] x 100 %, with A = LDH content from sample; B = LDH content of culture 
medium; C = maximal LDH content after cell lysis). 
Apoptosis assays 
Annexin V assay was used to evaluate cell apoptosis. Apoptosis was estimated in MG63 cells after 
18 hours of incubation with AC-nAU hydrogels directly deposited on cell layer. Azacitidine (50 
µM) was used as apoptosis positive control. Annexin V assay was performed using the Annexin V-
FITC Apoptosis Detection kit by Sigma according to the manufacture’s protocol and data collected 
by cytofluorimetric analysis. 
In vivo tests and histological analyses 
For in vivo test, the hydrogels were prepared according to the protocol reported above using 
ultrapure endotoxin-free alginate. After gelification, the hydrogels were dried under hood, cut in 
circular films with diameter 8 mm and thickness 1 mm and UV sterilized. 
The animal model  
Wistar rats (200–250 g) had free access to water and  a standard pellet diet (hatlan Teklad 2018); 
they were anesthetized using Tribromoethanol (Sigma, 250 mg/kg i.p.) and xilazin (Virbaxil 2 %, 
10 mg/kg i.p.). Rats were shaved on the back and cleaned with betadine. Four rats were used for 
each type of material (AC-nAg and AC-nAu). Each rat received one nanocomposite sample and one 
control sample (AC) subcutaneously on the back. Separate incisions were made for each implant 
type. The wounds were closed with two sutures (Ethilon 5-0 FS-3, Ethicon1, Johnson & Johnson, 
Belgium). The implants were kept for 1 month, in order to evaluate the fibrous capsule formation 
and the late inflammatory response. For explantation, the animals were sacrificed by CO2 
inhalation. The animal experiment was in compliance with Italian National law D.L.vo 116/92. 
Histological analysis  
After 1 month, the implants together with surrounding tissues were excised en bloc and immersed in 
10% buffered formalin for 3-5 days. The specimens were dehydrated in a graded series of ethanol 
and embedded in Paraplast® Plus Tissue Embedding Medium added with dimethyl sulphoxide 
(DMSO) (McCormick).The embedded tissue was sectioned in 3-4 µm thick section and stained 
with ematoxylin-eosin for light microscopy. The thickness of the fibrous capsule around each 
implant was analyzed at equally located points on both sides of the implant disk by light 
microscopy (Leica DMLB) equipped with photographic system (Leica DC100). 
 
Results and discussion 
Colloidal solutions containing gold nanoparticles were prepared by reduction of corresponding 
metal ions (Au+++) to zeroth-valent metal nanoparticles in the presence of polysaccharides solutions 
(Chitlac or chitosan). The reduction of gold ions occurred upon heating the polysaccharide solution 
with HAuCl4 at 55°C, according to the procedure proposed by Huang et al.[25]. During the thermal 
treatment the solutions turned from light yellow to red-violet, suggesting the formation of the 
metallic nanoparticles. The formation of a surface plasmon resonance band arising from gold 
nanoparticles was monitored by means of UV-Vis absorption spectroscopy after 24 hours of 
incubation at 55°C (Figure 1a). Figure1b shows the variation of the plasmon band intensity as a 
function of the heating time in the case of nanoparticles formation in Chitlac (4 g/L); after about 24 
hours the intensity reaches a plateau, suggesting the completion of nanoparticles formation. The 
effect of Chitlac concentration on the plasmon resonance band was also explored (Figure 1a, solid 
lines): the changes in absorption spectra indicate that size and dispersion of gold nanoparticles are 
strongly affected by polysaccharide concentration. In particular, the highest peak was recorded for 
the Chitlac concentration of 4 g/L and was centred at about 530 nm, while lower or higher 
concentrations were associated with lower peak intensities (8 g/L, 12 g/L) or red shifted non-
symmetrical curves (2 g/L). As a comparison, the UV-Vis spectrum after 24 h in the case of 
chitosan 4 g/L was recorded (Figure 1a, dashed line): the spectrum is less intense and asymmetrical 
and the plasmon peak is red-shifted with respect to Chitlac. These data suggest the formation of 
smaller and better stabilized nanoparticles in Chitlac, whereas in chitosan there is a higher tendency 
to aggregation.  TEM images confirmed this indication: Figure 1c,d shows the presence of well 
dispersed nanoparticles in Chitlac smaller than 20 nm, while in chitosan we can observe both 
dispersed nanoparticles and large aggregates with branched structures (Figure 1e,f).  
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Figure 1: a) UV-Vis spectra of gold nanoparticles in Chitlac at various polysaccharide concentration (solid lines) and of 
gold nanoparticles in chitosan (dashed line). b) Evolution of the plasmon peak intensity in Chitlac-nAu (Chitlac = 4 
g/L) as a function of incubation time at 55°C. c,d) Gold nanoparticles formed in Chitlac 4 g/L. e,f) Separate gold 
nanoparticles and branched aggregates formed in chitosan 4 g/L.  
 
The better performance of Chitlac with respect to chitosan might be attributed to the presence of the 
hydrophilic and bulky lactitol groups decorating the modified polysaccharide[17]; they account for 
a higher steric hindrance toward nanoparticle aggregation and formation of larger structures. Given 
the UV-Vis results, the Chitlac concentration was set at 4 g/L for the preparation of the colloidal 
system used for all subsequent biological characterizations (hereafter named “Chitlac-nAu”). 
In order to evaluate the antimicrobial activity of the Chitlac-nAu colloidal solution,  both Gram+ 
and  Gram- strains were considered. Bacteria growth inhibition tests were performed incubating S. 
aureus and P. aeruginosa in 20% Mueller-Hinton broth in the presence of Chitlac-nAu. Bacterial 
growth was followed as increase of absorbance at 620 nm. A marked inhibition of the bacterial 
growth is achieved in the presence of Chitlac-nAu in comparison with the growth control (Figure 
2a,b): in fact, the bacterial growth curve remained close to zero in the case of gold-treated runs, thus 
indicating the effective bacterial inhibition associated with Chitlac-nAu. Similar results were 
obtained for E. coli and S. epidermidis (data not shown). 
 
Figure 2. Top: Bacteria growth kinetics of P. aeruginosa (a) and S. aureus (b) treated with the colloidal solution 
Chitlac-nAu (square) and with Mueller-Hinton broth (circles).  Bottom: Growth of P. aeruginosa (c) and S. aureus (d) 
on AC-nAu nanocomposite hydrogels (violet gels) and on agar plates (transparent gels). 
 
The Chitlac-nAu colloidal solution was also tested in vitro on eukaryotic cells: LDH cytotoxicity 
assays pointed out a cytotoxic effect both on human hepatocarcinoma (HepG2) and human 
osteosarcoma (MG63) cell lines leading to cell death after 24 hours (data not shown). This result 
was expected since also in the case of silver the Chitlac-nAg colloidal solution was toxic towards 
the same cell lines[17]; this fact was attributed to the lack of physical barriers to nanoparticle 
diffusion into cells which determines their generalized (bio)availability, with the risk of a massive 
nanoparticles uptake by eukaryotic cells. For this reason, we prepared three dimensional structures 
to entrap gold nanoparticles by exploiting the gel forming properties of alginate and its miscibility 
with Chitlac-nAu colloidal solutions. In an ideal case, as already demonstrated for AC-nAg 
gels[17], such nanocomposite hydrogel could prevent nanoparticles from being available for cell 
uptake and, at the same time, preserve their antimicrobial activity allowing the direct interaction of 
the nanoparticles with bacteria surface proteins, which are considered the main molecular targets of 
nanoparticles[34]. The binary mixture of alginate and Chitlac-nAu allowed for the preparation of 
homogeneous hydrogels by exploiting the in situ gelification technique[35;36]: the result was a 
violet semi-transparent construct (Figure 4b). It is also important to underline that neither 
nanoparticle aggregation or polymer phase separation were observed during and after gel formation. 
To assess the extent of bacterial growth on the nanocomposite hydrogel, bacteria were smeared on 
the surface of AC-nAu gels while agar plates were used as controls. After overnight incubation, 
bacterial colonies were clearly visible on agar plates, while they were completely absent on the gold 
nanoparticles-containing gels (Figure 2c,d), showing that the antibacterial activity persists also in 
the semi-solid structure. 
In vitro cytotoxicity of the nanocomposite hydrogel (AC-nAu) towards HepG2 and MG63 cell-lines 
was tested by means of LDH assay (Figure 3). A similar approach was previously followed by the 
authors in the case of AC-nAg gels where no cytotoxic effect was detected on the same cell-
lines[17]. At variance, the gold-nanoparticles containing gels were found to exert cytotoxic activity 
both by direct contact with cells and as extraction media solutions from the gel. As a matter of fact, 
there was a significant difference in the release of lactate dehydrogenase (LDH) between the AC-
nAu treated cells and control groups after 24 hours (Figure 3).  
 
Figure 3. Effect of AC-nAu gels on LDH leakage from (a) human hepatocarcinoma (HepG2), and (b) human 
osteosarcoma (MG63) cell lines. The cytotoxicity test was performed both with the extract from gel material (GE) and 
with the gel material itself by direct contact with cell layer (GC). Control cells cultured in adhesion in complete DMEM 
medium and cells treated with AC gels lacking gold nanoparticles (NGC and NGE extract) were run in parallel to AC-
nAu gels treated groups. The percentage of LDH release was calculated by dividing the amount of activity in the 
medium by the total activity (medium and cell lysate) after subtraction of the control. Polyurethane sheets (PU) were 
used as contact positive control, plastic sheets (PS) were used as contact negative control and Triton was used as extract 
positive control. The data are expressed as mean ±SD of four independent experiments.  
 
This was an interesting finding because, in the case of AC-nAg, the gel structure was able to embed 
silver within the structure and the cell viability was not affected.  Thus, in the case of gold, the 
metal (both as nanoparticles and ionic species) does not seem to be entrapped within the gel matrix 
as efficiently as in the case of silver. One could speculate that this effect is caused by different 
coordination ability of the polysaccharides towards the two metals. Hence, at this point of the 
research, the cause of AC-nAu gel toxicity might in principle be ascribed to the release of both 
metallic (nanoparticles) and anionic species of gold; further studies are required for a deeper 
understanding of this complex mechanism. 
A study on cellular death mechanism was tackled in order to elucidate whether it is related with cell 
necrosis or apoptosis. To this aim, the cells were incubated with AC-nAu gels for 18 hours and then 
processed for cytofluorimetric analysis (Figure 4a,c). The results showed that, after 18 hours of 
incubation with AC-nAu gels, the late apoptotic cells increased from 2.8 % to 10.8 % (Q2 
quadrant), while cells in early apoptosis increased from 0.5 % to 4.9 % (Q4 quadrant) with respect 
to non-treated cells. In view of these results, the hypothesis of cell necrosis can be ruled out since 
the death mechanism associated with metal release can be ascribed to apoptosis. 
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Figure 4. a,c) Cytofluorimetry plots of MG63 cells respectively untreated (a) and treated (c) for 24 h with AC-nAu. b) 
The semi-transparent nanocomposite hydrogel embedding gold nanoparticles (AC-nAu)  
 
The biological behaviour of the nanocomposite hydrogels was further explored by means of in vivo 
tests in a rat model; for this test, the samples were dried, sterilized and implanted subcutaneously 
and after 1 month histological analyses were carried out (Figure 5). As control materials, both AC 
and AC-nAg were considered. The images show, from the inside tissues towards the implant (white 
zone on top), the cutaneous muscle, the connective soft tissues and a fibrotic tissue composed by 
fibroblast cells and collagen fibres: the three different samples have all induced the formation of a 
fibrotic capsule, while no damage, inflammation or morphological alteration of the surrounding 
tissues were observed.  
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Figure 5. Histological analyses of the fibrous capsule surrounding the implants; the arrows indicate the section of the 
fibrous capsules formed after 1 month at the interface with the samples (white zones on top). Top: peri-implant tissues 
in the case of AC (a), AC-nAg (b)  e AC-nAu (c). Bottom (d,e,f): magnifications of the fibrotic capsules near the three 
different samples.  
 
This capsule is thinner in the case of AC and AC-nAg (~ 50 µm) while in the case of AC-nAu the 
thickness is higher (~ 80÷100 µm). The increased thickness of the capsule in the case of gold is in 
line with its in vitro cytotoxicity. In facts, although for the in vivo test the material is in contact with 
a much more complex biological system, the higher level of toxicity revealed by LDH assays seems 
to be confirmed in the rat model in terms of a thicker fibrotic capsule formation. In the literature, 
the fibrous capsule thickness has been correlated to enhanced ion release and ion toxicity when 
metals and their alloys were inserted in rabbit muscle[37]; toxic materials, like copper-coated 
implants, induced a dense fibrous capsule of thickness about 150–200 µm with newly formed blood 
vessels and inflammatory cells, while a capsule around titanium (standard control material clinically 
used) exhibited a well organized thin capsule of only 90 µm[38]. These data strengthen the 
hypothesis that in the case of AC-nAu samples the release of gold causes adverse effects displayed 
by cytotoxicity in vitro, and by the increased thickness of fibrotic capsules in vivo. The issue 
regarding the form and amount of gold release remains to be elucidated. 
 
Conclusions 
In the present study we have obtained homogeneous nanocomposite systems based on natural 
polysaccharides and gold nanoparticles formed in Chitlac solutions, whose lactose moieties account 
for the preparation of smaller and better dispersed particles with respect to chitosan. Although these 
mixed hydrogels displayed considerable antimicrobial activity, they exerted also toxic effect 
towards eukaryotic cells as demonstrated by in vitro assays, at variance with similar gels containing 
silver nanoparticles; the gold-related cytotoxicity is due apoptotic mechanisms as demonstrated by 
cytofluorimetric studies. In vivo tests showed a good biocompatibility of these metal 
nanocomposites that caused only the formation of a limited fibrous capsules around the implant 
without signs of chronic inflammation, although gold-based nanocomposites displayed the highest 
fibrogenic potential, thus confirming the in vitro indications. 
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 2 
1.0 INTRODUCTION TO SILVER NANOCOMPOSITES 
 
By definition, nanocomposites are materials containing domains or inclusions that are of nanometer size 
scale1. Nanocomposite materials that exploit the properties of silver at the nanoscale for biomedical 
applications are of increasing interest in the scientific literature (Figure 1)  and today they can be found in 
many commercial products, like wound dressings and creams. 
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Figure 1. Publication counts derived from the Thompson ISI Web of Science database on October 2009, using the key 
word “silver nanocomposites”.  
 
The idea behind these novel materials is that silver at the nanometer scale displays unique properties that can 
be used for different purposes, ranging from antimicrobial to optical and catalytic applications2,3. 
This section overviews the state-of-the-art of silver nanocomposites for the most promising pathways in the 
biomedical field; it is structured in 5 main parts. Chapter 1 gives a brief introduction about the new class of 
materials referred to as “silver nanocomposites”, while Chapter 2 discusses the main routes of preparation of 
silver nanoparticles and the final composite constructs. Chapter 3 presents the main results and applications 
of these materials over the last few years, with a particular attention to the antimicrobial field: in fact, as the 
largest efforts aim at exploiting the antimicrobial properties of silver, chapter 3.1 is meant to sum up results 
and hypothesis about the detailed antimicrobial mechanism, which is today only partially understood. 
Paragraphs 3.2 to 3.4 specifically consider the use of silver nanocomposites for applications related to wound 
healing, inflammations and biological sensing. Chapter 4 deals with the possible biological hazards of such 
materials, which are rarely taken into account and often represent a matter of controversy in terms of 
contradictory results. Finally, Chapter 5 suggests possible upcoming biomedical applications of this class of 
materials. 
 
 
 3 
2.0 PREPARATION AND CHARACTERIZATION OF SILVER NANOCOMPOSITES 
 
2.1 PREPARATION TECHNIQUES 
Since silver nanocomposite constructs are meant to exploit the properties of silver at the nano-scale,  many 
efforts are aimed at finding efficient and reproducible routes to produce silver nanoparticles (hereafter 
AgNPs). Many potential uses for these novel materials are being explored, ranging from antimicrobial 
purposes to molecular imaging. When preparing homogeneous nanocomposite materials containing AgNPs, 
a crucial issue is the tendency of nanoparticles to aggregate, which leads to the loss of the peculiar properties 
associated with the nano-scale. For instance, in the antimicrobial field, studies by Lok et al.4 revealed that 
non-stabilized AgNPs prepared by standard chemical methods (reduction of silver salt solutions) tend to 
aggregate in culture media and biological buffers which have high salt contents (chloride and phosphate 
being considered the most problematic anions): the aggregation leads to a decrease in the effective surface of 
the nanoparticles or the degree to which they can associate to bacteria. The so called “ex situ” preparation 
methods consist in the synthesis of nanoparticles as a first step, and then in mixing the pre-formed 
nanoparticles with a matrix (typically a polymer); however with this conventional technique it is difficult to 
disperse homogeneously the nanoparticles5. At variance, an “in situ” approach aims at synthesizing the 
nanoparticles within a suitable matrix in order to achieve a homogeneous dispersion in the composite 
materials. To date, the preparation and stabilization of metal nanoparticles represent an open challenge. The 
methods for preparing non-aggregated AgNPs for biomedical applications can be divided into two groups6: 
 
• wet chemical synthesis in the presence of a reducing agent and a stabilizing agent; 
• synthesis through physical processes  
 
The chemical approach is based on the use of a silver salt in an aqueous environment; silver ions are then 
reduced to zeroth-valent silver in the presence of a stabilizing agent in order to limit aggregation of the so-
formed nanoparticles. The stabilizing agent is meant to cap the particles and prevent further growth. The 
most accepted mechanism for the synthesis of a particle suggests a two-step process, i.e., nucleation followed 
by successive growth. In the first step, part of the metal ions in solution is reduced by a suitable reducing 
agent. The atoms thus produced act as nucleation centres and catalyze the reduction of the remaining metal 
ions present in the bulk solution. The atomic coalescence leads to the formation of metal clusters whose 
dimensions can be controlled by ligands, surfactants or polymers; in the absence of a stabilizer, clusters in 
aqueous solution undergo further growth leading ultimately to precipitation of the metal 7. 
Polymers and more generally many organic molecules can bind to the particle surface and thus serve the role 
of stabilizer. In general, the stabilization of metal nanoparticles is explained by the electronic interaction of 
the polymer functional groups with the metal particles. In fact,  nucleophilic groups can bind the metal 
particles by donating electrons 3. A common approach to prepare stable AgNPs involves the use of polymer 
solutions: to this end, a variety of polymers can be used, ranging from synthetic to natural ones. Nitrogen-
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containing stabilizing polymers, such as poly-(ethyleneimine) and poly(vinylpyrrolidone), act via lone 
electron pairs. Protective polymers can coordinate metal ions before reduction, forming a polymer-ion 
complex; such a complex can then be reduced under mild conditions, resulting in metal particles of smaller 
dimensions and a narrower size distribution than those obtained without protective polymers 8. Once the 
reduction occurred, the stabilizing effect of these macromolecules is attributable to the fact that either the 
particles are attached to the much larger protecting polymers or the protecting molecules cover or 
encapsulate the metal particles 9. This chemical approach can be generalized in Figure 2. 
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Figure 2. Preparation of AgNPs in the presence of a stabilizing polymer (wet synthesis) 
 
In particular, owing to the presence of many different functional groups, polyelectrolytes are successfully 
used in the preparation of stable AgNPs. Polyelectrolytes at low concentrations (such as polyphosphate, 
polyacrylate, poly-(vinyl-sulfate), poly-(ethylene-imine) 2,3,10, poly-(allyl-amine) 9, and chitosan 11-13) have 
been used with different outcomes to stabilize nanoparticles preventing the growth of aggregates. As already 
mentioned, poly-(vinyl-pyrrolidone) 5,14, a neutral polymer, has been widely used for the stabilization of 
silver nanoparticles. It must be noticed that in order to find applications in the field of biomaterials, both the 
stabilizing and the reducing agents must not represent a biological hazard 15. 
Considering the reduction step, various exogenous agents can be used, such as ascorbic acid16,17, sodium 
borohydride18, sodium citrate19,20, alcohols20, hydrogen21, polyols, hydroxyalkyl radicals, and aldehyde 
groups of reducing sugars22-24. For a “green synthesis” of nanoparticles15, reducing saccharides can be used 
as non-toxic and environmental-friendly reducing agents. In this case the synthesis is based on a Tollens 
reaction that involves the reduction of a silver ammoniacal solution with a reducing sugar (e.g., glucose, 
maltose, xylose…)25.  
By the choice of the stabilizer and the reducing agent, one can control the growth process and manipulate 
shape and size of the metal nanoparticles in the nanocomposites. For instance, a lactose-substituted chitosan  
(1-deoxylactit-1-yl chitosan) was successfully used to prepare stable silver nanoparticles using this particular 
polymer either as stabilizing agent only, or as both reducing and stabilizing agent at the same time26,27. In the 
first case, the nanoparticles are obtained in a polysaccharide solution with silver ions  reduced by ascorbic 
acid (C6H8O6) according to the following stoichiometry16,17: 
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2Ag+ + C6H8O6                                    2Ag0     +     C6H6O6     +     2H+ 
 
The nanoparticles thus obtained were mostly round-shaped and well dispersed with an average diameter of 
30 nm as revealed by image analysis based on transmission electron micrographs. 
 
 
Figure 3:  Left) Schematic representation of the polymeric chains of  lactose-modified chitosan providing the nitrogen 
atoms for the coordination and stabilization of silver nanoparticles. From Travan et al. (2009), reproduced with 
permission. Center and right) Nanocomposite hydrogels based on AgNPs and polysaccharides. From Travan et al. 
(2009), reproduced with permission. 
 
This polysaccharide acts as an efficient stabilizing ligand for silver ions and AgNPs thanks to the presence of 
amino groups. Esumi et al.8 demonstrated that metal nanoparticles can be protected by the exterior amino 
groups of dendrimers which act as stabilizers. In the case of the lactose-modified chitosan (chitlac) it was 
suggested that when AgNO3 is mixed with the polyelectrolyte solutions, Ag+ ions give rise to a localized 
binding to the polymer macromolecules via amino groups chelation that persists also with the formed 
AgNPs. The hydrophilic lactitol side-chains also play a fundamental role in the stabilization by embedding 
the AgNPs bound in the proximity of the polymer backbone and isolating them from the surrounding species 
(Figure 3, left). Furthermore, the complete miscibility of this colloidal solution with the anionic 
polysaccharide alginate can lead to the preparation of homogeneous nanocomposite hydrogels that entrap 
highly stabilized silver nanoparticles, the yellow colour witnessing the good dispersion of the AgNPs within 
the gel matrix (Figure 3, center and right). Huang et al.12discussed the preparation of silver-chitosan 
nanocomposites obtained by chemical synthesis from a chitosan solution  in the presence of AgNO3 reduced 
by NaBH4; the evaporation of the solvent in this colloidal solution brings to the formation of a 
nanocomposite film. The morphology of the film shows a rod-like structure, whose formation is attributed to 
the presence of the silver clusters that act as an accelerant to the precipitation of polymer crystallites. Silver 
nanocomposites can be prepared in the form of nanofibres by means of the electrospinning technique, a 
process by which a suspended droplet of polymer solution is charged to high voltage to produce fibres with a 
diameter typically smaller than 500 nm. If the solution contains AgNPs stabilized by the polymer, it is 
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possible to obtain nanocomposite fibres. Wang et al.5 successfully prepared AgNPs through reduction of 
AgNO3 by ethanol in PVP/ethanol solution and managed to obtain nanocomposite fibres with AgNPs smaller 
than 10 nm (Figure 5, left). 
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Figure 5. Left) TEM image of Ag/PVP nanocomposite electrospun fibre. From Wang et al. (2006), reproduced with 
permission. Center) Schematics of the layer-by-layer self-assembly procedure for creating antimicrobial thin films, 
adapted from Grunlan et al. (2005). Right) TEM image of a silver-PEI-PAA film that shows the dispersion of  spherical 
AgNPs with a mean diameter of 4 nm. From Dai et al. (2002), reproduced with permission. 
 
The need to obtain antimicrobial coatings and films can be fulfilled by incorporating AgNPs into polymeric 
matrixes by means of the so-called “layer-by-layer” technique. This is a simple and straightforward approach 
based on the alternate deposition on a substrate of layers of polyelectrolytes with opposite charges through a 
dipping process (Figure 5, center). The dipping process is repeated until a desired number of layers is 
obtained, each layer having a thickness in the range of a few nanometers. With this method it is possible to 
incorporate in one or more layers bioactive agents like silver. According to this approach, Grunlan et al.10 
prepared polyelectrolyte multilayers using silver nitrate and/or cetrimide (antiseptic agent) as antimicrobial 
agents. The films were prepared by alternately dipping poly(ethylene terephtalate) (PET) substrate into 
solutions of poly(acrylic acid) (PAA) and poly(ethylene imine) in mixture with the bioactive agents. Dai et 
al.2 followed the layer-by-layer approach to obtain multilayered polyelectrolyte films that incorporate 
homogeneously dispersed AgNPs; in this work a polyethyleneimmine (PEI) solution was used to prepare 
stabilized silver ions from AgNO3. Then, the alternated deposition on a substrate of the PEI-silver layer and 
of a poly(acrylic acid) (PAA) solution followed by reduction with NaBH4 led to the formation of a 
multilayered film based on the two oppositely charged polysaccharides containing finely dispersed AgNPs 
(Figure 5, right). Multilayers can be fabricated by means of the layer-by-layer technique not only on planar 
substrates, but also on three-dimensional templates. In the case of a spherical template, its eventual 
dissolution after the film formation allows obtaining multlayered capsules that can embed bioactive agents 
like AgNPs; Choi et al.28synthesised polyelectrolyte capsules with two types of nanoparticles embedded: 
AgNPs for the antimicrobial activity and goethite nanoparticles to endow the capsules with the possibility to 
be moved by external magnetic fields. The capsules were prepared by means of copolymerized 
polyelectrolytes composed of poly(styrene sulfonate) (PSS) and poly(acrylic acid) (PAA) in addition to 
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poly(allylamine hydrochloride) (PAH). Then, metal ions were loaded from aqueous solution into the 
capsules and were finally let react to create the two different types of nanoparticles. Ho et al.29developed a 
nanocomposite film where a polymer network based on poly(ethylene imine) derivatized with double bonds 
was copolymerized with 2-hydroxyethyl acrylate; after a UV-initiated polymerization the film was loaded 
with silver ions that were subsequently reduced to form AgNPs. After immersing the film in AgNO3 
solution, the chemical reduction of Ag+ complexed within the polymer network occurred by treating the film 
in ascorbic acid solution until the film turned to yellowish-brown, which suggests the formation of well 
dispersed nanoparticles. Polyols can be used as reducing agents for silver ions: in this case, the silver-
reduction mechanism typically involves a heat treatment. Wiley et al.23,30 prepared AgNPs with different 
shapes (quasi-spherical particles, single-crystal cubes, tetrahedrons, rods, triangular nanoplates, nanowires 
with pentagonal cross sections, twinned structures…) by reducing AgNO3 with ethylene glycol at high 
temperature in the presence of PVP.  
 
Figure 6. Schematic showing the reduction of silver ions by ethylene glycol (I); the formation of silver clusters (II); the 
nucleation of seeds (III); and the growth of seeds into nanocubes, nanorods or nanowires, and nanospheres (IV). From 
Wiley et al. (2005), reproduced with permission. 
 
These studies showed how the crystallinity of seeds was determined by the molar ratio between  the capping 
agent (PVP) and AgNO3 as well as by the strength of the chemical interaction between the polymer and 
various crystallographic planes of silver (Figure 6). Silver nanocomposites can be prepared using polymeric 
dendrimers as stabilizing agents. In fact dendrimers are branched macromolecules that possess architecture 
and ligand sites that allow the pre-organization of metal ions and an effective stabilization of silver owing to 
the formation of stable complexes at atomic/molecular level dispersion. Balogh et al.31 discussed the 
preparation of silver complexes within poly(amidoamine) dendrimers for antimicrobial applications. Kuo et 
al.9 reported the formation of AgNPs stabilized in pseudo-dendritic poly(allylamine) derivates. Following the 
same strategy, other organic macromolecules can be used to stabilize AgNPs: for instance Lok et al.4 
reported the preparation of antimicrobial AgNPs stabilized by bovine serum albumin (BSA). Inorganic 
stabilizers are also being explored for the preparation of silver nanocomposites. Su et al.6 prepared AgNPs 
immobilized within inorganic phyllosilicate clays in order to obtain nanohybrids exploiting an ion exchange 
between Ag+ (provided by AgNO3) and  Na+ from the clay, followed by in situ reduction of silver ions by 
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methanol at 80°C. In this case the nanoparticles thus formed are free of polymeric surfactants and have a 
narrow size distribution with an average diameter around 30 nm (Figure 7).  
 
 
Figure 7. Silver nanoparticles dispersed on silicate clay. (A) The surface structure of the AgNP/Clay is characterized by 
Field-Emission SEM. (B) Representations of the nanocomposite structure. From Su et al. (2009), reproduced with 
permission. 
 
Silver nanocomposites can be obtained in the form of bioceramics in order to endow osteoconductive 
materials with antimicrobial properties. Rameshbabu et al.32 prepared silver-substituted hydroxyapatite 
nanocrystals by microwave processing. 
Although the conventional chemical synthesis represents to date the most popular approach for the 
preparation of silver nanocomposites, other techniques are being explored which are based on physical 
processes. A promising technique is the radiolytic method  used for the generation of AgNPs in solution; 
with this technique, radiolytically generated species, solvated electrons and secondary radicals, exhibit strong 
reducing potentials towards metal ions. Krkljes et al.33 reported the preparation of Ag-PVA nanocomposites 
by radiolytic procedure using steady state gamma irradiation. Alternatively, ablation of a metal surface 
immersed in a liquid can produce nanoparticles of the metal in the liquid. In the laser ablation technique 
metal atoms and small metal clusters are ablated from a metal rod by laser irradiation; self-aggregation of the 
nanoparticles suspended in the liquid can be prevented by hindering direct contact of the nanoparticles by 
means of a surfactant. Mafunè et al.34 performed the preparation of AgNPs by laser ablation against a silver 
plate in an aqueous solution of sodium dodecyl sulphate. Photochemical methods can be used to prepare 
polymer-stabilized AgNPs35. Mallick et al.7 prepared colloidal silver under UV photo irradiation of silver 
nitrate solution in the presence of methoxy poly(ethylene glycol) which acts as a reducing and stabilizing 
agent. Further interesting routes to prepare silver nanocomposites are sonochemical treatments36, 
potentiostatic and galvanostatic methods37, vapour deposition38, microwave irradiation39, electron beam 
irradiation40, synthesis templated by DNA41, Langmuir-Blodgett-based techniques 42, ion implantation, 
sputtering, vapor-phase co-deposition, and vacuum co-condensation43. 
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2.2 CHARACTERIZATION TECHNIQUES 
The characterization of silver nanocomposites can be performed by means of different techniques; the most 
important ones are spectroscopic techniques (UV-Vis, infrared and X-ray photoelectron spectroscopy), X-ray 
diffraction and microscopic techniques (TEM, SEM, Dark-Field, AFM, NSOM). 
In the chemical synthesis, colloidal solutions of AgNPs are obtained upon reduction of Ag+ to the metal atom 
and consecutive coalescence of atoms yelding larger particles. The transition from atom to metal 
nanoparticle can be studied by pulse radiolysis techniques3,20. When a sufficient number of atoms coalesce, 
the particles start to display a typical property called “Surface Plasmon Resonance”, which is produced by a 
collective excitation of all the free electrons in the particles3. Under the influence of the electric field due to 
the incoming light, the movement of electrons leads to a dipole excitation across the particle sphere that 
makes the electrons oscillate (Figure 8, left).  
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Figure 8. Left) Polarization of a spherical metal particle by the electrical field vector of the incoming light. Adapted 
from Henglein (1993). Right) A plasmon resonance band in the UV-Vis spectrum accounts for the presence of metallic 
nanoparticles. 
 
The electron density within a surface layer (a few angstroms thick) oscillates, while the density in the interior 
of the particle remains constant. When the condition of resonance is reached, the UV-Vis spectrum displays 
an intense absorption band called “Surface Plasmon Resonance Band” (Figure 8, right).  
A typical example is given by the formation of the plasmon resonance peak at about 400 nm during the 
chemical synthesis of AgNPs in a chitosan-derivative (chitlac) solution27; the absorption peak increases with 
time after the addition of the reducing agent, which indicates the coalescence of the reduced ions to form the 
metallic nanoparticles (Figure 9, left) 
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Figure 9. Left) Time dependence of UV-vis spectra variations of  polymer-stabilized silver nanoparticles after the 
addition of the reducing agent. From Travan et al. (2009), reproduced with permission. Centre) Absorption spectra of 
silver colloids obtained at various citrate concentrations. From Henglein et al. (1999), reproduced with permission. 
Right) The surface plasmon resonance absorption of reduced AgNPs (solid line), oxidized AgNPs (dotted line), and 
oxidized AgNPs re-reduced by NaBH4 (dashed line). From Lok et al. (2007), reproduced with permission.   
 
A symmetrical shape of the plasmon band suggests that the nanoparticles are well dispersed and spherical9. 
At variance, the aggregation of nanoparticles leads to a broader plasmon band, with a red-shifted 
maximum44. A systematic study on the formation of silver nanoparticles by absorption spectroscopy was 
tackled by Henglein45 who reported the preparation of AgNPs from AgClO4 solutions at a fixed 
concentration and studied the variations of the UV-Vis spectra as a function of the concentration of sodium 
citrate used as both reducing and capping agent. The UV-Vis spectra in Figure 9 (center) suggest that sodium 
citrate plays a drastic effect on the formation of AgNPs with different size; in fact according to its 
concentration it can determine the formation of well stabilized AgNPs or the coalescence of poorly stabilized 
polycrystallites. Excess charge carriers influence the wavelength of the plasmon resonance band; a blue shift 
of the plasmon peak occurs upon electron donation to the particles, while a red shift occurs upon injection of 
positive holes into the particles. Furthermore, chemical modification on the surface of the particles, like 
interaction with organic molecules, strongly affects the plasmon absorption band.  
Anions able to form complexes or insoluble salts with silver ions are strongly adsorbed on silver particles. 
Also the Fermi level floats upon chemisorption, depending whether the adsorbed molecule is nucleophilic or 
electrophilic. A surface atom carrying an adsorbed nucleophile molecule acquires a slightly positive charge 
(“preoxidation state”); the excess electron density is simultaneously transferred into the metal particle. Thus, 
the chemisorption of a nucleophile is accompanied by a shift of the Fermi potential to a more negative value. 
AgNPs are highly sensitive to oxygen, resulting in the formation of partially oxidized AgNPs with 
chemisorbed Ag+ on the surface. In the absorption spectra this partial oxidation leads to a red-shift of the 
surface plasmon resonance band, according to the following equation44: 
 
λ = λ 0(1 + [Ag+]/[Ag])1/2 
 
where λ0 is the wavelength of the plasmon peak before oxidation, and λ after oxidation. 
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Lok et al.4 reported that borohydride reduced (zeroth-valent) AgNPs in the presence of citrate exhibit a 
surface plasmon resonance peak at 375 nm, while subsequent exposure to oxygen led to a rapid shift of the 
absorption peak to 398 nm, with broadening of the band width and lowering of the maximum absorption. 
These changes in the absorption spectrum can be attributed to the partial oxidation of the nanoparticles with 
the formation of chemisorbed Ag+ on thier surface, indicating the sensitivity of AgNPs to oxygen. Further 
addition of borohydride induced a shift in the plasmon resonance band to the intensity and shape of non-
oxidized zeroth-valent nanoparticles (Figure 9, right). It is important to notice that the presence of oxidized 
(or partially oxidized) atoms on the surface of the nanoparticle affects its biological properties, as discussed 
in chapter 3.1.4. Infrared spectroscopy (IR) can provide information about the interaction (chemical bonding) 
between the nanoparticles and the matrix in a silver nanocomposite structure. Krkljes et al.33 carried out IR 
analysis to point out the interaction between AgNPs and PVA chains via its OH groups. By means of Fourier 
Transform IR Dai et al.2 characterized poly(acrylic acid)/polyethyleneimine-silver nanocomposites in order 
to evaluate the influence of silver reduction on the polymer matrix and Zhang et al.46 verified the formation 
of coordination bonds between the amino/amide groups of a poly(amidoamine) derivative and AgNPs.  
Transmission Electron Microscopy (TEM) is commonly used to investigate size, structure (crystallography, 
existence of twin planes, stacking faults…) and dimensional distribution of AgNPs: AgNPs prepared upon 
chemical reduction in the presence of chitlac27 appeared as spheroidal particles with average dimensions 
between 20 and 30 nm (Figure 10, left). 
              
Figure 10. Left) TEM image of silver nanoparticles stabilized by a lactose-modified chitosan. From Travan et al. 
(2009), reproduced with permission. Right) TEM characterization of AgNPs with different morphologies obtained  by 
polyol synthesis. From Wiley et al. (2005), reproduced with permission. 
 
Wiley et al.30,47 carried out TEM investigations to study a polymer-mediated polyol process that allows for 
the preparation of silver nanostructures with a number of different morphologies (e.g., cubes, rods, wires, 
and spheres) as reported in Figure 10, right.  
Wang et al.48 prepared polyelectrolyte multilayer films containing AgNPs and evaluated the distribution of 
the particles in the polymer matrix by means of  cross-sectional TEM imaging. The pictures show spherical 
particles uniformly and randomly distributed throughout the film (Figure 11, left). 
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Figure 11. Left)  Cross-sectional TEM image of a polyelectrolyte multilayer containing AgNPs. From Wang et al. 
(2002), reproduced with permission. Right) FE-SEM image of AgNPs obtained by polyol synthesis. The main image 
shows truncated cubes (indicated by an octagon) and truncated tetrahedrons (indicated by a hexagon), while the insets 
show the convergent beam electron diffraction patterns showing that these particles are single crystals. From Wiley et 
al. (2004), reproduced with permission. 
 
Metal nanocomposites have been studied by means of Scanning Electron Microscopy (SEM), especially 
equipped with field-emission guns (FE-SEM) that allow avoiding the sputtering step of conventional SEM 
which could cover or affect the nanoparticles on the surface of the nanocomposite material28,49. Wiley et al.23 
carried out a polyol synthesis of AgNPs whose structure was analysed by FE-SEM: the images proved the 
formation of single-crystal, truncated cubes and tetrahedrons (Figure 11, right). 
Among other techniques, Atomic Force Microscopy (AFM) is a useful means to characterize the morphology 
of nanocomposites materials containing a dispersion of nanoparticles50,51. Deshmukh et al.43 explored by 
AFM the surface and bulk morphology of poly(methyl methacrylate) (PMMA) nanocomposite films 
containing AgNPs. Figure12 (left) shows AFM image of the nanoparticles on the surface of the polymer 
film. 
 
             
Figure 12. Left) AFM image and size distribution of silver nanoparticles dispersed in a PMMA film. The x-axis 
corresponds to the size of the protruding nanoparticles covered by the PMMA layer. From Deshmukh et al. (2007), 
reproduced with permission. Centre and Right)TEM image of a cross section and AFM (phase mode) image of the 
surface of poly(ethylene imine)-based films containing silver nanoparticles. From Ho et al. (2004), reproduced with 
permission. 
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Ho et al.29compared AFM and TEM techniques to characterize nanocomposite films based on poly(ethylene 
imine) and AgNPs. AFM images in the phase-contrast mode show the dispersion of nanoparticles that appear 
as bright spots on the surface of the film, while the corresponding TEM image of a cross-section of the film 
indicates the presence of non-aggregated nanoparticles with a size that ranges from 4 to 50 nm (Figure 12, 
center an right). 
The crystallographic structure of AgNPs formed within a matrix can be studied by means of XRD. Wang et 
al.5 used such technique to carachterize Ag/PVP nanocomposite films: the XRD pattern revealed the 
presence of face-centred cubic (fcc) nanocrystals formed within the polymer matrix (Figure 13, left). 
 
   
Figure 13. Left) XRD pattern of Ag/PVP nanocomposite film. From Wang et al. (2006), reproduced with permission. 
Right) X-ray photoelectron spectra of O 1s of pure PVP and PVP/Ag nanocomposite. From Wang et al. (2006), 
reproduced with permission. 
 
X-ray photoelectron spectroscopy (XPS) is a surface chemical analysis technique that can be used to analyze 
silver-nanocomposite materials. XPS was used by Zeng et al.52 to characterize polymer films (poly(styrene) 
and acrylonitrile–styrene copolymer) filled with silver nanoparticles: this technique pointed to the existence 
of charge transfer interaction between AgNPs and acrylonitrile segments, while no obvious interaction 
between silver and styrene segments was found. Stofik et al.53prepared silver-dendrimer nanocomposites for 
immunosensors application and confirmed with XPS the synthesis of AgNP. XPS studies on PVP-silver 
nanocomposite fibres showed the interaction between silver and the carbonyl oxygen; this strong Ag:O 
coordination can prevent AgNPs from aggregation within the polymer matrix5(Figure 13, right). 
Silver nanoparticles are extremely bright and can be directly observed using dark-field single nanoparticle 
optical microscopy and spectroscopy; with this technique Lee et al.54 characterized AgNPs embedded in 
zebrafish embryos for studying their transport, biocompatibility, and toxicity in real time. Lu et al.42 reported 
dark-field images of a high-density nanocomposite film obtained from poly (N-isopropylacrylamide) and 
AgNP (Figure 14, left). 
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Figure 14. Left) Optical dark-field microscope images of silver nanoparticles on a poly(N-isopropylacrylamide film. 
From Lu et al. (2005), reproduced with permission. Right) Near-field scanning optical image of azo film sample doped 
with silver nanoparticles. From Zhou et al. (2007), reproduced with permission.  
 
Silver nanocomposites have also been characterized by means of Near-Field Scanning Optical Microscopy 
(NSOM), a microscopic technique that allows for performing a surface inspection with high spatial, spectral 
and temporal resolution overcoming the far-field resolution limit by exploiting the properties of evanescent 
waves. Zhou et al.55 studied the dispersion of AgNPs in polymer films containing azo groups by NSOM 
(Figure 14, right). 
All the above mentioned techniques are the most widely used means of characterization for biomedical silver 
nanocomposites. Nevertheless, other techniques can provide valuable information regarding this new class of 
materials; to name a few, DSC33, TGA56, Dynamic Light Scattering57,58 and Zeta Potential 
measurements58can also provide a deeper insight into some specific properties of the constructs, like 
thermodynamic properties and thermal stability, size, surface charge and diffusion. 
 
 
3.0 BIOMEDICAL APPLICATIONS 
 
3.1 SILVER NANOCOMPOSITES FOR BIOCIDAL APPLICATIONS (ANTIMICROBIAL, 
ANTIVIRAL, ANTIFUNGINE) 
 
3.1.1 General considerations 
Nanoscale materials have emerged as novel bioactive agents thanks to their unique physical-chemical 
properties and their high surface area-to-volume ratio. A large interest in silver-based nanocomposites is due 
to silver biocidal properties 59,60. In fact, silver has been extensively used to control infections since ancient 
times. For centauries it has been in use for the treatment of burns and chronic wounds. In the 1940s penicillin 
was introduced and the use of silver for the treatment of bacterial infections diminished. In 1968 silver 
nitrate was combined with sulphonamide to obtain silver sulfadizine cream to treat burns 59. Nowadays 
antibiotic-resistant bacterial strains have become a major issue in public health care and this is why silver-
based nanocomposites in a variety of forms (i.e. wound dressings, coated medical devices, hydrogels) have 
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made a tremendous comeback for anti-infective applications27. Silver-based medical products, ranging from 
topical ointments and bandages for wound healing to coated stents, have been proven to be effective in 
retarding and preventing bacterial infections 61. Improvements in the development of novel silver 
nanoparticles-containing products are continuously sought. In particular, there is an increasing interest 
towards the exploitation of silver nanoparticles technology in the development of new bioactive biomaterials, 
aiming at combining the unique antibacterial properties of the metal at the nano-scale with the performance 
of the biomaterial 9,12,16,31,62. Silver containing nanomaterials represent a promising strategy to combat 
infections related to indwelling medical devices like catheters, stents and bone prosthesis. These infections 
are the fifth leading-cause of hospital patients’ death it the US63. Although silver is known and used 
primarily for its antibacterial properties, silver nanoparticles have been shown to exhibit also promising 
antiviral and antifungal properties.  Ag-NPs exert cytoprotective activities towards HIV-infected T-cells by 
inhibiting the in vitro production of extracellular virions. It is hypothesized that the direct interaction 
between these nanoparticles and double-stranded DNA of HBV viral particles is responsible for their 
antiviral mechanism 64; however, the effects of silver nanoparticles towards other kinds of viruses remain 
largely unexplored. Although antifungal drug resistance does not seem to be as much of a problem as 
resistance to antibacterial agents in bacteria, one long-term concern is that the number of fundamentally 
different types of antifungal agents that are available for treatment remains extremely limited. There is an 
inevitable and urgent medical need for drugs with novel antifungal mechanisms. In the last years attention 
has been focused on the potential use of silver as an antifungal agent. Experimental results evidence that 
AgNPs exhibit potent antifungal effects on tested fungi, probably through destruction of membrane integrity 
65-67
.  
 
3.1.2 Overview of in vitro results 
This section overviews the most promising applications of silver nanocomposites as biocidal systems 
developed during the last few years. Silver-based materials are generally considered as good candidate for 
coating medical devices and many recent literature data deal with the preparation of nanocomposite-coatings 
based on polymers and silver nanoparticles. As it will be discussed in chapter 3.1.3, the mechanism by which 
silver-based materials exert biocidal activity is only partially understood; this fact often leads to different 
interpretations of experimental results. For this reason, the results and discussions summarized in this 
paragraph in some cases may appear conflicting. For central venous catheter (CVCs) applications, Stevens et 
al.63 reported the use of various hydrophilic polymer coatings loaded with silver nanoparticles in order to 
assess both the antimicrobial efficacy and the impact of silver on the coagulation of contacting blood. The 
roll-plate assay68 showed that bacteria inhibition begins when silver ions released from the nanoparticles into 
the suspension exceeds 100 nM and no bacteria are found for Ag+ concentrations higher than 10 µM. On the 
other hand, thrombin generation and platelet activation starts at Ag+ concentrations higher than 100 µM. 
Interestingly, thrombin generation can occur also upon activation of blood platelets through collision (direct 
contact) with silver particles exposed on the surface, so it was suggested that the use of silver nanocomposite 
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coatings for CVCs may enhance thrombus formation. Su et al.6 successfully prepared AgNPs/Clay 
nanocomposites and by inductively coupled plasma mass spectrometry (ICP-MS) analysis showed that the 
immersion of the nanocomposite in water at 0.1 wt% after centrifugation causes a release of silver ions of 
only 139 ppb. A nanocomposite concentration of 0.05 wt% was enough for a complete inhibition of S. 
aureus, S. pyogenes, P. aeruginosa and E. coli. It must be noticed that the solution obtained from 0.5 wt% 
dispersion after centrifugation of the slurry was not effective for the inihition of S. aureus. This fact means 
that in this case AgNPs, and not the released Ag+, appear to be involved in the antibacterial mechanism. In 
the case of multilayered nanocomposites, Dai et al.2demonstrated that their film based on the alternated 
deposition of poly(ethylene imine) and poly(acrylic acid) including AgNPs was effective in inhibiting E. coli 
growth. Remarkably, the effect was the same when the film contained silver ions or when it contained 
AgNPs; the latter case may be more desirable because it should minimize the amount of Ag+ absorbed in the 
body. Grunlan et al.10prepared a multilayered film based on poly(acrylic acid) and poly(ethylene imine) 
containing silver ions and cetrimide (an organic quaternary ammonium molecule) as antimicrobial agents. 
The biocidal activity was studied by means of the Zone Of Inhibition (ZOI) test with E. coli and S. aureus 
(Figure 15, left).  
 
    
Figure 15. Left) Kirby-Bauer test performed to evaluate the Zone Of Inhibition (ZOI) after 24 h of S. aureus incubation. 
Letters (A-B-C) associated with the test films refer to different amounts of silver and cetrimide. The film in the lower 
left corner of the plate is a PET film with no antimicrobial coating. From Grunlan et al. (2005), reproduced with 
permission. Right) Optical density of a suspension of E. coli with silver-embedded (filled diamond) or without silver 
(nonfilled diamond) capsules as a function of exposure time (redrawn from Choi et al. 2005 ) 
 
It was shown that such materials were effective in preventing bacteria growth and the antimicrobial efficacy 
of the silver containing films was further enhanced by the use of cetrimide. Choi et al.28 tested 
nanocomposite capsules based on polyelectrolytes with AgNPs with a suspension of E. coli; optical density 
measurements at 260 nm, which are proportional to the number of bacteria, showed that the amount of 
bacteria decreased after only 1 min exposure to silver-embedded capsules. As a control, in the absence of 
silver the optical density of the E. coli suspension remained almost unchanged (Figure 15, right). 
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Antimicrobial studies were carried out on a nanocomposite systems based on lactose-modified chitosan 
(chitlac) and AgNPs either as a colloidal solution or as hydrogels obtained in association with alginate27. In 
both cases the materials displayed a remarkable bactericidal effect on four types of bacteria strains: S. 
epidermidis, E. coli, S. aureus, and P. aeruginosa. Figure 16 (left) reports the results for the S. epidermidis 
strain, as representative data. The number of viable cells drastically decreased (a drop of 3 log units in 
CFU/mL) after only 30 min of incubation with the colloidal system and a complete inactivation of bacterial 
cells was found after 2 h of treatment. The activity was preserved also in the hydrogel state; Figure 16 
(center) shows that bacteria, smeared on the surface of hydrogels without silver, could grow (control gel), but 
they were completely absent on the AgNPs-containing gels.  
 
                    
releasing
contact-active
substrate
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Figure 16. Left) killing kinetics of polymer-stabilized silver colloidal solution (solid line) against S. epidermidis; the 
dashed line indicates control runs in the absence silver. Center) growth of S. epidermidis on polysaccharide-based 
hydrogels without (upper Petri dish) and with (lower Petri dish) silver nanoparticles. From Travan et al. (2009), 
reproduced with permission. Right) Representation of an antimicrobial nanocomposite coating that exploits both the 
release of silver ions and the direct contact of silver nanoparticles within a polymer matrix (adapted from Ho et al. 
2004) 
 
The release of silver ions from the hydrogels into a saline solution was measured by means of ICP-MS; the 
concentration after 4 weeks was quite low (58 µg/L) and MTT essays proved that such amount was not toxic 
to three different eukaryotic cell-lines (fibroblasts NIH-3T3, osteoblasts MG63, and hepatocytes HepG2). 
Interestingly, LDH cytotoxicity assays revealed that the polysaccharide-AgNPs colloidal system in solution 
was toxic to these eukaryotic cell-lines, whereas the hydrogel system obtained from its combination with 
alginate was not. This fact suggests that the 3D system could prevent nanoparticles from being available for 
eukaryotic cellular uptake but, at the same time, preserve its antimicrobial activity allowing the direct 
interaction of the nanoparticles with the proteins localized on the bacterial surface. Ho et al.29 reported the 
preparation of antimicrobial nanocomposite films based on poly(ethylene imine) and AgNPs which exploit 
both the release of silver ions and the direct contact between bacteria and nanoparticles (Figure 16, right). S. 
aureus was allowed to adhere to the film surface and then cultivated in agar to evaluate the viable cells. 
Results show that the film inhibits bacteria growth for 12 hours. When the amount of silver in the film 
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reached the value of 10 µg/cm2 no bacteria could grow even after two weeks, indicating a bactericidal effect 
of the nanocomposite material. 
 
3.1.3 Effects of nanoparticles properties and role of the matrix 
Many factors influence the biocidal activity associated with AgNPs-based constructs, which may complicate 
the understanding of the antibacterial mechanism, as discussed in chapter 3.1.4; for this reason it is not easy 
to evaluate one property at a time, which can lead to conflicting results in the literature. Moreover the 
biological effects of AgNPs are affected by the dispersing agent or matrix of each particular nanocomposite 
system. In general, it can be stated that nanoparticles size, shape, surface properties, dispersion and stability 
are important issues for tailoring their biological performances. In particular, the effect of the particles 
dimensions has often been taken into account while characterizing the antibacterial activity: various 
researchers have documented that the size of AgNPs affects the biocidal effectiveness46,69. The antibacterial 
activity of AgNPs can be related to their size since the activity of smaller particles is higher due to the 
increase in surface area when compared on the basis of equivalent silver mass content. For such speculations 
it can be useful to evaluate the number of silver atoms in a nanoparticle (n) from the following relation45: 
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where dm is the particle diameter in nanometres, Na is Avogadro’s number and Vm is the molar volume of 
silver (mL/mol). Considering the effect of AgNPs dimensions against E. coli, Lok et al.4 showed that AgNPs 
with an average diameter of 9.2 nm were 9 times more active than particles with an average diameter of 62 
nm. Morones et al.70 reported that the bactericidal properties of the carbon-stabilized AgNPs are size 
dependent in four types of Gram-negative bacteria, since the only nanoparticles that displayed a direct 
interaction with bacteria preferentially had a diameter of 1–10 nm. At variance, Su et al.6 prepared silver 
nanocomposites of different sizes (45.7 nm and 25.9 nm) within a silicate clay and found that the bacterial 
growth inhibition was not significantly dependent on the particle size but only on the silver amount (Figure 
17, left). 
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Figure 17. Left) Antimicrobial study on AgNP/Clay nanocomposites: in this system the biocidal effect depends on the 
silver content and not on particles size (redrawn from Su et al. 2009). Right) Comparative graph of the dynamics of E. 
coli growth in the presence of spherical silver nanoparticles, triangular nanoparticles and of ionic silver (AgNO3) 
(redrawn from Pal et al. 2007) 
 
The crystallographic structure and shape of the nanoparticles are considered as important properties affecting 
the antimicrobial behaviour. Recent works have demonstrated that the reactivity is favoured by high atom 
density facets such as {111}70. According to Pal et al.71 truncated triangular nanoparticles display a higher 
antibacterial activity as compared to spherical nanoparticles and ionic silver (Figure 17, right). 
Comparing the antibacterial activities of metallic and partially oxidized AgNPs, Lok et al.4 indicated that 
only partially oxidized particles exhibited antibacterial activities and since smaller AgNPs have a higher 
surface area-to-mass ratio, they provide higher relative concentration of chemisorbed silver ions. The matrix 
where the nanoparticles are dispersed is of primary importance to determine the performance of the material; 
in fact, in the final nanocomposite constructs, stabilizers  play a fundamental role to control the formation of 
nanoparticles as well as their dispersion stability. For example, in the case of polymer solutions, the 
concentration of the stabilizer operates as a controller of nucleation, affecting the size of the final 
nanoparticles as can be monitored by UV-Vis spectra and TEM observations. Polymeric dispersants or 
capping agents are generally used to stabilize AgNPs, but it must also be considered that they may deactivate 
the nanoparticles functions because the organic wrapping on the metal surface can limit or prevent its surface 
reactivity6.  
 
3.1.4 Antimicrobial mechanism 
Three main strategies can be pursued to render materials antimicrobial29, by choosing:   
1. the anti-adhesiveness; 
2. the biocide-release activity; 
3. the activity by contact. 
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Silver-based systems can be developed both as biocide-releasing systems (Ag+) and as contact-active 
materials. Although the toxic effects of silver on bacteria have been investigated for more than 60 years, the 
mechanism by which silver is able to kill bacteria is still only partially understood 59,70. Several investigations 
have suggested possible mechanisms involving the interaction of silver ions with biological macromolecules.  
 
   
Figure 18:  Left) Interaction sites of silver ions on microorganisms. Right) Internal structure of E.coli cells treated with 
silver ions. a) Cytoplasm membrane detachment from cell wall (arrow). B) Electro-dense granules around the cell wall 
(arrow). From Feng et al. (2000), reproduced with permission. 
 
 
Most of the Ag+ sensitive sites are likely to be proteins and their alterations will result in cell disruption due 
to structural and/or severe metabolic damage (Figure 18, left). Silver ions inhibit a number of enzymatic 
activities reacting with electron donor groups containing sulfur, oxygen, or nitrogen such as carboxylates, 
phosphates, hydroxyl, amines, imidazoles, indoles and especially sulfhydryl groups72-75. In the bacterial cell 
wall, free sulfhydryl groups are localized on transmembrane and outer-membrane proteins, including 
proteins of the electron transport chain, and they protrude in the extracellular portion of the membrane where 
they represent a very accessible interaction site for silver ions 70,73,76-78.  
The Na+-translocating NADH:ubiquinone oxydoreductase (NQR) has been recognized as one of the primary 
targets for Ag+ ions. It is a component of the respiratory chain of various bacteria and it generates a redox-
driven transmembrane electrochemical Na+ potential. In two independent studies, submicromolar 
concentrations of Ag+ ions were demonstrated to inhibit energy-dependent Na+ transport in membrane 
vesicles of the NQR-possessing Bacillus sp. strain 79 and to inhibit purified NQR of V. alginolyticus 80. 
Dibrov et al. 81 showed that low concentrations of Ag+ (submicromolar) induce a massive proton leakage 
through the Vibrio cholerae membrane, which results into a complete alteration and elimination of 
transmembrane proton gradient, de-energization, followed by cell death. 
A study performed on E. coli as a bacterial model pointed out that the bactericidal action of silver ions is 
correlated with the interaction with ribosomal subunit proteins and with the suppression of enzymes and 
proteins necessary for ATP production82. 
a) b) 
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Ag+ also forms complexes with the DNA bases, inducing DNA condensation. It is known that the replication 
of DNA molecules is effectively conducted only when DNA molecules are in a relaxed state. In a condensed 
form, DNA molecules lose their replicating abilities 59,70,73. 
Feng et al. 73 have provided a morphological and structural study on the changes that occur on bacteria when 
treated with silver ions. They observed detachment of the cytoplasm membrane from the cell and the 
presence of dense electron granules around the cell wall and in the cytoplasm. As explained by Feng, these 
electron-dense granules, likely formed by the combination of silver and proteins, are prevented from 
permeating through the membrane, denying electron transport. Silver ions produce the formation of a low 
molecular weight region in the centre of the bacteria, which is considered a defense mechanism by which the 
bacteria conglomerates its DNA to protect it from toxic compounds when the bacteria senses a disturbance of 
the membrane (Figure 18, right).  
As to silver nanocomposite materials, it is still not clear whether the biocidal mechanism of the AgNPs 
involves only silver ions or it also follows different routes 6. Various mechanisms have been suggested 
according to the morphological and structural changes of bacteria. Generally, silver is believed to interact 
with the bacterial membrane either by direct contact between the nanoparticle and the membrane causing a 
direct transfer (solvent free) of Ag+ ions, or by means of silver ions released into the medium. A combination 
of the two mechanisms is also possible. Stevens et al. 63 suggested that when bacteria are in direct contact 
with silver nanoparticles in the medium they locally encounter high amounts of silver ions resulting in their 
death. In fact, the high surface-to-volume ratio of the nanoparticles accounts for a sustained local supply of 
silver ions at the material-bacterium interface, preventing bacterial adhesion and biofilm formation (Figure 
19, left). It must be also taken into account that if plasma proteins adsorb onto the biomaterial surface, the 
release of Ag+ can be hampered as well as the direct contact between nanoparticles and bacteria can be 
prevented. 
 
   
Figure 19. Left) Schematic representation of the possible antimicrobial mechanisms by ions elution or by contact-
dependent transfer of silver ions following collision with the silver nanoparticle-containing surface. From Stevens et al. 
(2009), reproduced with permission. Right) Antibacterial activity of reduced, oxidized and re-reduced silver 
nanoparticles (redrawn from Lok et al. 2007) 
 
Catellano et al.83 suggested that when metallic silver reacts with the moisture in the wounded skin it gets 
ionized and binds to bacterial membrane proteins, DNA and RNA, leading to bacteria death. Lok et al.4 
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reported that the antibacterial activity of AgNPs is dependent on surface oxidation; in contrast with zeroth-
valent nanoparticles, only partially oxidized AgNPs exhibit antibacterial activities suggesting that partially 
oxidized AgNPs may be carriers of chemisorbed Ag+ in quantities that are sufficient to cause bacterial 
damage (Figure 19, right). A possible way of delivery of Ag+ from oxidized AgNPs may involve a direct 
interaction with the bacterial membrane. Su et al.6 studied the antimicrobial mechanism of AgNPs/Silicate 
Clay nanocomposites; these constructs appear to exert their biocidal effect by means of a direct contact with 
the nanoparticles and not by means of the silver ions released, which indicates that in this system a simple 
contact with AgNPs is sufficient to trigger membrane leakage and cell death. 
One of the main target sites of silver nanoparticles is the bacterial membrane where deep morphological 
changes are induced leading to a significant increase of permeability and to the alteration of transport 
mechanisms through the plasma membrane 27,84. As reported by the authors27, a colloidal system  based on a 
lactose-modified chitosan and AgNPs, noticeably affects membrane potential and permeability. Cell 
membrane depolarization has been assessed by addition of a fluorescent probe (DiBAC4(3)) able to 
selectively enter and label bacteria whose membrane potential has collapsed. The fluorescence intensity of 
AgNPs-treated bacteria increases with respect to untreated cells after only 10 min of incubation with the 
silver-based colloidal solution, revealing a remarkable depolarization of the cell population (97.5 % of cells) 
that boosts to 99.6% after 30 min, proving a strong interaction with the bacterial membrane. Since the 
antimicrobial mechanism is supposed to involve a damage of the bacterial membrane, the membrane 
integrity has been also evaluated by means of the fluorescent probe propidium iodide (PI), which allowed to 
reveal a remarkable permeabilizing effect as a function of time of incubation (Figure 20, left). 
          
Figure 20. Left) Effect of polymer-stabilized silver nanoparticles on the membrane integrity of S. epidermidis. From 
Travan et al. (2009), reproduced with permission. Right) (a) Silver nanoparticles on the membrane and inside E. coli 
bacteria. (b) Magnification of E. coli membrane, where the presence of silver nanoparticles is clearly observed. From 
Morones et al. (2005), reproduced with permission. 
 
Morones et al. 70 have tested silver nanoparticles on four types of Gram-negative bacteria: E. coli, V. cholera, 
P. aeruginosa and S. typhus. They observed silver nanoparticles attached to the cell membrane and in the 
cytoplasm of the bacteria (Figure 20, right). The mechanism by which the nanoparticles are able to penetrate 
into the bacteria is not totally understood, but the observation of silver nanoparticles on the cell surface and 
inside the bacteria is fundamental in the understanding of the bactericidal mechanism. In analogy with the 
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mechanism suggested for silver ions, nanoparticles might tend to react with sulfur-containing proteins, as 
well as with phosphorus-containing compounds such as DNA, inducing irreversible cellular damages. 
Proteomic data revealed that a short exposure of E. coli cells to antibacterial concentration of AgNPs resulted 
in an accumulation of envelope proteins precursors, indicative of the dissipation of proton motive force. 
Consistent with these proteomic findings, nano-Ag was shown to destabilize the outer membrane, to collapse 
the plasma membrane potential and to deplete the levels of intracellular ATP85. As free-radicals increase is 
considered as one of the possible explanation of the antimicrobial mechanism 86,87, Su et al.6studied the burst 
of free radicals and reactive species of oxygen (ROS) in AgNPs/Clay-treated bacteria by measuring 2,7-
dichlorofluorescin-diacetate (DCFH-DA) as intracellular-ROS indicator. Results show that 40.3% of the 
AgNPs/Clay-treated bacteria became DCF+, indicating that ROS were generated and played a role in the 
killing mechanism. In addition it was observed that bacteria lost their mobility upon treatment with the 
nanocomposites, meaning that the motor function of the cytoskeleton is hampered with a consequent 
prevention of cytokinesis (Figure 21). Nanocrystalline silver-supported activated carbon 88 show kinetics of 
bacterial inactivation, in the presence of hydroxyl radical scavengers and superoxide anion radical inducer 
that suggest the contribution of the reactive oxygen species (ROS) to antibacterial effect. However, these 
ROS scavengers did not show any inhibition of bactericidal activity after approximately 1 hour, suggesting 
that generated ROS are responsible for E. coli inactivation only during the initial hour of the incubation time. 
The antibacterial process was found to be highly increased at higher temperature, which was ascribed to the 
enhanced ROS formation and Ag+ elution.  
 
Figure 21. Possible mechanisms of AgNP/Clay-mediated cytotoxicity. (A) AgNPs on synthetic platelet clay show electrostatic 
attraction to bacteria and form AgNP clusters on the bacterial cell wall. (B) Electronic transport through the respiratory chain on 
plasma membrane of E. coli through complex I, ubiquinone oxidoreductase (Q) and cytochrome bo/bd ubiquinone oxidase (bo/bd 
complex). (C) AgNP/Clay on the cell wall interacts with transmembrane proteins and consequently interferes with the proton pool 
in the intermembrane space or the electronic flow through the respiratory chain. Accumulated electrons due to a disturbance of 
complex I are transferred to oxygen to form O2 and H2O2, contributing to oxidative damage and membrane leakage in bacteria. 
From Su et al. (2009), reproduced with permission.   
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3.2 SILVER NANOCOMPOSITES IN WOUND HEALING  
Non-healing chronic wounds (e.g., diabetic ulcerations, pressure, venous and arterial ulcers and burn wound) 
are a serious problem in the healthcare system all over the world; they cause great pain and suffering to 
patients, affecting their quality of life; moreover they have a serious financial impact on health systems. 
When the wound bio-burden exceeds a host-manageable level, a wound may become infected. Chronic 
wounds can be easily contaminated with several species and the progression to local infection occurs in 
stages, often leading to critical colonisation 89. Chronic infections are clearly detrimental to wound healing 
and they are one of the main factors that contribute to the formation of a non-healing wound 90. When they 
occur and the host response is depressed, the normal healing process is broken off because of a prolonged 
inflammatory response, molecular and cellular abnormalities in the wound bed and granulation tissue 
disruption, resulting in a deteriorating wound 91. Appropriate management of infected and critically 
colonised wounds is therefore essential to encourage wound healing progression 92. Unfortunately, not only 
critical colonisation or infection are difficult in diagnosing, but traditional topical antimicrobials can be toxic 
to granulation tissues or increase the chance of resistant organisms. Silver, in its ionic form or as 
nanoparticles, is particularly attractive as an antibacterial agent for infected wound treatments because it can 
be readily incorporated into dressing materials or included in topic antimicrobial ointments. Topical 
antimicrobial agents, such as silver-based formulations, are often used to prepare the wound for healing. 
Silver ions are effective against a broad range of micro-organisms such as yeast, mold, and bacteria, 
including MRSA (Methicillin-Resistant Staphylococcus aureus) and VRE (Vancomycin-Resistant 
Enterococci) when they are provided at an appropriate concentration. The commonly used forms are silver-
coated dressings, which have been demonstrated to be more effective in killing a broader range of bacteria 
than cream-based silver applications. They are less irritating than silver nitrate solution and better tolerated 
93
. Chronic wounds take advantages by the use of AgNPs-based devices not only for their antimicrobial 
activity but also for the additional biological properties displayed by metal nanoparticles which improve the 
opportunity for wound healing by creating conditions that are unfavourable to micro-organisms and 
favourable for the host repair mechanisms.  One of the major contributors to delayed wound healing is a 
prolonged inflammatory response in the wound 94. Normally, the inflammatory response occurs immediately 
following wounding and it starts to induce phagocytosis and removal of bacteria and tissue debris. It also 
releases factors that cause the migration and division of cells involved in the proliferative phase and in the 
deposition of new tissues components. A prolonged inflammatory response, however, may result in the 
destruction of tissue by the same processes that normally have protective and restorative functions. 
Increasing evidence from in vivo and in vitro studies indicates that AgNPs promote wound healing thanks to 
their potent anti-inflammatory activity 95-98. This activity seems to be correlated to increased expression of 
anti-inflammatory molecular signals such as vascular endothelial growth factor (VEGF), IL-10 and to 
reduction of pro-inflammatory cytokines as IL-6 and interferon-γ. VEGF promote wound healing inducing 
vascular permeability and endothelial cell proliferation. IL-10 is a vital mediator of the anti-inflammatory 
cascade produced by keratinocytes as well as inflammatory cells involved in the healing process, including T 
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lymphocytes, macrophages, and B lymphocytes.  One of the unique actions of IL-10 is its ability to inhibit 
the synthesis of pro-inflammatory cytokines including IL-6. IL-6 is secreted by polymorphonuclear cells and 
fibroblasts and it has been recognized as an initiator of events in the physiological alterations of 
inflammation after thermal injury 99. It promotes inflammation through monocyte and macrophage 
chemotaxis and activation 100. Decreased levels of IL-6 may results in fewer neutrophils and macrophages 
recruited to the wound and less cytokines being released into the wound with, subsequently, a lower 
paracrine stimulation of cellular proliferation, fibroblast and keratinocyte migration, and extracellular matrix 
production. This lack of amplification of the inflammatory cytokine cascade may be important in providing a 
permissive environment for scarless wound repair to proceed. Moreover, silver-induced neutrophil apoptosis, 
decreased matrix metalloproteinases (MMPs) activity, and inhibition of free radicals formations (ROS/RNS) 
also contribute to the overall decrease in the inflammatory response and, as a consequence, an increased rate 
of wound healing97,101-104. MMPs are a group of proteinases including collagenases, elastase, and gelatinases 
that can be endogenous (cellular) or exogenous (bacterial) in origin and that have been shown to be present 
in chronic ulcers at abnormally high levels, as compared with acute wounds and may contribute to the 
chronicity of the wounds 105. MMPs function in the controlled degradation of the extracellular matrix to 
remove damaged components and to allow cell migration and angiogenesis to occur 106. However, it has been 
proposed that elevated activities of these enzymes may contribute to excessive matrix destruction and 
therefore to wound repair delay. In the biomedical field, market offer a large select of wound dressing 
containing silver in different chemical forms such as silver salts, silver oxides and metallic silver. With the 
advent of the nanotechnologies the interest has been focused primarily on silver salts, since, in comparison 
with silver ions and metallic silver, they exhibit both improved bactericidal and fungicidal effectiveness due 
to their nanoscale dimensions and good silver release kinetics because of their slight solubility. Table 1 
offers a list of type and composition of some commercially available silver-based dressing. All new 
commercial wound care products have typically a multilayer structure. From the top, they include an outer 
acrylic adhesive layer that protects wound from the external environment, a middle layer to absorb the 
exudates and finally a wound contact layer where are incorporated silver particles. The selection of suitable 
silver substrate depends upon many factors like designing of wound care product, type of wound, fabric 
strength, thickness etc. The substrate materials may include cotton, viscose, silk, polyamide fibers, hydrogels 
(alginate and agarose) and hydrophilic polyuretane foam.  
Silver formulation Product name Manufacturer 
SILCRYST Nanocrystalline 
(Patented Silver technology) 
Acticoat ® Smith&Nephew 
Nanocrystals of metallic silver Acticoat 7 ® Smith&Nephew 
Ionic silver Aquagel Ag ® Convatec 
Metallic silver Actisorb  Silver 220® Johnson&Johnson 
Silver particles Polymem Silver® Ferris Mfg. Corp. 
Ionic silver Suprasorb A+Ag® Activa Healthcare 
Silver sulphadiazine Urgotul SSD ® Urgo Medical 
 
Table 1: Commercially available silver-based dressings 
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3.3 SILVER NANOCOMPOSITES AND INFLAMMATION 
Besides the anti-inflammatory activity of AgNPs related to wound healing, numerous studies have suggested 
that nanocrystalline silver have a general anti-inflammatory effect, but its molecular and cellular mechanism 
of action have not been fully elucidated 107-111. On allergic contact dermatitis models, anti-inflammatory 
activity of topical nanocrystalline silver cream is comparable with the effects of topical steroids and currently 
available immunosuppressant 107-109,112. This study shows that nanocrystalline silver treatments uniquely 
decrease induced erythema and edema, increasing apoptosis in inflammatory cells, decreasing MMPs 
activity and inhibiting proinflammatory cytokine expression such as TNF-α, TGF-β, interleukin-12 and -8.  
The reduction of pro-inflammatory factors and MMPs activity is ascribed both to a specific inhibition of 
gene expression 108 and to the reduction of inflammatory cells via apoptosis 109. Programmed cell death, or 
apoptosis, occurs in various physiological and pathological conditions, and takes place through a 
characteristic mechanism of intercellular sequential reactions. During inflammation events, apoptosis 
contributes to the elimination of inflammatory cells from the inflamed area. When cells, like neutrophils and 
T-lymphocytes, die by apoptosis, they initially maintain plasma membrane integrity, and granulocytes lose 
the ability to secrete granular contents consisting of numerous cytotoxic and pro-inflammation factors 113,114. 
Apoptotic cells are recognized and phagocytised by neighbouring macrophages, further minimizing local 
inflammation and tissue injury114. In contrast, when inflammatory cells die by necrosis they burst and release 
numerous cytotoxic compounds, including proteases, oxygen radicals, and various acids, which further 
amplify local inflammation115-118. In this perspective, cell death by apoptosis represents an injury-limiting 
clearance mechanism and plays an important role in the resolution of local inflammation. Interestingly, anti-
inflammatory effects were observed only or mostly for silver nanoparticles and not for comparable 
concentrations of silver salts 102,109. Moreover, silver salts such as AgNO3 may even have an opposite effect, 
being pro-inflammatory with subsequent delay healing 119,120. The apparent discrepancy may be solved by the 
hypothesis proposed in a recent work by Nadworny et al. 109 who demonstrated that in porcine models of 
contact dermatitis, dressings containing nanostructured silver induce apoptotic processes in a discriminatory 
way toward dermal cells and did not target keratinocytes. Otherwise, apoptotic activity was induced 
indiscriminately by AgNO3-based dressings in all cell types at the tissue surface, including keratinocytes. 
The authors therefore assume that the anti-inflammatory activity displayed by nanocrystalline silver is not 
due to Ag+ form but it may be related to Ag0 form. This species may be anti-inflammatory such as other 
noble metals. For instance, colloidal gold is successfully used as rheumatoid arthritis treatment121,122. Various 
gold-containing compounds, used as anti-inflammatory agents in the treatment of rheumatoid arthritis, 
induce apoptosis in cells including T cells and macrophages through multiple mechanisms. Moreover Au0 
nanoparticles suppress the activity of IL-6 and TNF-α thus relieving rheumatoid arthritis symptoms 123,124. In 
vitro and in vivo studies indicate that in a biological environment, gold in its monovalent state (Au(I)) when 
not tightly bound to ligands, such as cyanide, a phosphine, or molecules containing sulphur(II), 
spontaneously dismutate to finely divided metallic gold (Au0) and auric (Au(III)) complexes. The crystal 
structures (face-centered cubic) and Pauling covalent raddii for silver and gold are equal; thus they conclude 
 27 
that silver and gold can replace each other in crystal lattices, suggesting that Au0 and Ag0 clusters should be 
physically identical, and therefore may have similar biological activity. 
 
3.4 SILVER NANOCOMPOSITES FOR APPLICATIONS IN BIOLOGICAL SENSING AND 
NANOSCALE PHOTONICS 
Metal nanocomposites are being studied also with respect to nanoparticle plasmonics, an emerging research 
field related to the optical properties of noble metal nanoparticles of various size, shape and structure. In 
particular, the scattering of plasmon-resonant nanoparticles and their colours in dark-filed microscopy allow 
for many applications in biomedical imaging. Depending on the type of nanoparticles and on nature of the 
stabilizing shell on their surface, plasmon resonant nanoparticles can emit bright resonance light scattering of 
various wavelengths125. These nanoparticles can be addressed to well defined biological targets by means of  
surface functionalization with proper molecular signals; selected biomacromolecules can be attached to the 
metal nanoparticles, used as optical labels, to target specific receptors. According to this rationale, noble 
metal nanoparticles, especially gold and silver are being studied for in vivo imaging applications in order to 
overcome the limitations associated with traditional fluorescence probes (photobleaching, autofluorescence 
of living cells, ect…).  
Among noble metal nanoparticles, AgNPs offer the highest quantum yield of Rayleigh scattering and for this 
reason colloidal silver can be efficiently used as optical probe for in vivo imaging in real time with sub-100 
nm spatial resolution and millisecond time resolution54. Schrand et al.126 demonstrated that low 
concentrations of AgNPs (<25 µg ml−1) bind to the plasma membranes of living cells, and intensely scattered 
light when imaged at submicron resolution with high illumination light microscopy, thereby demonstrating 
their potential use as biological labels. Lee et al.54 reported the use of silver colloids for the study of 
nanoparticles transport, biocompatibility, and toxicity in early development of zebrafish embryos in real time 
by means of dark-field single nanoparticle optical microscopy and spectroscopy. Huang et al.57 have 
developed functionalized silver nanoparticle biosensors to quantitatively measure the binding kinetics and 
affinity of single protein molecules on single living cells for an extended period of time (hours) using single-
nanoparticle optical microscopy and spectroscopy (Figure 22). These silver nanocomposites offer the 
possibility to monitor cascades of biochemical reactions in real time through a quantitative molecular 
imaging. 
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Figure 22. Left) Schematic illustration of preparation of single-nanoparticle biosensors to image and detect single T-ZZ 
molecules on single living cells. (A) Functionalizing AgNPs. (B) Covalently linking with immunoglobulin G. (C) 
Attaching T-ZZ onto living cells to detect single T-ZZ molecules on single living cells. Right) Imaging and sensing of 
single T-ZZ molecules on single living cells using single AgMMUA-IgG nanoparticle biosensors by SNOMS imaging 
system. The scale bar is 10 µm. From Huang et al. (2007), reproduced with permission.  
 
Hu et al.127  have developed biocompatible polyelectrolyte-coated AgNPs for targeted in vitro labelling of 
pancreatic cancer cells; these particles can be conjugated with monoclonal antibodies and proteins and act 
like plasmon enhanced scattering probes for dark-field multiplex and TEM imaging of pancreatic cancer 
cells. Nanoparticle optics can be also employed as a tool for real-time monitoring of the effect of antibiotics 
in living bacteria cells with millisecond temporal and nanometer-sized resolution; Kyriacou et al.128 studied 
the modes of action and the pharmacokinetics of antibiotics in P. aeruginosa treating bacteria with silver 
colloidal solutions and evaluating the membrane permeability and the disruption of the cell wall by means of 
optical darkfield microscopy and spectroscopy. Lesniak et al.58 synthesized fluorescent and biocompatible 
silver/ poly(amidoamine) dendrimers carrying various surface functionalities for applications as cell labelling 
agents as demonstrated by in vitro assays with four different cell lines. 
Aside of the bioimaging field, the strong plasmon resonance of silver nanoparticles can find other 
applications in the field of nanophotonics. A particular area of interest of silver nanocomposites constructs 
for biomedical purposes is in the field of Raman Spectroscopy, since a significant enhancement of the 
Raman signal can be achieved in the presence of plasmon resonant nanoparticles. This phenomenon called 
“Surface Enhanced Raman Scattering” (SERS) provides chemical information of molecules in the proximity 
of metal nanostructures. Since the enhancement factor can be as much as 1014-1015, this technique can be 
used for the detection of very diluted compounds or even single molecules129. The size and arrangement of 
the nanoparticles strongly affect the enhancement factor, thus the structural properties of the nanocomposite 
system determine its efficient use in SERS applications. Jia et al.130 developed a “green synthesis” 
preparation of silver nanocomposites based on the formation of AgNPs within a cuttlebone-derived organic 
matrix as a natural macroporous dispersing material. It was shown that the resulting nanocomposite films can 
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be successfully employed for trace analysis in SERS applications. Many efforts aim at developing effective 
ways to organize the nanoscale particles into functional structures and devices. In particular efficient routes 
for the fabrication of films characterized by a high density of nanoparticles with controllable spacing on solid 
substrates are sought; Lu et al.42 developed a silver nanocomposite film with temperature-controllable 
interparticle spacing for a tuneable SERS substrate. In such constructs, the scattering signal enhancement 
factor can be dynamically tuned by thermal activation; in fact, the spacing between nanoparticles can be 
controlled by adjusting the temperature in order to approach strongest coupling between adjacent particles 
and match the plasmon resonance wavelength to the laser excitation wavelength (Figure 23). This 
nanocomposite system can find applications in label-free biomolecular detections, environmental 
monitoring, and biological warfare agents sensing.  
  
                                           
 
 
Figure 23. Top: schematic illustration of a nanoparticle monolayer on a thermo-responsive polymer film. Bottom: SERS 
spectra of Rhodamine 6G on the nanocomposite film at different temperatures. From Lu et al. (2005), reproduced with 
permission. 
 
Biocompatible SERS substrates based on chitin (cicada wings) and silver were prepared by Stoddart et al.131 
who propose a molecular detection limit as low as nanomolar level.   
 
 
4.0 BIOLOGICAL HAZARDS OF SILVER NANOCOMPOSITES 
 
Nano-sized materials are currently being used in medicine, biotechnology, energy and environmental 
technology. Given the wide variety and growing number of applications on the market, there is a lack of 
studies and information regarding the effects of nano-sized materials (silver nanoparticles included) on 
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general human health and environment. At present silver-based products are widespread available on the 
market primarily as formulations for topical applications, both in the medical areas such as wound dressing 
and surgical instruments, coated or embedded with AgNPs, and in daily life where consumers have access to 
silver containing detergents and soaps, room sprays, water purificants, textiles, personal care products, 
handles and furniture for public places. Silver-based systems are also used in some food processing industry 
where pipelines are susceptible to biofilm formation. Besides, more recently AgNPs have been studied to be 
exploited for systemic applications and for the preparation of internal prosthesis and devices (e.g. bone 
cement, catheters). Hundreds of silver-based products are currently on the market, but there are not specific 
reporting requirements, risk assessments or official government indications for the commercialization of 
these kinds of products. The widespread use of AgNPs and silver ion-based products is partially justified by 
the fact that till few years ago and even nowadays, many researchers associated to ionic silver low toxicity in 
the human body and expected minimal risk with respect to clinical exposure by inhalation, ingestion, dermal 
application or through the urological or haematogenous routes. Silver is not known as a systemic toxic agent 
for humans, except at extreme doses. The most evident secondary effects derived by chronic ingestion or 
inhalation of silver preparations (especially colloidal silver) is the deposition of particles in the skin 
(argyria), eye (argyrosis) and other organs. These conditions are generally not considered life-threatening but 
simply cosmetically undesirable. Silver in form of ions is absorbed into the human body and enters the 
systemic circulation as a protein complex to be eliminated by the liver and kidneys with a metabolism 
modulated by induction and binding to metallothioneins. These protein complexes can mitigate the cellular 
toxicity of silver and contributes to tissue repair132. Literature does not report cases of people specifically 
harmed by the use or exposure AgNPs: this fact could be attributed to the lack of knowledge about what 
effects to expect.  A recent work by Larese et al., demonstrated the absorption of silver nanoparticles through 
intact and damaged skin, detecting the presence of nanoparticles in the stratum corneum and the outermost 
surface of the epidermis 133. In fact, in sharp contrast with the attention paid to new applications of silver 
nanocomposites, few studies provide insights (and only scant ones) into the possible interaction of AgNPs 
with the human body after entering via different routes, and not only through skin. Systemic distribution and 
translocation, organ accumulation, degradation, possible adverse effects and toxicity in human tissues start to 
be considered and open major questions associated with the increased medical use of silver nanocomposites. 
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An important and often disregarded aspect to be considered when studying the biological effect of silver 
nanocomposites is that nanoparticles show an impressive array of unusual physical-chemical properties that 
confer them higher and often unpredictable bioactivity when compared to the identical bulk materials. For 
instance, based upon size alone and not upon physical or chemical properties, nanomaterials have 
capabilities (normally attributed to micro-organisms like viruses) to penetrate circulatory system and to reach 
and to translocate in all living organs including the blood-brain barrier. In the last 5 years most of the in vitro 
studies regarding the exposure of cellular cell lines to silver nanoparticles have evidenced the presence of a 
potential cytotoxic mechanism that is strictly dependent on particle size and concentration. In spite of the 
limited number of cell lines tested, all experimental data agree that the mitochondria are the main 
intracellular target of silver nanoparticles. AgNPs mediate their toxicity through an oxidative stress with 
increase of ROS levels and following activation of the apoptotic mitochondrial pathway 134-138. This is a 
mechanism shared by all cell lines tested 139-145, in which apoptosis and apoptosis-like change of morphology 
occur when AgNPs are applied.  Ag NPs induce mitochondrial membrane perturbation, generation of ROS, 
depletion of antioxidant GSH and reduction of mitochondrial function in BRL 3A rat liver cells 143, rat 
alveolar macrophages 140 and  human THP-1 monocytic cells141. Furthermore, GSH depletion in human skin 
carcinoma and fibrosarcoma cell lines is associated to expression of apoptotic markers 146 and in human 
hepatoma cells HepG2 to the over expression of oxidative stress-related genes such us catalase and 
superoxide dismutase144.It is to note a report where four commercially available silver dressings were tested 
in terms of cytotoxicity towards keratinocyte HaCaT and fibroblast 142BR cells147; the results, as similarly 
observed by  Burd et al.148, showed that all tested dressings induce, albeit to a different degree, apoptotic cell 
death in a way dependent on the cell line and type of dressing investigated. 
Although the molecular mechanism  at the base of silver nanoparticles potential toxicity is yet to be 
completely elucidated, a work by Hsin et al.142 shed partially light on it. The mitochondria-dependent 
apoptotic mechanisms identified in eukaryotic cells constitute an intrinsic and an extrinsic pathway 
characterized by the activation of pro-apoptotic proteins such as Bid, Bad, Bak and the inactivation of anti-
apoptotic proteins as Bcl-2 e Bcl-Xl. Activation of Bad and Bak results in their traslocation and 
oligomerization on mitochondria membrane, to form ion channels allowing exit of cytochome C and other 
apoptotic factors. The tumour suppressor protein p53 is able to exert a pro-apoptotic effect both by direct 
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transcriptional activation of pro-apoptotic genes as BAK and inhibition of expression of anti-apoptotic 
protein as Bcl-2 and Bcl-X and by direct binding to pro-apoptotic (Bax and Bak) and anti-apoptotic protein 
effectors  (Bcl-2 , BcXL) 149,150,150,151. In NIH-3T3 (mouse fibroblast) cells, pro-apoptotic internalized AgNPs 
induce intracellular ROS generation leading to the activation of JNK and p53 genes, and subsequently, to 
Bax translocation, cytochrome c release and PARP cleavage. Moreover, the elevated expression of the anti-
apoptotic Bcl-2 protein induced in HCT116 (human colon cancer) cells, apparently shields these cells from 
silver-mediated apoptosis. In the same way, a study152 comparing the biological effects of uncoated and 
polysaccharide-coated AgNPs in mouse embryonic stem cells (mES) and in embryonic fibroblast (MEF) has 
shown p53 upregulation in both cell lines and p53 phosphorylation in mES cells.  By the experimental data 
so far collected by the researches till now, the prevailing hypothesis is that AgNPs interact with thiol groups 
of proteins and enzymes after passing through eukaryotic cell membrane. Most of those proteins can be 
involved in the antioxidant defense mechanism, like reduced glutathione, catalase, superoxide dismutase, 
that prevent tissue damage under normal conditions neutralizing ROS produced by the aerobic energy 
metabolism 153,154. Over accumulation of ROS, an inflammatory response is induced and irreversible 
mitochondrial membrane damage and pemeabilization occurs, with following release of cytochrome C and 
of others apoptogenic factors 155.  Besides mitochondrial pathway activation, cell membrane destruction and 
lipoperoxidation can also take place and they represent another aspect of AgNPs toxicity (Figure 24).  
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Figure 24: Cytotoxic effect of silver nanoparticles on eukaryote cells  
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Silver nanoparticles can be internalized through the membrane by different mechanisms that include passive 
diffusion, receptor-mediated endocytosis and clathrin- or caveolae-mediated endocytosis140,144,152,156     
(Figure 25).  
 
Figure 25: TEM images of ultrathin sections of cells. Untreated cells showed no abnormalities (A), whereas cells treated 
with Ag-NP showed large endosomes near the cell membrane with many nanoparticlesinside (B). Electron micrographs 
showing lysosomes with nanoparticles inside (thick arrows) and scattered in cytoplasm (open arrow). Diamond arrow 
shows the presence of the nanoparticle in the nucleus (C). Magnified images of nanogroups showed that the cluster is 
composed of individual nanoparticles rather than clumps (D). Image shows endosomes in cytosol that are lodged in the 
nuclear membrane invaginations (E) and the presence of nanoparticles in mitochondria and on the nuclear membrane 
(F). From AshaRani 2009, reproduced with permission. 
 
The mechanism of action of AgNPs described above seems to be shared by silver ions157, and supports the 
hypothesis that part of the toxic potentiality of silver nanoparticles is due to the Ag+ release from them.  
The literature survey clearly shows that over the last years studies were mainly focused to asses the adverse 
biological affects of AgNPs by administering them at dose and concentrations that lead to cell death or 
irreversible cellular damage. These studies fail to consider concentrations of nanoparticles that may not result 
in cellular death but may cause sub-lethal cellular alterations leading to serious consequences on human 
health. The most important examples are DNA damage and induction of inflammation processes. Mutation 
of DNA, induced by genotoxic materials, leads to carcinogenesis and has a deep impact on the biology of 
reproductive cells. As recently reviewed by Singh et al.145, metal nanoparticles can generate DNA damage 
indirectly, by inducing oxidative stress and inflammation responses.  ROS, whose increase is associated to an 
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oxidative stress and subsequence redox imbalance, react with many biological macromolecules, including 
DNA, enzymes and lipids; in particular, they cause oxidative damage on DNA in the form of breads of single 
and double-strands, purine, pyrimidine and deoxyribose modifications, abasic sites  and  DNA-DNA 
coupling158. At the same time, if small enough, nanoparticles can gain direct access to the nucleus either 
though passive diffusion or transport across the nuclear pore complexes.  Within this site they can trigger 
aggregation of nuclear proteins with subsequent inhibition of transcription, replication and cell proliferation 
159-162
. Although there is a substantial experimental evidence on the genotoxic potential of many metal-based 
nanomaterials, the data accumulated on silver NPs point only very marginally on their genotoxicity. The 
detection of γ-H2AX phosphorylation, which is indicative of DNA double strand break, was described in 
HepG2 cells treated with 2 µg/ml of AgNPs144, and  mouse embryonic stem and fibroblast cells exhibit a 
severe DNA damage response suggested by increased expression of Rad51,  a key double strand break repair 
protein and phosphorilation at serine 139 of histone H2AX152. An initial screen of nanomaterials toxicity 
must be always accomplished using in vitro studies, but they must be always supported by in vivo test, since 
the in vitro-in vivo gap is associated with the complexity of biological interactions in a higher order organism 
that are not reproducible by an in vitro system. In vivo tests require animal models to evaluate markers of 
inflammation, oxidant stress, and cell proliferation in portal-of-entry and selected remote organs and tissues, 
deposition, translocation of the materials and its degradation products, toxicokinetics and biopersistence 
studies, effects of multiple exposures and finally potential effects on the reproductive system, placenta, and 
fetus. In the field of silver nanocomposite materials the scarcity of toxicity data obtained on cellular models 
goes in parallel with the almost lack of exhaustive studies performed using in vivo models. In Zebrafish 
embryos, AgNPs in a concentration range between 250 and 0,25 µM cause toxic lethal and sub-lethal 
(morphological malformations) effects albeit in a size-dependent manner for some concentrations and time 
points163. Silver nanoparticles administrated via intra-peritoneal injection in adult mice are able to traslocate 
to the circulatory system and reach the brain were they generate neurotoxicity by inducing free-radical 
oxidative stress and by altering gene expression and by producing apoptosis164. A study performed to 
compare the effects on liver caused on mice fed with nano- and micro-sized silver particles, revealed in both 
cases induction of liver inflammation156. Micro- and nano-silver particles implanted into rat's back muscle 
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reveal a good biological effect on days 7 and 14 but an inflammation process at day 30, more serious in 
AgNPs-treated rats than in the micro-silver treated ones165. 
All the studies are acute toxicity tests and no information was obtained from more informative chronic tests.  
An increasing number of papers take into consideration the development and characterization of materials 
based on silver nanocomposites and their interaction with eukaryotic systems. As examples, Fu et al.16  
describe the realization of antibacterial multilayer films containing AgNPs via layer-by-layer assembly of 
heparin and chitosan, lacking of toxic effects on osteoblasts. Nanocomposite materials based on acrylic 
resins and Ag NPs stimulate fibroblast and osteoblast aggregation and growth without displaying any toxic 
effect166,167, and stainless steel orthopaedic materials already commonly used in the biomedical field, when 
coated with silver, efficiently sustain the growth of osteoblasts and do not show genotoxicity168. Recently, 
Travan et al.27 used silver nanoparticles formed and stabilized by a bioactive chitosan-derived to develop 
alginate-based hydrogel structures that display antimicrobial properties, but not cytotoxicity on different 
eukaryotic cell lines. The same nanocomposite systems based on chitosan- derived and on silver 
nanoparticles has been exploited to realize a non-cytotoxic coating for acrylic resins (manuscript in 
preparation by the authors). 
However, beside to the potential toxicity of silver when topically or systematically administrated, a general 
concern must be also considered on the hazardous effects of nanoparticles accumulation in the environment. 
As the scientific literature often points out, there is a great lack of knowledge about AgNPs impact on human 
health but even less is what we know about its environmental pathways and its environmental effects. At 
present, silver is classified by EPA (US  Environmental Protection Agency) as an environmental hazard 
because in some circumstances it is toxic, persistent, and bio-accumulative. Nanotechnology is not well 
researched or regulated, so the environmental impact and risks of silver nanoparticles is not known. 
Nanoparticles can accumulate in air and soil but primarily in water where many substances have their most 
significant effects since in this environment materials can be more easily degraded, transformed and 
accumulated in a number of ways. When silver is present in a bioavailable chemical form 169,170 it is more 
toxic to aquatic organism than any other metal except mercury171, but no comparable information are 
available for AgNPs. The environmental hazard of silver can be mitigated by its complexation with other 
compounds especially sulfide that reduce their bioavaibility. Nitrification inhibition by silver nanoparticles 
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was demonstrated in nitrifying bacteria isolated from wastewater treatment plants. Moreover, the results 
suggest that AgNPs have the same behaviour of surface complexation as silver ions, and inhibition by 
nanosilver in wastewater treatment may be removed by reaction of AgNPs with soluble sulfide species87,172. 
Exposure of bacteria, algae, invertebrates and fishes to AgNPs proved that organism models of various 
trophic levels and feeding strategies (zebrafish, daphnis and algal species) show differential susceptibility to 
AgNPs, with filter-feeding invertebrates being markedly more susceptible compared with larger organism 
(i.e. zebrafish)173.  Although the scientific community is in agreement to retain that the paucity of data 
renders it premature to formulate any definite risk assessment about silver-based materials, an increasing 
public debate is emerging, and very contradictory opinions and experimental evidences about the potential 
impact of these nanomaterials on health 174,175are often presented. A central point is that silver 
nanocomposites should not be considered as a uniform group of materials. The toxicity of nanocomposite 
materials may be influenced by particle concentration, size distribution, agglomeration state, shape, chemical 
and physical nature of the matrix, physical status of the composite and finally site and time of exposure. The 
ultimate and main goal in the field of silver nanotechnology remains still the development and choice of 
products with a superior profile of functionality e.g., high infection control, associated to reduced host cell 
cytotoxicity and a moderate environmental risk to fully exploit the potential benefits and limit the 
unnecessary risks of this technology. In general, the rapid proliferation of many different engineered 
nanomaterials presents at a moment a dilemma to regulators regarding hazard identification. The 
International Life Sciences Institute Research Foundation/Risk Science Institute 176 convened an expert 
working group to develop a screening strategy for the hazard identification of engineered nanomaterials. 
Based on the evaluation of the limited data currently available, the report presents only a broad data 
gathering strategy applicable to this very early stage in the development of a risk assessment process for 
nanomaterials. Oral and dermal inhalation as well as injection routes of exposure must be considered 
recognizing that, depending on use patterns,  exposure to nanomaterials may occur by any of these routes. In 
particular, three key elements of the toxicity screening strategy have been identified: 1) Physicochemical 
Characteristics, 2) In Vitro Assays (cellular and non-cellular), 3) In Vivo Assays. It is common opinion that 
in the next future every new nanomaterial entering the market will need to be screened for toxicity and 
biopersistence, using low-cost, fast-throughput but scientifically rigorous and standardized tests.  
 37 
5.0 PERSPECTIVES 
 
Novel potential applications of silver nanocomposites are continuously sought in particular in the biomedical 
field. Metal nanoparticles-based systems are being considered as a means of minimally invasive diagnostics 
for early detection of diseases, to facilitate targeted drug delivery and to enhance the effectiveness of selected 
therapies177,178. More specifically, by combining the scattering brightness and biocompatibility of silver 
nanocomposites, these systems could be employed as a new generation of contrast agents for early diagnosis 
of human cancer127.  
Liong et al.179 have recently been studying multifunctional silica nanoparticles that incorporate iron oxide, 
gold or silver for applications in drug delivery, magnetic resonance and fluorescence imaging, magnetic 
manipulation, and cell targeting. These versatile multifunctional nanoparticles could potentially be used for 
simultaneous imaging and therapeutic towards cancer cells. 
In a different approach, Balogh et al.180 synthesized, by reactive encapsulation, fluorescent 
poly(amidoamine) dendrimer/silver nanocomposite particles for labeling and selective destruction of cancer 
cells. To explore biochemical targeting, B16 melanoma cancer cells and KB cells were incubated with the 
nanocomposite  particles; subsequently a laser-induced optical breakdown was able to selectively destroy 
targeted cells, without affecting viability of others. With this technique a range of effects can be monitored 
by simultaneous real-time acoustic and optical microscopy. Huang et al.57 suggested the use single-
nanoparticle biosensors to quantitatively analyze single ligand and single receptor molecules on single living 
cells for effective characterization of anticancer vaccines and for a deeper understanding of their biological 
functions. 
The tailorability of the Ag nanoparticles through surface engineering allows for a great variety of in vivo 
applications126; therefore, taking advantage of the various desirable properties of AgNPs while protecting the 
body from harmful side effects is a worthwhile long-term goal. The surface modification of silver 
nanoparticles appears to be one of the key factors in order to design nanocomposites that can fulfil these 
expectations. 
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